Dolby Laboratories (DLB) 10-K 17 Nov 22 2022 FY Annual report Financial data

Cover

Cover - USD ($) $ in Billions	12 Months Ended
	Sep. 30, 2022	Oct. 28, 2022	Apr. 01, 2022
Entity Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-32431
Entity Registrant Name	DOLBY LABORATORIES, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	90-0199783
Entity Address, Address Line One	1275 Market Street
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94103-1410
City Area Code	415
Local Phone Number	558-0200
Title of 12(b) Security	Class A common stock, $0.001 par value
Trading Symbol	DLB
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
ICFR Auditor Attestation Flag	true
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Public Float			$ 4.6
Documents Incorporated by Reference	DOCUMENTS INCORPORATED BY REFERENCE Portions of the registrant’s Definitive Proxy Statement to be filed with the Commission pursuant to Regulation 14A in connection with the registrant’s 2023 Annual Meeting of Stockholders, to be filed subsequent to the date hereof, are incorporated by reference into Part III of this Report. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission not later than 120 days after the conclusion of the registrant’s fiscal year ended September 30, 2022. Except with respect to information specifically incorporated by reference in this Form 10-K, the Definitive Proxy Statement is not deemed to be filed as part of this Form 10-K.
Entity Central Index Key	0001308547
Current Fiscal Year End Date	--09-30
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false
Class A Common Stock [Member]
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		59,871,783
Common Class B [Member]
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		36,085,779

Audit Information

Audit Information	12 Months Ended
	Sep. 30, 2022
Audit Information [Abstract]
Auditor Firm ID	185
Auditor Name	KPMG LLP
Auditor Location	San Francisco, California

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Current assets:
Cash and cash equivalents	$ 620,127	$ 1,225,380
Restricted cash	8,244	7,652
Short-term investments	189,213	38,839
Accounts receivable, net of allowance for credit losses of $11,834 and $8,744	243,593	232,609
Contract with Customer, Asset, after Allowance for Credit Loss, Current	176,093	182,316
Inventories	23,549	10,965
Prepaid expenses and other current assets	50,075	62,737
Total current assets	1,310,894	1,760,498
Long-term investments	102,514	62,819
Property, plant and equipment, net	513,481	534,381
Operating lease right-of-use assets	46,530	67,128
Intangible assets, net	112,265	122,890
Goodwill	365,147	340,694
Deferred taxes	183,568	156,020
Other non-current assets	55,149	61,257
Total assets	2,689,548	3,105,687
Current liabilities:
Accounts payable	14,171	17,779
Accrued liabilities	230,237	262,728
Income taxes payable	1,265	1,334
Contract liabilities	18,588	18,473
Operating lease liabilities	13,257	15,403
Total current liabilities	277,518	315,717
Non-current contract liabilities	23,203	23,713
Non-current operating lease liabilities	37,685	56,715
Other non-current liabilities	100,122	105,310
Total liabilities	438,528	501,455
Stockholders' equity:
Retained earnings	2,297,730	2,607,909
Accumulated other comprehensive income	(51,641)	(10,030)
Total stockholders’ equity – Dolby Laboratories, Inc.	2,246,183	2,597,979
Controlling interest	4,837	6,253
Total stockholders’ equity	2,251,020	2,604,232
Total liabilities and stockholders’ equity	2,689,548	3,105,687
Class A Common Stock [Member]
Stockholders' equity:
Common stock	53	59
Class B Common Stock [Member]
Stockholders' equity:
Common stock	$ 41	$ 41

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) $ in Thousands	Sep. 30, 2022 USD ($) vote $ / shares shares	Sep. 24, 2021 USD ($) vote $ / shares shares
Allowance for doubtful accounts | $	$ 11,834	$ 8,744
Contract with customer, asset, allowance for credit loss | $	$ 125	$ 208
Class A Common Stock [Member]
Common stock, par value (usd per share) | $ / shares	$ 0.001	$ 0.001
Common stock voting right per share (votes per share) | vote	1	1
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	59,798,862	64,986,316
Common Stock, Shares, Outstanding	59,798,862	64,986,316
Class B Common Stock [Member]
Common stock, par value (usd per share) | $ / shares	$ 0.001	$ 0.001
Common stock voting right per share (votes per share) | vote	10	10
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	36,085,779	36,086,779
Common Stock, Shares, Outstanding	36,085,779	36,086,779

Consolidated Statements Of Oper

Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Revenue:
Revenue	$ 1,253,793	$ 1,281,256	$ 1,161,792
Cost of revenue:
Total cost of revenue	141,360	130,025	146,498
Gross margin	1,112,433	1,151,231	1,015,294
Operating expenses:
Research and development	261,174	253,640	239,045
Sales and marketing	358,716	332,671	335,933
General and administrative	275,315	224,161	219,753
Gain on sale of assets	0	(13,871)	0
Restructuring charges	(10,623)	(10,240)	(1,821)
Total operating expenses	905,828	806,841	796,552
Operating income	206,605	344,390	218,742
Other income/expense:
Interest income	6,568	3,493	12,725
Interest expense	(394)	(479)	(186)
Other income/(expense), net	2,500	7,108	8,434
Total other income	8,674	10,122	20,973
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	215,279	354,512	239,715
Provision for income taxes	(31,381)	(36,689)	(8,096)
Net income including controlling interest	183,898	317,823	231,619
Less: net (income) attributable to controlling interest	189	(7,596)	(256)
Net income attributable to Dolby Laboratories, Inc.	$ 184,087	$ 310,227	$ 231,363
Net Income Per Share:
Basic (usd per share)	$ 1.84	$ 3.07	$ 2.30
Diluted (usd per share)	$ 1.81	$ 2.97	$ 2.25
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Basic (shares)	99,990	101,190	100,564
Diluted (shares)	101,983	104,622	102,944
Cash dividend declared per common share	$ 1.02	$ 0.91	$ 0.88
Cash dividend paid per common share	$ 1	$ 0.88	$ 0.88
Licensing
Revenue:
Revenue	$ 1,164,533	$ 1,214,147	$ 1,078,577
Cost of revenue:
Cost of revenue	61,597	55,421	50,822
Products and services
Revenue:
Revenue	89,260	67,109	83,215
Cost of revenue:
Cost of revenue	$ 79,763	$ 74,604	$ 95,676

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income Statement - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Statement of Comprehensive Income [Abstract]
Net income including controlling interest	$ 183,898	$ 317,823	$ 231,619
Other comprehensive income/(loss):
Currency translation adjustments, net of tax	(31,586)	5,510	7,552
Unrealized gains/(losses) on investments, net of tax	(6,206)	(598)	(1,380)
Unrealized gains on cash flow hedges, net of tax	(4,361)	(4,091)	3,969
Other Comprehensive Income (Loss), Net of Tax	(42,153)	821	10,141
Comprehensive income	141,745	318,644	241,760
Less: comprehensive (income) attributable to controlling interest	731	(7,853)	(366)
Comprehensive income attributable to Dolby Laboratories, Inc.	$ 142,476	$ 310,791	$ 241,394

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income Statement (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Statement of Comprehensive Income [Abstract]
Currency translation tax	$ (245)	$ (501)	$ 22
Unrealized gains/(losses) on investments,tax	50	108	(926)
Unrealized gains on cash flow hedges, tax	$ 324	$ (419)	$ (407)

Consolidated Statements Of Stoc

Consolidated Statements Of Stockholders' Equity - USD ($) $ in Thousands	Total	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income [Member]	Total Dolby Laboratories,Inc.[Member]	Controlling Interest [Member]	Common Class A [Member] Common Stock [Member]	Common Class B [Member] Common Stock [Member]
Beginning balance, shares at Sep. 27, 2019							63,911,000	36,230,000
Beginning balance, value at Sep. 27, 2019	$ 2,313,030	$ 0	$ 2,327,877	$ (20,625)	$ 2,307,351	$ 5,679	$ 58	$ 41
Net income	231,619		231,363		231,363	256
Other comprehensive income, net of tax	10,141			10,031	10,031	110
Distributions to controlling interest	(283)					(283)
Stock-based compensation expense	86,628	86,628			86,628
Repurchase of common stock, shares							(2,564,000)
Repurchase of common stock, value	(173,742)	(146,218)	(27,521)		(173,742)		$ (3)
Cash dividends declared and paid on common stock	(88,581)		(88,581)		(88,581)
Class A common stock issued under employee stock plans, shares							3,063,000
Class A common stock issued under employee stock plans, value	82,658	82,655			82,658		$ 3
Shares repurchased for tax witholdings on vesting of restricted stock, shares							343,000
Shares repurchased for tax witholdings on vesting of restricted stock, value	(23,065)	(23,065)			(23,065)
Transfer of Class B common stock to Class A common stock, shares							(101,000)	101,000
Ending balance, shares at Sep. 25, 2020							64,168,000	36,129,000
Ending balance, value at Sep. 25, 2020	2,438,405	0	2,443,138	(10,594)	2,432,643	5,762	$ 58	$ 41
Net income	317,823		310,227		310,227	7,596
Other comprehensive income, net of tax	821			564	564	257
Distributions to controlling interest	(7,362)					(7,362)
Stock-based compensation expense	99,698	99,698			99,698
Repurchase of common stock, shares							(2,584,000)
Repurchase of common stock, value	(245,864)	(189,577)	(56,284)		(245,864)		$ (3)
Cash dividends declared and paid on common stock	(89,172)		(89,172)		(89,172)
Class A common stock issued under employee stock plans, shares							3,714,000
Class A common stock issued under employee stock plans, value	122,088	122,084			122,088		$ 4
Shares repurchased for tax witholdings on vesting of restricted stock, shares							354,000
Shares repurchased for tax witholdings on vesting of restricted stock, value	(32,205)	(32,205)			(32,205)
Transfer of Class B common stock to Class A common stock, shares							(42,000)	42,000
Ending balance, shares at Sep. 24, 2021							64,986,000	36,087,000
Ending balance, value at Sep. 24, 2021	2,604,232	0	2,607,909	(10,030)	2,597,979	6,253	$ 59	$ 41
Net income	183,898		184,087		184,087	(189)
Other comprehensive income, net of tax	(42,153)			(41,611)	(41,611)	(542)
Distributions to controlling interest	(1,435)					(1,435)
Stock-based compensation expense	114,925	114,925			114,925
Capitalized stock-based compensation expense	$ 746	746			746
Repurchase of common stock, shares	(7,002,550)						(7,003,000)
Repurchase of common stock, value	$ (530,486)	(137,100)	(393,379)		(530,486)		$ (7)
Cash dividends declared and paid on common stock	(100,067)		(100,067)		(100,067)
Class A common stock issued under employee stock plans, shares							2,224,000
Class A common stock issued under employee stock plans, value	57,848	57,846			57,848		$ 2
Shares repurchased for tax witholdings on vesting of restricted stock, shares							409,000
Shares repurchased for tax witholdings on vesting of restricted stock, value	(36,418)	(36,417)			(36,418)
Transfer of Class B common stock to Class A common stock, shares							(1,000)	1,000
Deconsolidation of subsidiary	(70)		(820)		(820)	750
Ending balance, shares at Sep. 30, 2022							59,799,000	36,086,000
Ending balance, value at Sep. 30, 2022	$ 2,251,020	$ 0	$ 2,297,730	$ (51,641)	$ 2,246,183	$ 4,837	$ 53	$ 41

Consolidated Statements Of St_2

Consolidated Statements Of Stockholders' Equity And Comprehensive Income (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Statement of Stockholders' Equity [Abstract]
Currency translation tax	$ (245)	$ (501)	$ 22
Unrealized gains/(losses) on investments,tax	$ 50	$ 108	$ (926)

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Operating activities:
Net income including controlling interest	$ 183,898	$ 317,823	$ 231,619
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	88,461	95,860	90,878
Stock-based compensation	114,925	99,698	86,628
Amortization of operating lease right-of-use assets	15,148	16,897	21,006
Amortization of premium on investments	1,440	1,373	800
Provision for doubtful accounts	5,460	(2,889)	7,689
Deferred income taxes	(29,465)	(37,048)	(5,274)
Gain on sale of assets	0	(13,871)	0
Other non-cash items affecting net income	(5,037)	(5,452)	10,920
Changes in operating assets and liabilities:
Accounts receivable	(14,314)	(49,034)	1,251
Contract assets, net	6,300	(21,154)	34,297
Inventories	(11,759)	17,154	(11,784)
Operating lease right-of-use assets	266	(5,199)	(34,522)
Prepaid expenses and other assets	8,760	17,165	(5,680)
Accounts payable and other liabilities	(33,542)	44,230	(43,545)
Income taxes, net	8,446	(2,975)	(50,586)
Contract liabilities	(413)	2,361	(4,621)
Operating lease liabilities	(15,399)	(11,369)	15,618
Other non-current liabilities	(4,599)	(15,817)	(845)
Net cash provided by operating activities	318,576	447,753	343,849
Investing activities:
Purchases of marketable securities	(311,313)	(67,101)	(287,777)
Proceeds from sales of marketable securities	9,459	10,892	244,517
Proceeds from maturities of available-for-sale securities	108,546	53,893	246,621
Purchases of property, plant and equipment	(47,928)	(54,454)	(66,347)
Proceeds from sale of assets	0	16,365	0
Acquisitions, net of cash acquired	(38,171)	(4,500)	0
Purchases of intangible assets	(11,528)	0	(2,640)
Purchases of other investments	(5,000)	0	0
Net cash provided by/(used in) investing activities	(295,935)	(44,905)	134,374
Financing activities:
Proceeds from issuance of common stock	57,848	122,088	82,658
Repurchase of common stock	(530,486)	(245,864)	(173,742)
Payment of cash dividend	(100,067)	(89,172)	(88,581)
Distribution to controlling interest	(1,435)	(7,362)	(283)
Shares repurchased for tax withholdings on vesting of restricted stock	(36,418)	(32,205)	(23,065)
Payment related to prior purchases of intangible assets	0	0	(91)
Payments for Deferred Consideration	0	0	4,671
Net cash used in financing activities	(610,558)	(252,515)	(207,775)
Effect of foreign exchange rate changes on cash and cash equivalents	(16,744)	2,720	3,938
Net increase/(decrease) in cash, cash equivalents, and restricted cash	(604,661)	153,053	274,386
Cash, cash equivalents, and restricted cash at beginning of period	1,233,032	1,079,979	805,593
Cash, cash equivalents, and restricted cash at end of period	628,371	1,233,032	1,079,979
Supplemental disclosure:
Cash paid for income taxes, net of refunds received	40,340	70,737	52,869
Non-cash investing activities:
Change in property, plant, and equipment purchased, unpaid at period-end	(1,481)	2,772	(3,417)
Purchase consideration payable for acquisition	0	500	0
Purchase consideration payable for intangible assets	$ 0	$ 30	$ 260

Consolidated Statements Of Op_2

Consolidated Statements Of Operations (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Revenue from contract with customer	$ 1,253,793	$ 1,281,256	$ 1,161,792
Operating Expense
Related party rent expense	0	(392)	126
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Included in net income attributable to controlling interest	$ 284	$ 381	$ 455

Basis Of Presentation

Basis Of Presentation	12 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	. Basis of Presentation Principles of Consolidation The consolidated financial statements include the accounts of Dolby Laboratories, Inc. and our wholly owned subsidiaries. In addition, we have consolidated the financial results of jointly owned affiliated companies in which our principal stockholder has a controlling interest. We report these controlling interests as a separate line in our consolidated statements of operations as net income attributable to controlling interest and in our consolidated balance sheets as a controlling interest. We eliminate all intercompany accounts and transactions upon consolidation. Use of Estimates The preparation of our financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported and disclosed in our consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include estimated shipments by our licensees for which we are owed a sales-based royalty. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Our estimates of royalty-based revenue also take into consideration the macroeconomic effect of global events that may impact our licensees' supply chain activities as well as demand for shipments. Additional significant items subject to such estimates and assumptions include ESPs for performance obligations within revenue arrangements; allowance for credit losses for accounts receivable; carrying values of inventories and certain PP&E, goodwill and intangible assets; fair values of investments; accrued liabilities including unrecognized tax benefits, deferred income tax assets and liabilities, and contingent liabilities: and stock-based compensation. Actual results could differ from our estimates. Fiscal Year

Summary Of Significant Accounti

Summary Of Significant Accounting Policies	12 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	. Summary of Significant Accounting Policies Concentration of Credit Risk Our financial instruments that are exposed to concentrations of credit risk principally consist of cash, cash equivalents, investments, and accounts receivable. Our investment portfolio consists of investment grade securities diversified amongst security types, industries, and issuers. All our securities are held in custody by a recognized financial institution. Our policy limits the amount of credit exposure to a maximum of 5% to any one issuer, except for the U.S. Treasury, and we believe no significant concentration risk exists with respect to these investments. We also mitigate counterparty risk through entering into derivative contracts with high-credit-quality financial institutions. The majority of our licensing revenue is generated from customers outside of the U.S. We manage this risk by performing regular evaluations of the creditworthiness of our licensing customers. In fiscal 2022, revenue from one individual customer accounted for 10% of our total revenue. For fiscal 2021 and 2020, we did not have any individual customers whose revenue exceeded 10% of our total revenue. Cash and Cash Equivalents We consider all short-term highly liquid investments with original maturities of 90 days or less from the date of purchase to be cash equivalents. Cash and cash equivalents primarily consist of funds held in general checking accounts, money market accounts, and U.S. agency securities. Restricted Cash Restricted cash on our consolidated balance sheets consists of cash contributed by Dolby and third-party licensors to Via, our wholly-owned subsidiary, that may only be used for licensor enforcement actions or licensee compliance activities related to certain Via-administered patent pools, as well as to disperse costs associated with any audit of Via for the Wideband Code Division Multiple Access (W-CDMA) patent pool. Investments All of our investments are classified as AFS, with the exception of our mutual fund investments held in our SERP, which are classified as trading securities, and our equity securities. Investments that have an original maturity of 91 days or more at the date of purchase and a current maturity of less than one year are classified as short-term investments, while investments with a current maturity of more than one year are classified as long-term investments. Our AFS securities and trading securities are recorded at fair value in our consolidated balance sheets. Unrealized gains and losses on our AFS securities are reported as a component of AOCI, while realized gains and losses and credit losses are reported as a component of net income. Upon sale, gains and losses are reclassified from AOCI into earnings, and are determined based on specific identification of securities sold. We evaluate our investment portfolio for impairment by comparing the fair value with the cost basis for each of our investment securities. If the fair value of our AFS securities is less than amortized cost, such securities are considered impaired. If we have the intent to sell the debt security, or if it is more likely than not that we will be required to sell the debt security before recovery of its amortized cost, the difference between the amortized cost (net of allowance, if any) and the fair value of the securities is reported as an impairment loss in net income. Impaired AFS securities that we intend to hold are evaluated to determine whether we need to recognize an allowance for credit losses, limited to the difference between the fair value and amortized cost of the security. Equity Securities Equity securities for which we possess the ability to exercise significant influence, but not control, over operating and financing decisions are accounted for under the equity method. In applying the equity method, we record the investment at cost and subsequently increase or decrease the carrying amount by our proportionate share of the investee's net earnings or losses. We record dividends or other equity distributions as reductions in the carrying value of the investment. Our share of the equity method investee's net income or loss is included in other income/(expense), net in the consolidated statements of operations, and was $5.0 million, $4.7 million, and $2.4 million in fiscal 2022, fiscal 2021, and fiscal 2020, respectively. Our equity method investment is included within long-term investments in our consolidated balance sheets. We also hold an investment in an equity security of a privately-held company without a readily determinable fair value. We elected to account for this investment using the measurement alternative, which is cost, less any impairment, adjusted for changes in fair value resulting from observable transactions for identical or similar investments of the same issuer. We perform a qualitative assessment at each reporting date to determine whether there are triggering events for impairment. This equity security is included within long-term investments in our consolidated balance sheets. Allowance for Credit Losses We maintain a provision for estimated credit losses on receivables resulting from our customers' inability to make required payments. In determining the provision, we pool receivables with similar risk characteristics to evaluate the collectability of our receivables. Risk characteristics considered in creating these risk pools include assessing historical or expected loss patterns, credit ratings, current macroeconomic conditions that could impact collectability of cash flows, and structure of customer agreements. In cases where circumstances have changed such that specific customers no longer share similar risk characteristics, customers are excluded from their current pool and their risk profiles are evaluated separately. We recognize allowances for credit losses based on our actual historical loss information, the current business environment, and reasonable and supportable forecasts. Actual future losses from uncollectible accounts may differ from our estimates. Inventories Inventories are accounted for using the first-in, first-out method, and are valued at the lower of cost and net realizable value. We evaluate our ending inventories for estimated excess quantities and obsolescence. Our evaluation includes the analysis of future sales demand by product within specific time horizons. Inventories in excess of projected future demand are written down to their net realizable value. In addition, we assess the impact of changing technology on our inventory balances and write-off inventories that are considered obsolete. Write-downs and write-offs of inventory are recorded as a cost of products in our consolidated statements of operations. We classify inventory that we do not expect to sell within twelve months as other non-current assets in our consolidated balance sheets. Property, Plant, and Equipment PP&E is stated at cost less accumulated depreciation. Depreciation expense is recognized on a straight-line basis according to estimated useful lives assigned to each of our different categories of PP&E as summarized within the following table: PP&E Category Useful Life Computer equipment and software 3 to 5 years Machinery and equipment 3 to 8 years Furniture and fixtures 5 to 8 years Leasehold improvements Lesser of useful life or related lease term Equipment provided under operating leases 15 years Buildings and building improvements 20 to 40 years We may encounter scenarios where assets we acquire may deviate from the established standard useful life provided above. Such occurrences are evaluated on a case by case basis, and are assigned a useful life commensurate with the facts and circumstances associated with the specific PP&E being acquired. We capitalize certain costs incurred during the construction phase of a project or asset into construction-in-progress until the construction process is complete. Once the related asset is placed into service, we transfer its carrying value into the appropriate fixed asset category and begin depreciating the value over its useful life. Equipment Provided Under Operating Leases. In arrangements that we assess as operating leases, we recognize our equipment installed at third-party sites as a fixed asset and depreciate the asset on a straight-line basis. Internal Use Software. We capitalize qualifying internal-use software development costs, consisting primarily of external and internal labor, including stock based compensation, incurred during the application development stage. Costs incurred during the preliminary project and post-implementation stages are charged to expense. Capitalized costs are included in PP&E, net of accumulated amortization in our consolidated balance sheets. Our capitalized internal use software costs are amortized on a straight-line basis over estimated useful lives of three Goodwill, Intangible Assets, and Long-Lived Assets We perform an assessment of goodwill for potential impairment annually during our third fiscal quarter or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. For our annual goodwill test as of the fiscal quarter ended July 1, 2022, a qualitative assessment was performed and we concluded that it was more likely than not that its fair value was in excess of its carrying amount. Accordingly, no quantitative assessment was performed and no impairment was recorded. We did not incur any goodwill impairment losses in any of the periods presented. Intangible assets are stated at their original cost less accumulated amortization, and those with definite lives are amortized over their estimated useful lives. Our intangible assets principally consist of acquired technology, patents, trademarks, customer relationships and contracts, the majority of which are amortized on a straight-line basis over their useful lives using a range from three We review long-lived assets, including intangible assets, for impairment whenever events or a change in circumstances indicate an asset’s carrying value may not be recoverable. Recoverability of an asset is measured by comparing its carrying value to the total future undiscounted cash flows that the asset is expected to generate. If it is determined that an asset is not recoverable, an impairment loss is recorded in the amount by which the carrying value of the asset exceeds its estimated fair value. Revenue Recognition We enter into revenue arrangements with our customers to license technologies, trademarks and patents for sound, imaging and voice solutions, and to sell products and services. We recognize revenue when we satisfy a performance obligation by transferring control over the use of a license, product, or service to a customer. For additional financial information and a summary of our accounting policy, refer to Note 3. "Revenue Recognition" to our consolidated financial statements. Cost of Revenue Cost of licensing. Cost of licensing primarily consists of amortization expenses associated with purchased intangible assets and intangible assets acquired in business combinations. Cost of licensing also includes IP royalty obligations to third parties, depreciation of our Dolby Cinema equipment provided under operating leases in collaborative arrangements, and direct fees incurred. Cost of products and services. Cost of products primarily consists of the cost of materials related to products sold, applied labor, and manufacturing overhead. Our cost of products also includes third party royalty obligations paid to license IP that we include in our products. Cost of services primarily consists of the personnel and personnel-related costs of employees performing our professional services, and those of outside consultants, and reimbursable expenses incurred on behalf of customers. Stock-Based Compensation We measure expenses associated with all employee stock-based compensation awards using a fair-value method and record such expense in our consolidated financial statements on a straight-line basis over the requisite service period. Advertising and Promotional Costs Advertising and promotional costs are charged to S&M expense as incurred. Our advertising and promotional costs were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Advertising and promotional costs $ 51,422 $ 52,253 $ 61,125 Foreign Currency Activities Foreign Currency Translation. We maintain business operations in foreign countries. We translate the assets and liabilities of our international subsidiaries, the majority of which are denominated in non-U.S. dollar functional currencies, into U.S. dollars using exchange rates in effect at the end of each period. Revenue and expenses of these subsidiaries are translated using the average rates for the period. Gains and losses from these translations are included in AOCI within stockholders’ equity. Foreign Currency Transactions. Certain of our foreign subsidiaries transact in currencies other than their functional currency. Therefore, we re-measure non-functional currency assets and liabilities of these subsidiaries using exchange rates at the end of each period. As a result, we recognize foreign currency transaction and re-measurement gains and losses, which are recorded within other income, net in our consolidated statements of operations. These losses were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Foreign currency transaction losses $ (1,283) $ (749) $ (1,361) Non-designated Hedges. In an effort to reduce the risk that our earnings will be adversely affected by foreign currency exchange rate fluctuations, we enter into foreign currency forward contracts exclusively to hedge against assets and liabilities for which we have foreign currency exchange rate exposure. These derivative instruments are carried at fair value with changes in the fair value recorded to other income/(expense), net, in our consolidated statements of operations. While not designated as hedging instruments, these foreign currency forward contracts are used to reduce the exchange rate risk associated primarily with intercompany receivables and payables. These contracts do not subject us to material balance sheet risk due to exchange rate movements as gains and losses on these derivatives are intended to offset gains and losses on the related receivables and payables for which we have foreign currency exchange rate exposure. As of September 30, 2022 and September 24, 2021, the outstanding derivative instruments had maturities of equal to or less than 31 days and 38 days, respectively, and the total notional amounts of outstanding contracts were $56.6 million and $35.3 million, respectively. The fair values of these contracts are included within prepaid expenses and other current assets and within accrued liabilities in our consolidated balance sheets. Cash Flow Hedges. We also enter into forward currency contracts exclusively designated as cash flow hedges, which have a maturity of thirteen months or less, to reduce the impact of currency volatility on U.S. dollar operating expenses. As of September 30, 2022 and September 24, 2021, the outstanding derivative instruments had maturities of equal to or less than 12 months and 3 months, respectively, and the total notional amounts of outstanding contracts were $74.1 million and $15.7 million, respectively. The gains and losses from the effective portions of cash flow hedges are recorded at fair value as a component of AOCI, until the hedged item is subsequently reclassified into earnings in the same period in which the hedged transaction affects earnings, with the corresponding hedged item. Amounts reclassified are recorded to the same line item in the consolidated statements of operations as the impact of the hedge transaction, concurrently with the hedged costs. The pre-tax loss attributed to the effective portion of cash flow hedges recognized in AOCI was $2.6 million in fiscal 2022. The pre-tax loss attributed to the effective portion of cash flow hedges recognized in AOCI was $12.7 million in fiscal 2021. The pre-tax effective portion of the loss reclassified to the consolidated statements of operations was $2.1 million in fiscal 2022, and the pre-tax effective portion of the gain reclassified to the consolidated statements of operations was $9.0 million in fiscal 2021. Income Taxes We use the asset and liability method, under which deferred income tax assets and liabilities are determined based upon the difference between the financial statement carrying amounts and the tax bases of assets and liabilities, and NOL carryforwards are measured using the enacted tax rate expected to apply to taxable income in the years in which the differences are expected to be reversed. In assessing the realizability of deferred tax assets, we consider whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The realization of deferred tax assets is additionally dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. We consider the scheduled reversal of deferred tax liabilities and projected future taxable income in making this assessment, and we record a valuation allowance to reduce our deferred tax assets when it's more-likely-than-not that some portion or all of the deferred tax assets will not be realized. We record an unrecognized tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the tax authorities. We include interest and penalties related to gross unrecognized tax benefits within our provision for income taxes. To the extent accrued interest and penalties do not ultimately become payable, amounts accrued are reversed in the period that such determination is made and are reflected as a reduction of the overall income tax provision. Repatriation of Undistributed Foreign Earnings. The Tax Act provides an exemption from federal income taxes for distributions by foreign subsidiaries made after December 31, 2017 that were not subject to the Transition Tax. U.S. state income taxes and foreign withholding taxes on undistributed earnings of certain foreign subsidiaries, that are no longer considered to be indefinitely reinvested, are not material. We consider the earnings of certain other foreign subsidiaries to be indefinitely reinvested outside the U.S. on the basis of estimates that future domestic cash generation will be sufficient to meet future domestic cash needs, and our specific plans for reinvestment of those subsidiary earnings. Recently Issued Accounting Standards We continually assess any ASUs or other new accounting pronouncements issued by the FASB to determine their applicability and impact on us. Where it is determined that a new accounting pronouncement will result in a change to our financial reporting, we take the appropriate steps to ensure that such changes are properly reflected in our consolidated financial statements or notes thereto. Adopted Standards Income Taxes. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which modifies and eliminates certain exceptions to the general principles of ASC 740, Income Taxes. We adopted this standard in the first quarter of fiscal 2022, and it did not have a material impact on our consolidated financial statements. Standards Not Yet Adopted

Revenue Recognition

Revenue Recognition	3 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition We enter into revenue arrangements with our customers to license technologies, trademarks and patents for sound, imaging and voice solutions, and to sell products and services. We recognize revenue when we satisfy a performance obligation by transferring control over the use of a license, product, or service to a customer. A. Identification of the Contract or Contracts with Customers We generally determine that a contract with a customer exists upon the execution of an agreement and after consideration of collectability, which could include an evaluation of the customer's payment history, the existence of a standby letter-of-credit between the customer’s financial institution and our financial institution, public financial information, and other factors. At contract inception, we also evaluate whether two or more non-standard agreements with a customer should be combined and accounted for as a single contract. B. Identification of Performance Obligations in a Contract We generate revenue principally from the following sources, which represent performance obligations in our contracts with customers: • Licensing. We license our technologies, including patents, to a range of customers who incorporate them into their products for enhanced audio, imaging and voice functionality across broadcast, mobile, CE, PC, gaming, and other markets. • Product Sales. We design and provide audio and imaging products for the cinema, television, broadcast, communications, and entertainment industries. • Services. We provide various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment, including equipment training, mixing room alignment, equalization, as well as audio, color and light image calibration. We also offer a developer platform, Dolby.io, that enables developers to access our technologies through audio and video APIs for building high-quality communications, media, and streaming solutions. • PCS. We provide PCS for products sold and for equipment leased, and we support the implementation of our licensing technologies in our licensees’ products. • Equipment Leases. We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences by leasing equipment and licensing our IP. We also lease hardware that facilitates the Dolby conferencing experience, including the Dolby Conference Phone, and the Dolby Voice Room solution. • Licensing Administration Fees. We generate service fees for managing patent pools on behalf of third party patent owners through our wholly-owned subsidiary, Via. Some of our revenue arrangements include multiple performance obligations, such as hardware, software, support and maintenance, and extended warranty services. We evaluate whether promised products and services are distinct performance obligations. The majority of our arrangements with multiple performance obligations pertain to our digital cinema server and processor sales that include the following distinct performance obligations to which we allocate portions of the transaction price based on their stand-alone selling price: • Digital cinema server hardware and embedded software, which is dependent on and interrelated with the hardware. Accordingly, the hardware and embedded software represent a single performance obligation. • The right to support and maintenance, which is included with the purchase of the digital cinema server hardware, is a distinct performance obligation. • The right to receive commissioning services is a distinct performance obligation within the sale of the Dolby Atmos Cinema Processor. These services consist of the review of venue designs specifying proposed speaker placement as well as calibration services performed for installed speakers to ensure optimal playback. C. Determination of Transaction Price for Performance Obligations in a Contract After identifying the distinct performance obligations, we determine the transaction price in accordance with the terms of the underlying executed contract which may include variable consideration such as discounts, rebates, refunds, rights of returns, and incentives. We assess and update, if necessary, the amount of variable consideration to which we are entitled for each reporting period. At the end of each reporting period, we estimate and accrue a liability for returns and adjustments as a reduction to revenue based on several factors, including past returns history. With the exception of our sales-based royalties, we evaluate whether a significant financing component exists when we recognize revenue in advance of customer payments that occur over time. For example, some of our licensing arrangements include payment terms greater than one year from when we transfer control of our IP to a licensee and the receipt of the final payment for that IP. If a significant financing component exists, we classify a portion of the transaction price as interest income, instead of recognizing all of the transaction price as revenue. We do not adjust the transaction price for the effects of financing if, at contract inception, the period between the transfer of control to a customer and final payment is expected to be one year or less. D. Allocation of Transaction Price to Distinct Performance Obligations in a Contract For our sales-based royalties where the license is the predominant item to which the royalties relate, we present all revenue as licensing. For revenue arrangements that include multiple performance obligations, we determine the stand-alone selling price for each distinct performance obligation based on the actual selling prices made to customers. If the performance obligation is not sold separately, we estimate the stand-alone selling price. We do so by considering market conditions such as competitor pricing strategies, customer specific information and industry technology lifecycles, internal conditions such as cost and pricing practices, or applying the residual approach method when the selling price of the good, most commonly a license, is highly variable or uncertain. Once the transaction price, including any variable consideration, has been determined, we allocate the transaction price to the performance obligations identified in the contract and recognize revenue as or when control is transferred for each distinct performance obligation. E. Revenue Recognition as Control is Transferred to a Customer We generate our licensing revenue by licensing our technologies and patents to various types of licensees, such as chip manufacturers ("implementation licensees"), consumer product manufacturers, software vendors, and communications service providers. Our revenue recognition policies for each of these arrangements are summarized below. Initial fees from implementation licensees. Implementation licensees incorporate our technologies into their chipsets that, once approved by Dolby, are available for purchase by OEMs for use in end-user products. Implementation licensees only pay us a nominal initial fee on contract execution as consideration for the ongoing services that we provide to assist in their implementation process. Revenue from these initial fees are recognized ratably over the contractual term as a component of licensing revenue. Sales-based licensing fees. In our royalty bearing licensing agreements with OEMs, control is transferred upon the later of contract execution or the contract’s effective date. We apply the royalty exception, which requires that we recognize sales-based royalties when the sales occur based on our estimates. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Generally, our estimates represent the current period’s shipments to which we expect our licensees to submit royalty statements in the following quarter. Upon receipt of royalty statements from the licensees with the actual reporting of sales-based royalties that we estimated previously, we record a favorable or unfavorable adjustment based on the difference, if any, between estimated and actual sales. In the first quarter of fiscal 2022, we recorded an unfavorable adjustment of approximately $6 million, which was primarily related to shipments that occurred in our fourth quarter of fiscal 2021 (July through September) and largely based on actual royalty statements received from licensees. In the second quarter of fiscal 2022, we recorded an unfavorable adjustment of $3 million, and in the third and fourth quarter of fiscal 2022, we recorded a favorable adjustment of $3 million and $3 million, respectively, each primarily related to shipments that occurred in the preceding fiscal quarter, and largely based on actual royalty statements received from licensees. Fixed and guaranteed licensing fees. In certain cases, our arrangements require the licensee to pay fixed, non-refundable fees. In these cases, control is transferred and fees are recognized upon the later of contract execution or the effective date. Additionally and separate from initial fees from implementation licensees, our sales- and usage-based licensing agreements include a nominal fee, which is also recognized at a point in time in which control of the IP has been transferred. Revenue from these arrangements is included as a component of licensing revenue. Recoveries. Through compliance efforts, we identify misreported licensed activity related to non-current periods. We may record a favorable or unfavorable revenue adjustment in connection with the findings from these compliance efforts generally upon resolution with the licensee through agreement of the findings, or upon receipt of the licensee’s correction statement. Revenue from these arrangements is included as a component of licensing revenue. We undertake activities aimed at identifying potential unauthorized uses of our technologies, which when successful result in the recognition of revenue. Recoveries stem from third parties who agree to remit payments to us based on past use of our technology. In these scenarios, a legally binding contract did not exist at time of use of our technology, and therefore, we recognize revenue recoveries upon execution of the agreement as that is the point in time to which a contract exists and control is transferred. This revenue is classified as licensing revenue. In general, we classify legal costs associated with activities aimed at identifying potential unauthorized uses of our technologies, auditing existing licensees, and on occasion, pursuing litigation as S&M in our consolidated statements of operations. We recognize licensing revenue gross of withholding taxes, which our licensees remit directly to their local tax authorities, and for which we receive a partial foreign tax credit in our income tax provision. In addition to our licensing arrangements, we also enter into arrangements to deliver products and services. Product Sales. Revenue from the sale of products is recognized when the customer obtains control of the promised good or service, which is generally upon shipment. Payments are generally made within 90 days of sale. Services. We provide various services, such as engineering services related to movie soundtrack print mastering, equipment training and maintenance, mixing room alignment, equalization, and image calibration, which we bill on a fixed fee and time and materials basis. Most of these services are of a short duration and are recognized as control of the performance obligations are transferred which is when the related services are performed. Cloud Services. We provide access to audio and video APIs through our developer platform as well as cloud encoding services, generally, on either a consumption or subscription basis. Revenue related to cloud services provided on a consumption basis is recognized when the customer utilizes the services, based on the quantity of services consumed. Revenue related to cloud services provided on a subscription basis is recognized ratably over the contract term as the customer receives and consumes the benefits of the cloud services. Collaborative Arrangements. We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences. Under such collaborations, Dolby and the exhibitor are both active participants, and share the risks and rewards associated with the business. Accordingly, these collaborations are governed by revenue sharing arrangements under which Dolby receives revenue based on box office receipts, reported to Dolby by exhibitor partners on a monthly or quarterly basis, our proprietary designs and trademarks as well as for the use of our equipment at the exhibitor's venue. The use of our product solution meets the definition of a lease, and for the related portion of Dolby's share of revenue, we apply ASC 842, Leases , and recognize revenue based on monthly box office reports from exhibitors. Our revenue share is recognized as licensing revenue in our consolidated statements of operations. In addition, we also enter into hybrid agreements where a portion of our revenue share involves guaranteed payments, which in some cases result in classifying the arrangement as a sales-type lease. In such arrangements, we consider control to transfer at the point in time to which we have installed and tested the equipment, at which point we record such guaranteed payments as product revenue. Via Administration Fee. We generate service fees for managing patent pools on behalf of third party patent owners through our wholly-owned subsidiary, Via. As an agent to licensors in the patent pool, Via receives a share of the sales-based royalty that the patent pool licensors earn from licensees. As such, we apply the sales-based royalty exception as the service provided is directly related to the patent pool licensors’ provision of IP, which results in recognition based on estimates of the licensee’s quarter shipments that use the pool’s patents. In addition to sales-based royalties, Via also has contracts where the fees are fixed. The revenue share Via receives from licensors on fixed fee contracts is recognized over the term in which we are providing services associated with the fixed fee contract. We recognize our administrative fees net of the consideration paid to the patent licensors in the pool as licensing revenue. Deferred revenue, which is a component of contract liabilities, represents amounts that are ultimately expected to be recognized as revenue, but for which we have yet to satisfy the performance obligation. On September 30, 2022, we had $41.5 million of remaining performance obligations, 45% of which we expect to recognize as revenue in fiscal 2023, 18% in fiscal 2024, and the balance of 37% in fiscal years beyond 2024. F. Disaggregation of revenue The following table presents a summary of the composition of our revenue for all periods presented (in thousands, except percentage amounts): Fiscal Year Ended Revenue September 30, 2022 September 24, 2021 September 25, 2020 Licensing $ 1,164,533 93 % $ 1,214,147 95 % $ 1,078,577 93 % Products and services 89,260 7 % 67,109 5 % 83,215 7 % Total revenue $ 1,253,793 100 % $ 1,281,256 100 % $ 1,161,792 100 % The following table presents the composition of our licensing revenue for all periods presented (in thousands, except percentage amounts): Fiscal Year Ended Licensing Revenue By Market September 30, 2022 September 24, 2021 September 25, 2020 Broadcast $ 433,992 37 % $ 475,648 39 % $ 439,415 41 % Mobile 238,735 21 % 261,232 22 % 226,972 21 % CE 186,285 16 % 181,944 15 % 152,608 14 % PC 151,079 13 % 141,919 12 % 132,302 12 % Other 154,442 13 % 153,404 12 % 127,280 12 % Total licensing revenue $ 1,164,533 100 % $ 1,214,147 100 % $ 1,078,577 100 % We license our technologies in approximately 70 countries, and our licensees distribute products that incorporate our technologies throughout the world. We generate the majority of our revenue from outside the U.S. Geographic data for our licensing revenue is based on the location of our licensees’ headquarters, products revenue is based on the destination to which we ship our products, and services revenue is based on the location where services are performed. The following table presents the composition of our revenue by geographic location for all periods presented (in thousands, except percentage amounts): Fiscal Year Ended Revenue By Geographic Location September 30, 2022 September 24, 2021 September 25, 2020 United States $ 468,246 37 % $ 419,901 33 % $ 460,972 40 % International 785,547 63 % 861,355 67 % 700,820 60 % Total revenue $ 1,253,793 100 % $ 1,281,256 100 % $ 1,161,792 100 % G. Contract balances Our contract assets represent rights to consideration from licensees for the use of our IP that we have estimated in a given period in the absence of receiving actual royalty statements from licensees. These estimates reflect our best judgment at that time, and are developed using a number of inputs, including historical data, industry estimates of expected shipments, anticipated sales price and performance, and third-party data supporting the percentage of markets using our technologies. In the event that our estimates differ from actual amounts reported, we record an adjustment in the quarter in which the royalty statement is received, which is typically the quarter following our estimate. Actual amounts reported are typically paid within 60 days following the end of the quarter of shipment. The main drivers for change in the contract assets account are variances in quarterly estimates, and to a lesser degree, timing of receipt of actual royalty statements. Our contract liabilities consist of advance payments and billings in advance of performance, deferred revenue that is typically satisfied within one year, and deferred interest where we have significant financing. The non-current portion of contract liabilities is separately disclosed in our consolidated balance sheets. We present the net contract asset or liability when we have both contract assets and contract liabilities for a single contract. In fiscal 2022, we recognized $16.8 million from prior period deferred revenue. The following table presents a summary of the balances to which contract assets and liabilities related to revenue are recorded for all periods presented (in thousands, except percentage amounts): September 30, 2022 September 24, 2021 Change ($) Change (%) Accounts receivable, net $ 243,593 $ 232,609 $ 10,984 5 % Contract assets, net 176,093 182,316 (6,223) (3) % Contract liabilities - current 18,588 18,473 115 1 % Contract liabilities - non-current 23,203 23,713 (510) (2) %

Composition Of Certain Financia

Composition Of Certain Financial Statement Captions	12 Months Ended
	Sep. 30, 2022
Composition Of Certain Financial Statement Captions [Abstract]
Composition Of Certain Financial Statement Captions	Composition of Certain Financial Statement Captions The following tables present detailed information from our consolidated balance sheets as of September 30, 2022 and September 24, 2021 (in thousands). Accounts Receivable and Contract Assets September 30, September 24, Trade accounts receivable $ 162,531 $ 160,112 Accounts receivable from patent administration program licensees 92,896 81,241 Contract assets 176,218 182,524 Accounts receivable and contract assets, gross 431,645 423,877 Less: allowance for credit losses on accounts receivable and contract assets (11,959) (8,952) Total accounts receivable and contract assets, net $ 419,686 $ 414,925 Trade accounts receivable of $162.5 million includes unbilled accounts receivable balances of $106.9 million and $97.5 million as of September 30, 2022 and September 24, 2021, respectively, related to amounts that are contractually owed. The unbilled balance represents our unconditional right to consideration related to fixed fee contracts which we are entitled to as a result of satisfying, or partially satisfying, performance obligations, as well as Via's unconditional right to consideration related to their patent administration programs. Allowance for Credit Losses Beginning Balance Charges/(Credits) Additions/(Deductions) Ending Balance For fiscal year ended: September 25, 2020 $ 9,775 $ 7,689 $ (1,556) $ 15,908 September 24, 2021 15,908 (2,889) (4,067) 8,952 September 30, 2022 8,952 5,460 (7) 14,405 Allowance for credit losses includes the provision for estimated credit losses on our sales-type leases, which was not material as of September 30, 2022 and as of September 24, 2021. Inventories September 30, September 24, Raw materials $ 10,026 $ 2,792 Work in process 4,955 3,461 Finished goods 8,568 4,712 Total inventories $ 23,549 $ 10,965 Inventories are stated at the lower of cost and net realizable value. Inventory with a consumption period expected to exceed twelve months is recorded within other non-current assets in our consolidated balance sheets. We have included $2.8 million and $1.9 million of raw materials inventory within non-current assets as of September 30, 2022 and September 24, 2021, respectively. Based on anticipated inventory consumption rates, and aside from existing write-downs due to excess inventory, we do not believe that material risk of obsolescence exists prior to ultimate sale. Prepaid Expenses And Other Current Assets September 30, September 24, Prepaid expenses $ 26,851 $ 29,964 Other current assets 23,224 32,773 Total prepaid expenses and other current assets $ 50,075 $ 62,737 Accrued Liabilities September 30, September 24, Amounts payable to patent administration program partners $ 63,106 $ 72,847 Accrued compensation and benefits 84,111 107,322 Accrued professional fees 13,057 11,737 Unpaid property, plant, and equipment additions 15,428 17,839 Accrued customer refunds 3,674 14,151 Accrued market development funds 7,206 7,777 Other accrued liabilities 43,655 31,055 Total accrued liabilities $ 230,237 $ 262,728 Other Non-Current Liabilities September 30, September 24, Supplemental retirement plan obligations $ 4,127 $ 4,877 Non-current tax liabilities (1) 83,758 85,063 Other liabilities 12,237 15,370 Total other non-current liabilities $ 100,122 $ 105,310 (1) Refer to Note 12 " Income Taxes" for additional information related to our tax liabilities.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Investments and Fair Value Measurements	Investments and Fair Value Measurements We use cash holdings to purchase investment grade securities diversified among security types, industries, and issuers. All of our investments in debt securities are measured at fair value, and are recorded within cash equivalents and both short-term and long-term investments in our consolidated balance sheets. With the exception of our mutual fund investments held in our SERP and classified as trading securities and our other long-term investments, all of our investments are classified as AFS securities. Derivative contracts are used to hedge currency risk, and these are carried at fair value and classified as other assets and other liabilities. Our investment in debt securities primarily consist of corporate bonds, government bonds, municipal debt securities, certificates of deposit, commercial paper, and U.S. agency securities. In addition, our cash and cash equivalents also consist of highly-liquid money market funds and U.S. agency securities. Consistent with our investment policy, none of our municipal debt investments are supported by letters of credit or standby purchase agreements. Our cash and investment portfolio consisted of the following (in thousands): September 30, 2022 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 474,813 $ — $ — $ 474,813 $ 474,813 $ — $ — Cash equivalents: Money market funds 134,987 — — 134,987 134,987 — — U.S. agency securities 10,328 — (1) 10,327 — 10,327 — Cash and cash equivalents 620,128 — (1) 620,127 609,800 10,327 — Short-term investments: Certificate of deposit 23,033 8 (47) 22,994 — 22,994 — U.S. agency securities 3,412 — (21) 3,391 — 3,391 — Government bonds 57,417 — (705) 56,712 52,833 3,879 — Commercial paper 8,786 1 (15) 8,772 — 8,772 — Corporate bonds 72,730 — (734) 71,996 — 71,996 — Municipal debt securities 25,589 — (241) 25,348 — 25,348 — Short-term investments 190,967 9 (1,763) 189,213 52,833 136,380 — Long-term investments: U.S. agency securities 861 — (39) 822 — 822 — Government bonds 43,816 — (2,222) 41,594 38,055 3,539 — Corporate bonds 29,684 4 (1,349) 28,339 — 28,339 — Municipal debt securities 21,483 — (626) 20,857 — 20,857 — Other investments (1) 10,902 — — 10,902 — — — Long-term investments 106,746 4 (4,236) 102,514 38,055 53,557 — Total cash, cash equivalents, and investments $ 917,841 $ 13 $ (6,000) $ 911,854 $ 700,688 $ 200,264 $ — Investments held in supplemental retirement plan: Assets $ 4,225 $ — $ — $ 4,225 $ 4,225 $ — $ — Included in prepaid expenses and other current assets and other non-current assets Liabilities $ 4,225 $ — $ — $ 4,225 $ 4,225 $ — $ — Included in accrued liabilities and other non-current liabilities Currency derivatives as hedge instruments: Liabilities: Included in other accrued liabilities $ — $ — $ (4,882) $ (4,882) $ — $ (4,882) $ — Liabilities: Included in other non-current liabilities — — (420) (420) — (420) — (1) Other investments as of September 30, 2022 is comprised of an equity method investment of $5.9 million and an equity security without a readily determinable fair value of $5.0 million. September 24, 2021 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 990,182 $ — $ — $ 990,182 $ 990,182 $ — $ — Cash equivalents: Money market funds 235,198 — — 235,198 235,198 — — Cash and cash equivalents 1,225,380 — — 1,225,380 1,225,380 — — Short-term investments: Certificate of deposit 1,795 — — 1,795 — 1,795 — U.S. agency securities 1,096 6 — 1,102 — 1,102 — Government bonds 100 2 — 102 102 — — Commercial paper 5,184 2 — 5,186 — 5,186 — Corporate bonds 18,850 116 — 18,966 — 18,966 — Municipal debt securities 11,660 29 (1) 11,688 — 11,688 — Short-term investments 38,685 155 (1) 38,839 102 38,737 — Long-term investments: U.S. agency securities 2,264 13 (2) 2,275 — 2,275 — Government bonds 11,784 38 (16) 11,806 4,966 6,840 — Corporate bonds 32,116 61 (25) 32,152 — 32,152 — Municipal debt securities 10,080 58 (8) 10,130 — 10,130 — Other investments (1) 6,456 — — 6,456 — — — Long-term investments 62,700 170 (51) 62,819 4,966 51,397 — Total cash, cash equivalents, and investments $ 1,326,765 $ 325 $ (52) $ 1,327,038 $ 1,230,448 $ 90,134 $ — Investments held in supplemental retirement plan: Assets $ 4,975 $ — $ — $ 4,975 $ 4,975 $ — $ — Included in prepaid expenses and other current assets and other non-current assets Liabilities $ 4,975 $ — $ — $ 4,975 $ 4,975 $ — $ — Included in accrued liabilities and other non-current liabilities Currency derivatives as hedge instruments: Assets: Included in other current assets $ — $ 689 $ — $ 689 $ — $ 689 $ — Liabilities: Included in other accrued liabilities — — (197) (197) — (197) — (1) Other investments as of September 24, 2021 is comprised of one equity method investment. Fair Value Hierarchy. Fair value is the exchange price that would be received for an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants at the measurement date. We minimize the use of unobservable inputs and use observable market data, if available, when determining fair value. We classify our inputs to measure fair value using the following three-level hierarchy: Level 1: Quoted prices in active markets at the measurement date for identical assets and liabilities. We base the fair value of our Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments. Level 2: Prices may be based upon quoted prices in active markets or inputs not quoted on active markets but are corroborated by market data. We obtain the fair value of our Level 2 financial instruments from a professional pricing service, which may use quoted market prices for identical or comparable instruments, or model driven valuations using observable market data or inputs corroborated by observable market data. To validate the fair value determination provided by our primary pricing service, we perform quality controls over values received which include comparing our pricing service provider’s assessment of the fair values of our investment securities against the fair values of our investment securities obtained from another independent source, reviewing the pricing movement in the context of overall market trends, and reviewing trading information from our investment managers. In addition, we assess the inputs and methods used in determining the fair value in order to determine the classification of securities in the fair value hierarchy. The fair value of the currency derivatives are calculated from market spot rates, forward rates, interest rates, and credit ratings at the end of the period. Level 3: Unobservable inputs are used when little or no market data is available and reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. The following table describes the valuation techniques and inputs applicable to each class of security held within our investment portfolio as of September 30, 2022: Asset Type Primary Source Update Frequency Fair Value Methodology Secondary Source Level 1 Money Market Funds Not Applicable Daily $1 per share Not Applicable U.S. Government Bonds ICE (Intercontinental Exchange) Daily Institutional Bond Quotes - evaluations based on various market and industry inputs Bloomberg Level 2 Certificates of Deposit ICE (Intercontinental Exchange) Daily Institutional Bond Quotes - evaluations based on various market and industry inputs Bloomberg Commercial Paper U.S. Bank Pricing Unit Daily Matrix Pricing Not Applicable Corporate Bonds ICE (Intercontinental Exchange) Daily Institutional Bond Quotes - evaluations based on various market and industry inputs Bloomberg Municipal Debt Securities ICE (Intercontinental Exchange) Daily Evaluations based on various market and industry inputs Bloomberg U.S. Agency Securities ICE (Intercontinental Exchange) Daily Institutional Bond Quotes - evaluations based on various market and industry inputs Bloomberg Int'l Government Bonds ICE (Intercontinental Exchange) Daily Evaluations based on various market factors Bloomberg Securities In Gross Unrealized Loss Position. We periodically evaluate our investments for impairment by comparing the fair value with the cost basis for each of our investment securities. The unrealized losses on our AFS securities were primarily the result of unfavorable changes in interest rates subsequent to the initial purchase of these securities. The following table presents the gross unrealized losses and fair value for those AFS securities that were in an unrealized loss position for less than twelve months and for greater than twelve months as of September 30, 2022 and September 24, 2021 (in thousands): September 30, 2022 September 24, 2021 Less Than 12 Months Greater Than 12 Months Less Than 12 Months Investment Type Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Certificate of deposit $ 10,352 $ (47) $ — $ — $ 600 $ — U.S. agency securities 13,144 (5) 1,395 (55) 1,449 (2) Government bonds 89,741 (2,593) 8,566 (332) 8,940 (16) Commercial paper 5,770 (15) — — — — Corporate bonds 81,044 (1,523) 18,306 (561) 22,964 (25) Municipal debt securities 40,119 (712) 3,336 (156) 7,031 (9) Total $ 240,170 $ (4,895) $ 31,603 $ (1,104) $ 40,984 $ (52) As of September 24, 2021, there were no AFS securities that were in an unrealized loss position for twelve months or greater. Although we had certain securities that were in an unrealized loss position as of September 30, 2022 and September 24, 2021, we expect to recover the full carrying value of these securities. Investment Maturities. The following table summarizes the amortized cost and estimated fair value of the AFS securities within our investment portfolio based on stated maturities as of September 30, 2022 and September 24, 2021, which are recorded within cash equivalents and both short and long-term investments in our consolidated balance sheets (in thousands): September 30, 2022 September 24, 2021 Range of maturity Amortized Cost Fair Value Amortized Cost Fair Value Due within 1 year $ 336,291 $ 334,537 $ 273,884 $ 274,037 Due in 1 to 2 years 53,721 51,332 40,739 40,874 Due in 2 to 5 years 42,122 40,280 15,506 15,490 Total $ 432,134 $ 426,149 $ 330,129 $ 330,401

Property, Plant & Equipment

Property, Plant & Equipment	12 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	Property, Plant, and Equipment PP&E are recorded at cost, with depreciation expense included in cost of licensing, cost of products and services, R&D, S&M, and G&A expenses in our consolidated statements of operations. Depreciation expense was $59.5 million, $66.4 million, and $61.4 million in fiscal 2022, 2021, and 2020, respectively. As of September 30, 2022 and September 24, 2021, PP&E consisted of the following (in thousands): Property, Plant, and Equipment September 30, September 24, Land $ 41,774 $ 42,041 Buildings and building improvements 287,544 284,146 Leasehold improvements 86,793 88,549 Machinery and equipment 136,995 128,008 Computer equipment and software 232,108 258,981 Furniture and fixtures 33,797 33,565 Equipment provided under operating leases 229,177 214,109 Construction-in-progress 23,037 22,923 Property, plant, and equipment, gross 1,071,225 1,072,322 Less: accumulated depreciation (557,744) (537,941) Property, plant, and equipment, net $ 513,481 $ 534,381

Leases

Leases	12 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Leases	Leases As Lessee As a lessee, we enter into contracts to access and utilize office space, including those payable to our principal stockholder and portions attributable to the controlling interests in our consolidated subsidiaries. We determine if a contract contains a lease based on whether we have the right to obtain substantially all of the economic benefits from the use of an identified asset and whether we have the right to direct the use of an identified asset in exchange for consideration, which relates to an asset which we do not own. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets are recognized as the lease liability, adjusted for lease incentives received. Lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value of the future lease payments is our IBR, because the interest rate implicit in our leases is not readily determinable. The IBR is a hypothetical rate based on our understanding of what our credit rating would be and resulting interest we would pay to borrow an amount equal to the lease payments in a similar economic environment over the lease term on a collateralized basis. Lease payments may be fixed or variable, however, only fixed payments are included in our lease liability calculation. Variable lease payments are recognized in operating expenses in the period in which the obligation for those payments is incurred. The lease term of operating leases vary from less than a year to 10 years. We have leases that include one or more options to extend the lease term for up to 5 years as well as options to terminate the lease within one year. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. The components of lease expense were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Lease cost Operating lease cost $ 17,260 $ 19,261 $ 23,570 Variable lease cost 1,560 755 1,175 Total lease cost $ 18,820 $ 20,016 $ 24,745 Supplemental cash flow information related to leases was as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Other information Cash paid for amounts included in the measurement of operating lease liabilities $ 16,957 $ 19,173 $ 22,043 Right-of-use assets obtained in exchange for operating lease obligations 1,737 5,225 34,198 Supplemental balance sheet information related to leases was as follows: September 30, September 24, Operating Leases Weighted-average remaining lease term 5.5 years 5.8 years Weighted-average discount rate 3.2 % 3.1 % The following tables presents the maturity analysis of lease liabilities (in thousands): September 30, 2022 Operating Leases Fiscal 2023 $ 15,995 Fiscal 2024 12,529 Fiscal 2025 9,097 Fiscal 2026 5,957 Fiscal 2027 4,638 Thereafter 12,240 Total undiscounted lease payments 60,456 Less: imputed interest (9,514) Total lease liabilities $ 50,942 As Lessor As a lessor, we lease our Dolby Cinema product solution to exhibitors and Dolby Voice equipment to cloud conferencing service providers. The terms of these leases vary from 4 to 10 years. Lease components consist of fixed payments and/or variable lease payments based on contracted percentages of revenue. Generally, leases do not grant any right to the lessee to purchase the underlying asset at the end of the lease term. Dolby Cinema lease arrangements have options to extend the lease term at expiration by increments ranging from 1 to 5 years. Assets provided under an operating lease are carried at cost within property, plant and equipment, net on the consolidated balance sheets, and depreciated over the useful life of the asset using the straight-line method. Fixed operating lease payments are recognized on a straight-line basis over the lease term to revenue. Variable lease payments received under our Dolby Cinema operating leases are computed as shares of lessees' box office revenue and recognized to revenue in the period that box office sales occur. Lease incentive payments we make to lessees are amortized as a reduction in revenue over the lease term. The components of lease income were as follows (in millions): Fiscal Year Ended September 30, September 24, September 25, Operating Lease Income Variable operating lease income $ 31.6 $ 9.5 $ 10.4 Fixed operating lease income 3.0 4.2 3.7 If a lease is classified as a sales-type lease, the carrying amount of the asset is derecognized from property, plant and equipment, net, and a net investment in the lease is recorded. The net investment in the lease is measured at commencement date as the sum of the lease receivable and the estimated residual value of the equipment. The unguaranteed residual value of the equipment is determined as the estimated carrying value of the asset at the end of the lease term had the asset been depreciated on a straight-line basis. The unguaranteed residual value of sales-type leases was $1.1 million and $0.8 million as of September 30, 2022 and September 24, 2021, respectively. Selling profit or loss arising from a sales-type lease is recorded at lease commencement and presented on a gross basis. Over the term of the lease, we recognize interest income on the net investment in the lease, and variable lease payments, which are not included in the net investment in the lease. The variable lease payments are not material. The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): September 30, 2022 Operating Leases Sales-Type Leases Fiscal 2023 $ 767 $ 1,595 Fiscal 2024 787 795 Fiscal 2025 807 395 Fiscal 2026 732 395 Fiscal 2027 — — Thereafter — — Total undiscounted cash flows $ 3,093 3,180 Less: present value of lease payments (recognized as lease receivables) (2,801) Difference $ 379
Leases	Leases As Lessee As a lessee, we enter into contracts to access and utilize office space, including those payable to our principal stockholder and portions attributable to the controlling interests in our consolidated subsidiaries. We determine if a contract contains a lease based on whether we have the right to obtain substantially all of the economic benefits from the use of an identified asset and whether we have the right to direct the use of an identified asset in exchange for consideration, which relates to an asset which we do not own. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets are recognized as the lease liability, adjusted for lease incentives received. Lease liabilities are recognized at the present value of the future lease payments at the lease commencement date. The interest rate used to determine the present value of the future lease payments is our IBR, because the interest rate implicit in our leases is not readily determinable. The IBR is a hypothetical rate based on our understanding of what our credit rating would be and resulting interest we would pay to borrow an amount equal to the lease payments in a similar economic environment over the lease term on a collateralized basis. Lease payments may be fixed or variable, however, only fixed payments are included in our lease liability calculation. Variable lease payments are recognized in operating expenses in the period in which the obligation for those payments is incurred. The lease term of operating leases vary from less than a year to 10 years. We have leases that include one or more options to extend the lease term for up to 5 years as well as options to terminate the lease within one year. Our lease terms may include options to extend or terminate the lease when it is reasonably certain that we will exercise such options. The components of lease expense were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Lease cost Operating lease cost $ 17,260 $ 19,261 $ 23,570 Variable lease cost 1,560 755 1,175 Total lease cost $ 18,820 $ 20,016 $ 24,745 Supplemental cash flow information related to leases was as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Other information Cash paid for amounts included in the measurement of operating lease liabilities $ 16,957 $ 19,173 $ 22,043 Right-of-use assets obtained in exchange for operating lease obligations 1,737 5,225 34,198 Supplemental balance sheet information related to leases was as follows: September 30, September 24, Operating Leases Weighted-average remaining lease term 5.5 years 5.8 years Weighted-average discount rate 3.2 % 3.1 % The following tables presents the maturity analysis of lease liabilities (in thousands): September 30, 2022 Operating Leases Fiscal 2023 $ 15,995 Fiscal 2024 12,529 Fiscal 2025 9,097 Fiscal 2026 5,957 Fiscal 2027 4,638 Thereafter 12,240 Total undiscounted lease payments 60,456 Less: imputed interest (9,514) Total lease liabilities $ 50,942 As Lessor As a lessor, we lease our Dolby Cinema product solution to exhibitors and Dolby Voice equipment to cloud conferencing service providers. The terms of these leases vary from 4 to 10 years. Lease components consist of fixed payments and/or variable lease payments based on contracted percentages of revenue. Generally, leases do not grant any right to the lessee to purchase the underlying asset at the end of the lease term. Dolby Cinema lease arrangements have options to extend the lease term at expiration by increments ranging from 1 to 5 years. Assets provided under an operating lease are carried at cost within property, plant and equipment, net on the consolidated balance sheets, and depreciated over the useful life of the asset using the straight-line method. Fixed operating lease payments are recognized on a straight-line basis over the lease term to revenue. Variable lease payments received under our Dolby Cinema operating leases are computed as shares of lessees' box office revenue and recognized to revenue in the period that box office sales occur. Lease incentive payments we make to lessees are amortized as a reduction in revenue over the lease term. The components of lease income were as follows (in millions): Fiscal Year Ended September 30, September 24, September 25, Operating Lease Income Variable operating lease income $ 31.6 $ 9.5 $ 10.4 Fixed operating lease income 3.0 4.2 3.7 If a lease is classified as a sales-type lease, the carrying amount of the asset is derecognized from property, plant and equipment, net, and a net investment in the lease is recorded. The net investment in the lease is measured at commencement date as the sum of the lease receivable and the estimated residual value of the equipment. The unguaranteed residual value of the equipment is determined as the estimated carrying value of the asset at the end of the lease term had the asset been depreciated on a straight-line basis. The unguaranteed residual value of sales-type leases was $1.1 million and $0.8 million as of September 30, 2022 and September 24, 2021, respectively. Selling profit or loss arising from a sales-type lease is recorded at lease commencement and presented on a gross basis. Over the term of the lease, we recognize interest income on the net investment in the lease, and variable lease payments, which are not included in the net investment in the lease. The variable lease payments are not material. The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): September 30, 2022 Operating Leases Sales-Type Leases Fiscal 2023 $ 767 $ 1,595 Fiscal 2024 787 795 Fiscal 2025 807 395 Fiscal 2026 732 395 Fiscal 2027 — — Thereafter — — Total undiscounted cash flows $ 3,093 3,180 Less: present value of lease payments (recognized as lease receivables) (2,801) Difference $ 379

Goodwill & Intangible Assets

Goodwill & Intangible Assets	12 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill The following table outlines changes to the carrying amount of goodwill (in thousands): Goodwill Balance at September 25, 2020 $ 336,945 Acquired goodwill 3,345 Translation adjustments 404 Balance at September 24, 2021 $ 340,694 Acquired goodwill (1) 31,695 Translation adjustments (7,185) Measurement period adjustments (57) Balance at September 30, 2022 $ 365,147 (1) Refer to Note 15 " Business Combination " for additional information related to our acquired goodwill Intangible Assets Intangible assets are stated at their original cost less accumulated amortization, and principally consist of acquired patents, technology, customer relationships and contracts, and trademarks. Intangible assets subject to amortization consisted of the following (in thousands): September 30, 2022 September 24, 2021 Intangible Assets, Net Cost Accumulated Net Cost Accumulated Net Acquired patents and technology $ 355,622 $ (253,080) $ 102,542 $ 343,280 $ (233,789) $ 109,491 Customer relationships 66,142 (56,572) 9,570 65,822 (52,730) 13,092 Other intangible assets 22,973 (22,820) 153 22,972 (22,665) 307 Total $ 444,737 $ (332,472) $ 112,265 $ 432,074 $ (309,184) $ 122,890 During fiscal 2022, we purchased various patents for purchase consideration of $11.5 million, and upon acquisition, these intangible assets had a weighted-average useful life of 16 years. These intangible assets facilitate our R&D efforts, technologies, and potential product offerings. In addition, we acquired intangible assets in connection with a business combination completed in fiscal 2022. Refer to Note 15 "Business Combination" for additional information. Amortization expense for our intangible assets is included in cost of licensing, cost of products and services, R&D, S&M, and G&A expenses in our consolidated statements of operations. Amortization expense was $29.0 million, $29.5 million, and $29.5 million in fiscal 2022, 2021 and 2020, respectively. As of September 30, 2022, expected amortization expense of our intangible assets in future periods was as follows (in thousands): Fiscal Year Amortization Expense 2023 $ 26,057 2024 23,930 2025 8,860 2026 7,969 2027 7,285 Thereafter 38,164 Total $ 112,265

Stockholders' Equity And Stock-

Stockholders' Equity And Stock-Based Compensation	12 Months Ended
	Sep. 30, 2022
Stockholders' Equity And Stock-Based Compensation [Abstract]
Stockholders' Equity And Stock-Based Compensation	. Stockholders' Equity and Stock-Based Compensation We provide stock-based awards as a form of compensation for employees, officers and directors. We issue stock-based awards in the form of stock options and RSUs under our equity incentive plans, as well as shares under our ESPP. Common Stock - Class A and Class B Our Board of Directors has authorized two classes of common stock, Class A and Class B. As of September 30, 2022, we had authorized 500,000,000 Class A shares and 500,000,000 Class B shares. As of September 30, 2022, we had 59,798,862 shares of Class A common stock and 36,085,779 shares of Class B common stock issued and outstanding. Holders of our Class A and Class B common stock have identical rights, except that holders of our Class A common stock are entitled to one vote per share and holders of our Class B common stock are entitled to ten votes per share. Shares of Class B common stock can be converted to shares of Class A common stock at any time at the option of the stockholder and automatically convert upon sale or transfer, except for certain transfers specified in our amended and restated certificate of incorporation. Stock Incentive Plans Following shareholder approval in January 2005, our 2005 Stock Plan was adopted by our Board of Directors on February 16, 2005. In February 2020, our stockholders approved the name change of our 2005 Stock Plan to the 2020 Stock Plan and certain other changes described in our proxy statement for our 2020 annual meeting of stockholders. Our 2020 Stock Plan, as amended and restated, provides for the ability to grant incentive stock options, non-qualified stock options, restricted stock, RSUs, stock appreciation rights, deferred stock units, performance units, performance bonus awards, and performance shares. A total of 55.0 million shares of our Class A common stock have been authorized for issuance under the 2020 Stock Plan in total since inception of the plan. For awards granted prior to February 2011, any shares subject to an award with a per share price less than the fair market value of our Class A common stock on the date of grant and any shares subject to an outstanding RSU award will be counted against the authorized share reserve as two shares for every one share subject to the award, and if returned to the 2020 Stock Plan, such shares will be counted as two shares for every one share returned. For those awards granted from February 2011 onward, any shares subject to an award with a per share price less than the fair market value of our Class A common stock on the date of grant and any shares subject to an outstanding RSU award will be counted against the authorized share reserve as 1.6 shares for every one share subject to the award, and if returned to the 2020 Stock Plan, such shares will be counted as 1.6 shares for every one share returned. Stock Options. Stock options are granted at fair market value on the date of grant. Options granted to employees and officers generally vest over four years, with 25% of the options becoming exercisable on the one-year anniversary of the date of grant and the balance of the shares vesting in equal monthly installments over the following 36 months. These options expire on the earlier of ten years after the date of grant or three months after termination of service. All options granted vest over the requisite service period and upon the exercise of stock options, we issue new shares of Class A common stock under the 2020 Stock Plan. Our 2020 Stock Plan also allows us to grant stock awards which vest based on the satisfaction of specific performance criteria. Performance-Based Stock Options. From fiscal 2016 through fiscal 2019, we granted PSOs to our executive officers with shares of our Class A common stock underlying such options. The contractual term for the PSOs was seven years, with vesting contingent upon market-based performance conditions, representing the achievement of specified Dolby annualized TSR targets at the end of a three-year measurement period following the date of grant. Anywhere from 0% to 125% of the shares subject to a PSO vested based on achievement of the performance conditions at the end of the three-year performance period. In valuing the PSOs, which will be recognized as compensation cost, we used a Monte Carlo valuation model. Aside from the use of an expected term for the PSOs commensurate with their shorter contractual term, the nature of the valuation inputs used in the Monte Carlo valuation model were consistent with those used to value our non-performance based options granted under the 2020 Stock Plan. Compensation cost is being amortized on a straight-line basis over the requisite service period. The following table summarizes information about PSOs granted to our executive officers that have vested during the periods presented: Grant Date Aggregate Shares Granted at Target Award Aggregate Shares Exercisable at Vest Date (1) Percentage Vested of Target Award Vested Date December 15, 2016 276,199 240,539 95 % December 2019 December 15, 2017 264,000 253,440 96 % December 2020 December 15, 2018 241,100 158,700 75 % December 2021 (1) Aggregate shares exercisable at vest date does not include any shares that were cancelled before the vest date after they were granted. As of September 30, 2022, an aggregate of 424,249 shares of PSOs were exercisable and outstanding. The following table summarizes information about stock options, including PSOs, issued under our 2020 Stock Plan: Shares Weighted-Average Exercise Price Weighted-Average Remaining Contractual Life Aggregate Intrinsic Value (1) (in thousands) (in years) (in thousands) Options outstanding at September 25, 2021 4,577 $ 59.18 Grants 369 88.37 Exercises (766) 52.88 Forfeitures and cancellations (121) 73.58 Options outstanding at September 30, 2022 4,059 62.59 5.42 $ 29,902 Options vested and expected to vest at September 30, 2022 3,912 62.15 5.36 29,896 Options exercisable at September 30, 2022 3,091 57.16 4.60 29,690 (1) Aggregate intrinsic value is based on the closing stock price of our Class A common stock on September 30, 2022 of $65.15 and excludes the impact of options that were not in-the-money. Restricted Stock Units. In fiscal 2008, we began granting RSUs to certain directors, officers and employees. Awards granted to employees and officers generally vest over four years, with equal annual cliff-vesting. Awards granted from November 2010 onward to ongoing directors generally vest over approximately one year. Awards granted to new directors from fiscal 2014 onward vest on the earlier of the first anniversary of the award’s date of grant, or the day immediately preceding the date of the next annual meeting of stockholders that occurs after the award’s date of grant. At each vesting date, the holder of the award is issued shares of our Class A common stock. Compensation expense from these awards is equal to the adjusted fair market value of our Class A common stock on the date of grant, discounted to account for dividend payments forgone during the vesting period, and is recognized on a straight-line basis over the requisite service period. Certain grants may have other vesting conditions or other award terms as approved by the Compensation Committee of our Board of Directors. Our 2020 Stock Plan also allows us to grant RSUs that vest based on the satisfaction of specific performance criteria. Performance-Based Restricted Stock Units. In fiscal 2020, we began granting PSUs to our executive officers with shares of our Class A common stock underlying such awards. The terms of the PSU Agreement adopted in the first quarter fiscal 2020 provide for the grant of PSUs to our executive officers contingent on Dolby's achievement of annualized TSR targets measured against a comparator index over a three-year performance period following the date of grant. Anywhere from 0% to 200% of eligible restricted stock units may vest based on achievement of the performance conditions at the end of the three-year performance period. The value of the PSUs, which is recognized as compensation cost, is calculated using a Monte Carlo valuation model. Compensation cost is being amortized on a straight-line basis over the requisite service period. Certain grants may have other vesting conditions or other award terms as approved by the Compensation Committee of our Board of Directors. On December 15, 2021, we granted PSUs to our executive officers vesting for an aggregate of 60,301 shares at the target award amount, which would vest at 120,602 shares at 200% of the target award amount. On December 15, 2020, we granted PSUs to our executive officers vesting for an aggregate of 66,138 shares at the target award amount, which would vest at 132,276 shares at 200% of the target award amount. On December 16, 2019, we granted PSUs to our executive officers vesting for an aggregate of 62,000 shares at the target award amount, which would vest at 124,000 shares at 200% of the target award amount. As of September 30, 2022, PSUs which would vest for an aggregate of 162,846 shares at the target award amount (325,692 shares at 200% of the target award amount) were outstanding. The following table summarizes information about RSUs, including PSUs, issued under our 2020 Stock Plan: Shares Weighted-Average (in thousands) Non-vested at September 24, 2021 3,335 $ 77.46 Granted 1,737 86.42 Vested (1,205) 72.92 Forfeitures (365) 81.10 Non-vested at September 30, 2022 3,502 $ 83.09 The fair value as of the respective vesting dates of RSUs were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Restricted stock units - vest date fair value $ 106,919 $ 101,108 $ 72,426 Employee Stock Purchase Plan . Our plan allows eligible employees to have up to 10 percent of their eligible compensation withheld and used to purchase Class A common stock, subject to a maximum of $25,000 worth of stock purchased in a calendar year or no more than 1,000 shares in an offering period, whichever is less. An offering period consists of successive six-month purchase periods, with a look back feature to our stock price at the commencement of a one-year offering period. The plan provides for a discount equal to 15 percent of the lower of the closing price of our Class A common stock on the NYSE on the first and last day of the offering periods. The plan also includes an automatic reset feature that provides for an offering period to be reset and recommenced to a new lower-priced offering if the offering price of a new offering period is less than that of the immediately preceding offering period. Stock Option Valuation Assumptions We use the Black-Scholes option pricing model to determine the estimated fair value of employee stock options at the date of the grant. The Black-Scholes model includes inputs that require us to make certain estimates and assumptions regarding the expected term of the award, as well as the future risk-free interest rate, and the volatility of our stock price over the expected term of the award. Expected Term. The expected term of an award represents the estimated period of time that options granted will remain outstanding, and is measured from the grant date to the date at which the option is either exercised or canceled. Our determination of the expected term involves an evaluation of historical terms and other factors such as the exercise and termination patterns of our employees who hold options to acquire our Class A common stock, and is based on certain assumptions made regarding the future exercise and termination behavior. Risk-Free Interest Rate. The risk-free interest rate is based on the yield curve of U.S. Treasury instruments in effect on the date of grant. In determining an estimate for the risk-free interest rate, we use average interest rates based on these instruments’ constant maturities with a term that approximates and corresponds with the expected term of our awards. Expected Stock Price Volatility. The expected volatility represents the estimated volatility in the price of our Class A common stock over a time period that approximates the expected term of the awards, and is determined using a blended combination of historical and implied volatility. Historical volatility is representative of the historical trends in our stock price for periods preceding the measurement date for a period that is commensurate with the expected term. Implied volatility is based upon externally traded option contracts of our Class A common stock. Dividend Yield. The dividend yield is based on our anticipated dividend payout over the expected term of our option awards. Dividend declarations and the establishment of future record and payment dates are subject to the Board of Directors’ continuing determination that the dividend policy is in the best interests of our stockholders. The dividend policy may be changed or canceled at the discretion of the Board of Directors at any time. The weighted-average assumptions used in the determination of the fair value of our stock options were as follows: Fiscal Year Ended September 30, September 24, September 25, Expected term (in years) 4.78 4.88 4.91 Risk-free interest rate 1.5 % 0.4 % 1.6 % Expected stock price volatility 28.8 % 28.5 % 24.2 % Dividend yield 1.1 % 1.1 % 1.3 % The following table summarizes the weighted-average fair value (per share) of stock options granted and the total intrinsic value of stock options exercised (in thousands): Fiscal Year Ended September 30, September 24, September 25, Stock options granted - weighted-average grant date fair value $ 21.17 $ 20.93 $ 13.76 Stock options exercised - intrinsic value 22,885 102,812 47,267 Stock-Based Compensation Expense Stock-based compensation expense for equity awards granted to employees is determined by estimating their fair value on the date of grant, and recognizing that value as an expense on a straight-line basis over the requisite service period in which our employees earn the awards. Compensation expense related to these equity awards is recognized net of estimated forfeitures, which reduce the expense recorded in the consolidated statements of operations. The selection of applicable estimated forfeiture rates is based on an evaluation of trends in our historical forfeiture data with consideration for other potential driving factors. If in subsequent periods actual forfeitures significantly differ from our initial estimates, we will revise such estimates accordingly. The estimated annual forfeiture rates used for awards granted were 8.63%, 8.85%, and 9.74% in fiscal 2022, 2021, and 2020, respectively. The following two tables separately present stock-based compensation expense both by award type and classification in our consolidated statements of operations (in thousands): Expense - By Award Type Fiscal Year Ended September 30, September 24, September 25, Compensation expense Stock options $ 10,244 $ 13,724 $ 16,718 Restricted stock units (1) (2) 98,433 80,705 65,235 Employee stock purchase plan 6,248 5,269 4,675 Total stock-based compensation 114,925 99,698 86,628 Estimated benefit from income taxes (17,581) (15,790) (14,090) Total stock-based compensation, net of tax $ 97,344 $ 83,908 $ 72,538 (1) Stock-based compensation expense incurred by restricted stock units includes expense from PSUs. (2) Excludes $0.7 million of capitalized stock-based compensation related to internal use software in fiscal 2022. Expense - By Income Statement Line Item Classification Fiscal Year Ended September 30, September 24, September 25, Compensation expense Cost of products and services $ 1,819 $ 2,033 $ 2,072 Research and development 37,061 29,733 25,634 Sales and marketing 41,326 36,432 31,915 General and administrative 34,719 31,500 27,007 Total stock-based compensation 114,925 99,698 86,628 Estimated benefit from income taxes (17,581) (15,790) (14,090) Total stock-based compensation, net of tax $ 97,344 $ 83,908 $ 72,538 The tax benefit that we recognize from shares issued under our ESPP is excluded from the tables above. The tax benefit recognized was not material in fiscal 2022 and fiscal 2020, and was $1.2 million in fiscal 2021. Unrecognized Compensation Expense. As of September 30, 2022, total unrecognized compensation expense associated with employee stock options expected to vest was approximately $13.4 million, which is expected to be recognized over a weighted-average period of 2.3 years. As of September 30, 2022, total unrecognized compensation expense associated with RSUs expected to vest was approximately $190.8 million, which is expected to be recognized over a weighted-average period of 2.4 years. Common Stock Repurchase Program In November 2009, we announced a stock repurchase program, providing for the repurchase of our Class A common stock. The following table summarizes the initial amount of authorized repurchases as well as additional repurchases approved by our Board of Directors as of September 30, 2022 (in thousands): Authorization Period Authorization Amount Fiscal 2010: November 2009 $ 250,000 Fiscal 2010: July 2010 300,000 Fiscal 2011: July 2011 250,000 Fiscal 2012: February 2012 100,000 Fiscal 2015: October 2014 200,000 Fiscal 2017: January 2017 200,000 Fiscal 2018: July 2018 350,000 Fiscal 2019: July 2019 350,000 Fiscal 2021: July 2021 350,000 Fiscal 2022: February 2022 250,000 Fiscal 2022: August 2022 350,000 Total $ 2,950,000 Stock repurchases under the program may be made through open market transactions, negotiated purchases, or otherwise, at times and in amounts that we consider appropriate. The timing of repurchases and the number of shares repurchased depend upon a variety of factors, including price, regulatory requirements, the rate of dilution from our equity compensation plans, and other market conditions. The program does not have a specified expiration date, and can be limited, suspended, or terminated at our discretion at any time without prior notice. Shares repurchased under the program will be returned to the status of authorized but unissued shares of Class A common stock. As of September 30, 2022, the remaining authorization to purchase additional shares was $360.9 million. The following table provides information regarding share repurchase activity under the program during fiscal 2022: Quarterly Repurchase Activity Shares Cost (1) Average Price Paid Per Share (2) (in thousands) Q1 - Quarter ended December 31, 2021 408,508 $ 35,573 $ 87.08 Q2 - Quarter ended April 1, 2022 1,116,032 84,913 76.08 Q3 - Quarter ended July 1, 2022 2,549,474 190,000 74.53 Q4 - Quarter ended September 30, 2022 2,928,536 220,000 75.12 Total 7,002,550 $ 530,486 (1) Cost of share repurchases includes the price paid per share, and excludes commission costs. (2) Average price paid per share excludes commission costs. Dividend Program The following table summarizes dividends declared under the program during fiscal 2022: Fiscal Period Announcement Date Record Date Payment Date Cash Dividend Per Common Share Dividend Payment Q1 - Quarter ended December 31, 2021 February 3, 2022 February 16, 2022 February 23, 2022 $ 0.25 $25.3 million Q2 - Quarter ended April 1, 2022 May 5, 2022 May 17, 2022 May 25, 2022 $ 0.25 $25.1 million Q3 - Quarter ended July 1, 2022 August 9, 2022 August 23, 2022 August 31, 2022 $ 0.25 $24.3 million Q4 - Quarter ended September 30, 2022 November 17, 2022 November 30, 2022 December 8, 2022 $ 0.27 $25.9 million (1) (1) The dividend payment amount for the dividend declared in the fourth quarter of fiscal 2022 is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	12 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Accumulated Other Comprehensive Income	Accumulated Other Comprehensive Loss Other comprehensive income/loss consists of three components: unrealized gains or losses on our AFS marketable investment securities, gains and losses on derivatives in cash flow hedge relationships not yet recognized in earnings, and the gains and losses from the translation of assets and liabilities denominated in non-U.S. dollar functional currencies. Until realized and reported as a component of net income, these comprehensive income items accumulate and are included within accumulated other comprehensive loss, a subsection within stockholders’ equity in our consolidated balance sheets. Unrealized gains and losses on our investment securities are reclassified from AOCI into earnings when realized upon sale, and are determined based on specific identification of securities sold. Unrealized gains and losses on our cash flow hedges are reclassified from AOCI into earnings when the hedged operating expenses are recognized, which is also when the gains and losses are realized. The following table summarizes the changes in the accumulated balances during the period, and includes information regarding the manner in which the reclassifications out of AOCI into earnings affect our consolidated statements of operations (in thousands): Fiscal Year Ended Fiscal Year Ended September 30, 2022 September 24, 2021 Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Beginning Balance $ 220 $ (122) $ (10,128) $ (10,030) $ 818 $ 3,969 $ (15,381) $ (10,594) Other comprehensive income before reclassifications: Unrealized gains/(losses) (6,783) (2,588) — (9,371) (917) (12,704) — (13,621) Foreign currency translation gains/(losses) (1) — — (30,799) (30,799) — — 5,754 5,754 Income tax effect - benefit/(expense) 52 (8) (245) (201) 120 415 (501) 34 Net of tax (6,731) (2,596) (31,044) (40,371) (797) (12,289) 5,253 (7,833) Amounts reclassified from AOCI into earnings: Realized gains/(losses) (2) 527 (2,097) — (1,570) 211 9,032 — 9,243 Income tax effect - benefit/(expense) (3) (2) 332 — 330 (12) (834) — (846) Net of tax 525 (1,765) — (1,240) 199 8,198 — 8,397 Net current-period other comprehensive income/(loss) (6,206) (4,361) (31,044) (41,611) (598) (4,091) 5,253 564 Ending Balance $ (5,986) $ (4,483) $ (41,172) $ (51,641) $ 220 $ (122) $ (10,128) $ (10,030) (1) The foreign currency translation losses during fiscal 2022 were primarily due the strengthening of the U.S. dollar compared to other foreign currencies. (2) Realized gains or losses, if any, from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/(expense), net in our consolidated statements of operations. Realized gains or losses on foreign currency contracts designated as cash flow hedges are included in operating expenses in the consolidated statements of operations. (3) The income tax benefit or expense is included within provision for income taxes in our consolidated statements of operations.

Earnings Per Share

Earnings Per Share	12 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share Basic EPS is computed by dividing net income attributable to Dolby Laboratories, Inc. by the number of weighted-average shares of Class A and Class B common stock outstanding during the period. Through application of the treasury stock method, diluted EPS is computed in the same manner, except that the number of weighted-average shares outstanding is increased by the number of potentially dilutive shares from employee incentive plans during the period. Basic and diluted EPS are computed independently for each fiscal quarter and year-to-date period, which involves the use of different weighted-average share count figures relating to quarterly and annual periods. As a result, and after factoring the effect of rounding to the nearest cent per share, the sum of all four quarter-to-date EPS figures may not equal year-to-date EPS. Potentially dilutive shares represent the hypothetical number of incremental shares issuable under the assumed exercise of outstanding stock options (both vested and unvested) and vesting of outstanding RSUs. The calculation of dilutive shares outstanding excludes securities that would have an antidilutive effect on EPS. The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts): Fiscal Year Ended September 30, September 24, September 25, Numerator: Net income attributable to Dolby Laboratories, Inc. $ 184,087 $ 310,227 $ 231,363 Denominator: Weighted-average shares outstanding—basic 99,990 101,190 100,564 Potential common shares from options to purchase common stock 958 1,994 1,400 Potential common shares from restricted stock units 912 1,376 941 Potential common shares from employee stock purchase plan 123 62 39 Weighted-average shares outstanding—diluted 101,983 104,622 102,944 Net income per share attributable to Dolby Laboratories, Inc.: Basic $ 1.84 $ 3.07 $ 2.30 Diluted $ 1.81 $ 2.97 $ 2.25 Antidilutive awards excluded from calculation: Stock options 587 235 3,209 Restricted stock units 1,158 48 2 Employee stock purchase plan — 2 1

Income Taxes

Income Taxes	12 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesOur income tax expense, deferred tax assets and liabilities, and unrecognized tax benefits reflect management's best assessment of estimated current and future liabilities. We are subject to income taxes in both the U.S. and numerous foreign jurisdictions. Significant judgments and estimates are required in determining the consolidated income tax expense. Income Tax Provision The following two tables present the components of our income before provision for income taxes by geographic region and the portion of our provision for income taxes classified as current and deferred (in thousands): Fiscal Year Ended September 30, September 24, September 25, United States $ 33,318 $ 104,741 $ 32,426 Foreign 181,961 249,771 207,289 Total income before income taxes $ 215,279 $ 354,512 $ 239,715 Fiscal Year Ended September 30, September 24, September 25, Current: Federal $ 2,008 $ 7,216 $ (48,517) State 553 953 735 Foreign 58,285 65,568 61,153 Total current 60,846 73,737 13,371 Deferred: Federal (29,990) (36,035) (4,674) State 8 (63) (111) Foreign 517 (950) (490) Total deferred (29,465) (37,048) (5,275) Provision for income taxes $ 31,381 $ 36,689 $ 8,096 Repatriation of Undistributed Foreign Earnings As a result of the Tax Act, foreign accumulated earnings that were subject to the mandatory Transition Tax as of December 31, 2017, can be repatriated to the U.S. without incurring further U.S. federal tax. The Tax Act changed to a modified territorial tax system through the provision of a 100% dividend received deduction for the foreign-source portions of dividends received from controlled foreign subsidiaries. As a result, we have reevaluated our historical assertion and determined that we no longer consider a vast majority of these earnings to be indefinitely reinvested. During fiscal 2022, we repatriated $175 million of foreign subsidiary earnings which were exempt from foreign withholding tax. As of September 30, 2022, the total undistributed earnings of our foreign subsidiaries were approximately $207 million. The unrecognized deferred tax liability on the portion of the undistributed earnings considered indefinitely reinvested is not material. Deferred Income Taxes Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes, using enacted tax rates in effect for the year in which the differences are expected to reverse. A summary of the tax effects of the temporary differences were as follows (in thousands): Fiscal Year Ended September 30, September 24, Deferred income tax assets: Investments $ 1,339 $ 1,439 Inventories 6,851 6,551 Net operating loss 2,507 3,305 Accrued expenses 11,536 17,686 Stock-based compensation 17,295 16,926 Revenue recognition 4,275 4,245 Depreciation and amortization 105,114 81,963 Lease liability 10,589 15,377 Research and development credits 40,149 31,635 Foreign tax credits 21,244 12,793 Deemed repatriated earnings tax benefit 10,724 9,788 Other 5,657 4,801 Total gross deferred income tax assets 237,280 206,509 Less: valuation allowance (41,087) (33,284) Total deferred income tax assets 196,193 173,225 Deferred income tax liabilities: Right of use asset (10,046) (14,288) Intangible assets (2,579) (2,917) Deferred income tax assets, net $ 183,568 $ 156,020 Net Operating Losses and Tax Credit Carryforwards As of September 30, 2022, the NOL carryforwards for U.S. federal and California were $2.6 million and $5.6 million, respectively, and will start to expire in fiscal 2034 and 2029, respectively. Additionally, we had foreign NOL carryforwards of $7.7 million as of September 30, 2022, an amount which is not subject to expiration. As of September 30, 2022, we had foreign tax credit and federal R&D tax credit carryforwards of $16.4 million and $19.8 million, respectively, which will start to expire in fiscal 2029 and fiscal 2035, respectively. We had California R&D tax credits of $40.6 million, which will carry forward indefinitely, and foreign R&D tax credits of $4.0 million, which will start to expire in fiscal 2028. Valuation Allowance As of September 30, 2022, a $31.7 million valuation allowance was recorded against California deferred tax assets, a $2.9 million valuation allowance was recorded against federal foreign tax credit deferred tax assets, and a $6.5 million valuation allowance was recorded against foreign deferred tax assets for which ultimate realization of its future benefits is uncertain. Effective Tax Rate Each period, the combination of multiple different factors can impact our effective tax rate. These factors include both recurring items such as tax rates and the relative amount of income earned in foreign jurisdictions, as well as discrete items that may occur in, but are not necessarily consistent between periods. A reconciliation of the federal statutory tax rate to our effective tax rate on income from continuing operations was as follows: Fiscal Year Ended September 30, September 24, September 25, Federal statutory rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal effect 0.2 0.2 0.2 Stock-based compensation (0.1) (5.1) (2.2) Research and development tax credits (5.0) (2.6) (3.0) Foreign-derived intangible income deduction (2.3) (2.2) (2.2) U.S. tax on foreign entities 1.8 0.8 3.1 Foreign rate differential (1.8) (3.4) (1.8) Increase (decrease) unrecognized tax benefit 2.8 2.0 (12.9) Other (2.0) (0.4) 1.2 Effective tax rate 14.6 % 10.3 % 3.4 % Our effective tax rate was 14.6% in fiscal 2022, compared with our federal statutory rate of 21.0%, and with our effective tax rate in fiscal 2021 of 10.3%. The increase in our effective tax rate was primarily due to a shift in the mix of earnings to jurisdictions with higher tax rates and lower tax benefits related to settlement of stock-based awards partially offset by benefit from additional research and development tax credits. Our effective tax rate was 10.3% in fiscal 2021, compared with our effective tax rate in fiscal 2020 of 3.4%. The increase in our effective tax rate is primarily related to a benefit in fiscal 2020 from reversals of unrecognized tax benefits that did not recur in fiscal 2021 partially offset by higher benefits in fiscal 2021 related to changes in jurisdictional mix of income and settlement of stock-based awards. Uncertain Tax Positions As of September 30, 2022, the total amount of gross unrecognized tax benefits was $69.7 million, of which $44.0 million, if recognized, would reduce our effective tax rate. Our liability increased from fiscal 2021 primarily due to additional accruals in fiscal 2022. Our liability for unrecognized tax benefits is classified within other non-current liabilities in our consolidated balance sheets. Over the next twelve months, we estimate that there will be no reduction to this amount. Aggregate changes in the balance of gross unrecognized tax benefits, excluding interest and penalties, were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Beginning Balance $ 66,106 $ 60,691 $ 108,539 Gross increases - tax positions taken during prior years 822 220 5,504 Gross decreases - tax positions taken during prior years (178) (247) — Gross increases - tax positions taken during current year 7,784 6,979 7,509 Gross decreases - settlements with tax authorities during current year — (875) (37) Lapse of statute of limitations (4,852) (662) (60,824) Ending Balance $ 69,682 $ 66,106 $ 60,691 Classification of Interest and Penalties We include interest and penalties related to gross unrecognized tax benefits within our provision for income taxes. To the extent accrued interest and penalties do not ultimately become payable, amounts accrued are reduced in the period that such determination is made and are reflected as a reduction of the overall income tax provision. In fiscal year 2022, our current tax provision was increased by interest expense of $1.7 million, while in fiscal year 2021, our current tax provision was increased by interest expense of $1.0 million. Accrued interest and penalties are included within the related tax liability line item in our consolidated balance sheets. Our accrued interest and penalties on unrecognized tax benefits as of September 30, 2022 and September 24, 2021 were as follows (in thousands): Fiscal Year Ended September 30, September 24, Accrued interest $ 6,748 $ 5,030 Accrued penalties 119 47 Total $ 6,867 $ 5,077 We continue to monitor the progress of ongoing income tax controversies and the impact, if any, of the expected tolling of the statute of limitations in various taxing jurisdictions. We file income tax returns in the U.S. federal, states, and foreign jurisdictions. Our major tax jurisdictions are the U.S. federal, California, New York, and the Netherlands. Our operations in certain jurisdictions remain subject to examination for fiscal 2015 to 2021, some of which are currently under audit or review. The resolution of each of these audits is not expected to be material to our consolidated financial statements. We believe that an adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If resolution of any tax issues addressed in our current audits are inconsistent with management’s expectations, we may be required to adjust our tax provision for income taxes in the period such resolution occurs. Provisions enacted in the Tax Act related to the capitalization of research and development expenditures are effective beginning with our fiscal 2023 for U.S. income tax purposes. In addition, the final U.S. foreign tax credit regulations introduced significant changes to foreign tax credit utilization. These provisions are expected to have a material adverse effect on our fiscal 2023 and future tax provisions unless postponed or modified.

Restructuring

Restructuring	9 Months Ended
	Jun. 25, 2021
Restructuring Charges [Abstract]
Restructuring	Restructuring Restructuring charges recorded in our consolidated statements of operations represent costs associated with separate individual restructuring plans implemented in various fiscal periods. Costs arising from these actions, including fluctuations in related balances between fiscal periods, are based on the nature of activities under the various plans. Fiscal 2022 Restructuring Events. In January 2022, we implemented a restructuring plan within our entertainment organization to align resources with a revised business strategy and outlook, and to support our higher priority focus areas. As a result, we recorded $8.9 million in restructuring costs in the fiscal 2022, primarily representing severance and other related benefits offered to over 120 employees that were impacted by this action. Actions related to this plan are expected to be completed by the end of fiscal 2023. The table presented below summarizes the changes in our restructuring accruals (in thousands): Severance Leased facility exit costs and other costs Total Balance at September 25, 2020 $ — $ — $ — Restructuring charges 9,522 718 10,240 Cash payments and adjustments (9,359) (714) (10,073) Balance at September 24, 2021 $ 163 $ 4 $ 167 Restructuring charges 8,874 1,749 10,623 Cash payments and adjustments (3,256) (1,753) (5,009) Balance at September 30, 2022 $ 5,781 $ — $ 5,781 Accruals for restructuring charges incurred for the restructuring plan described above are included within accrued liabilities in our consolidated balance sheets, while restructuring charges are included within restructuring charges in our consolidated statements of operations.

Commitments And Contingencies

Commitments And Contingencies	12 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments And Contingencies	Commitments and Contingencies In the ordinary course of business, we enter into contractual agreements with third parties that include non-cancelable payment obligations, for which we are liable in future periods. These arrangements can include terms binding us to minimum payments and/or penalties if we terminate the agreement for any reason other than an event of default as described by the agreement. The following table presents a summary of our contractual obligations and commitments as of September 30, 2022 (in thousands): Payments Due By Fiscal Period Fiscal 2023 Fiscal Fiscal Fiscal Fiscal Thereafter Total Naming rights $ 12,474 $ 12,794 $ 13,126 $ 13,472 $ 8,534 $ 44,316 $ 104,716 Purchase obligations 28,228 8,425 1,270 252 — — 38,175 Donation commitments 1,797 116 116 116 86 417 2,648 Total $ 42,499 $ 21,335 $ 14,512 $ 13,840 $ 8,620 $ 44,733 $ 145,539 Naming Rights. We are party to agreements for naming rights of certain facilities, most significantly for naming rights and related benefits with respect to the Dolby Theatre in Hollywood, California, the location of the Academy Awards®. The term of this agreement is 20 years, over which we will make payments on a semi-annual basis until fiscal 2032. Our ongoing annual payment obligations are conditioned in part on the Academy Awards being held and broadcast from the Dolby Theatre. Our payment obligations may be suspended or reduced in certain circumstances, including the protracted closure of the Dolby Theatre. Purchase Obligations. Purchase obligations primarily consist of our commitments made under agreements to purchase goods and services related to Dolby Cinema and for purposes that include information technology and telecommunications, marketing and professional services, and manufacturing and other R&D activities. Donation Commitments. Our donation commitments relate to non-cancelable obligations that consist of maintenance services and installation of imaging and audio products in exchange for various marketing, branding, and publicity benefits. These donation agreements either transfer title of our audio and imaging products to the donee or offer use of the products free of charge for a specified period of time via a leasing arrangement. The recipients of these donations participate in or promote the cinema and entertainment industry and our commitments vary in length, lasting up to 15 years.

Business Combinations

Business Combinations	12 Months Ended
	Sep. 30, 2022
Business Combinations [Abstract]
Business Combination	Business Combination On January 31, 2022, we completed the acquisition of all outstanding interests of Millicast, a privately held company. Following the acquisition, Millicast is expected to enable developers to take the interactive events they build with Dolby.io, and stream them from the presenter to large audiences. We have included the financial results of Millicast in our consolidated financial statements from the date of acquisition, and these results were not material. Additionally, the transaction costs associated with the acquisition were not material. The total purchase consideration of the acquisition was $38.8 million. We allocated $8.7 million in purchase consideration to identifiable intangible assets, which primarily consisted of developed technology, with estimated useful lives of 1.5 years to 8 years. We also recorded $31.7 million of goodwill, which is representative of our expectation of benefits and synergies from the integration of Millicast technology with our existing technology and the assembled workforce of Millicast. The fair values assigned to assets acquired and liabilities assumed are based on management’s estimates and assumptions and may be subject to change as additional information is received and certain tax returns are finalized, including potential changes to income tax-related accounts. We expect to finalize the valuation within the one year measurement period.

Operating Segments and Geograph

Operating Segments and Geographic Data	12 Months Ended
	Sep. 30, 2022
Segments, Geographical Areas [Abstract]
Operating Segments and Geographic Data	Operating Segments and Geographic Information Operating Segments Operating segments are defined as components of an enterprise for which separate financial information is available, and which are evaluated regularly by the CODM, or decision-making group, in deciding how to allocate resources and assess performance. Our CODM is our Chief Executive Officer. Reporting segments are operating segments exceeding specified revenue, profit or loss, or asset thresholds for which separate disclosure of information is necessary. We operate as a single reportable segment. This reflects the fact that our CODM continues to evaluate our financial information and resources, and continues to assess the performance of these resources, on a consolidated basis. All required financial segment information is therefore included in our consolidated financial statements. Geographic Information The methods to determine revenue by geographic region for each of the three categories included within total revenue in our consolidated statements of operations are described within the table presented below. Revenue Category Basis For Determining Geographic Location Licensing Region in which our licensees’ headquarters are located Products Destination to which our products are shipped Services Location in which the relevant services are performed The following tables present selected information regarding total revenue by geographic location (amounts presented in thousands). Revenue Composition—U.S . and International Fiscal Year Ended Location September 30, September 24, September 25, United States $ 468,246 $ 419,901 $ 460,972 International 785,547 861,355 700,820 Total revenue $ 1,253,793 $ 1,281,256 $ 1,161,792 Revenue Concentration—Significant Individual Geographic Regions Fiscal Year Ended Location September 30, September 24, September 25, United States 37 % 33 % 40 % South Korea 13 % 14 % 12 % China 20 % 23 % 20 % Japan 8 % 11 % 9 % Europe 10 % 10 % 10 % Other 12 % 9 % 9 % Total 100 % 100 % 100 % Long-lived tangible assets, net of accumulated depreciation, by geographic region were as follows (in thousands): Location September 30, September 24, United States $ 415,493 $ 432,968 International 97,988 101,413 Total long-lived tangible assets, net of accumulated depreciation $ 513,481 $ 534,381

Legal Matters

Legal Matters	12 Months Ended
	Sep. 30, 2022
Loss Contingency, Information about Litigation Matters [Abstract]
Legal Matters	Legal Matters

Related Party Transactions

Related Party Transactions	12 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Parties We maintain contractual agreements relating to certain entities affiliated with the Dolby family, who is considered a related party as our principal stockholder. These jointly-owned entities were established for the purpose of acquiring and leasing commercial property in the U.S. and U.K. primarily for our operational use. Although the entities affiliated with the Dolby family are the limited member or LP in each of these entities, they have a controlling interest based on holding majority economic ownership. We are the managing member or general partner in each of these affiliated entities, and with the exception of isolated instances where portions of these facilities are leased to third parties, we occupy the majority of the space. Therefore, we have consolidated the entities’ assets and liabilities and results of operations in our consolidated financial statements. The share of earnings and net assets of the entities attributable to the limited member or LP, as the case may be, is reflected as controlling interest in our consolidated financial statements. Our interests in these consolidated affiliated entities and the location of the properties leased to Dolby Laboratories as of September 30, 2022 were as follows: Entity Name Minority Ownership Interest Location Of Properties Dolby Properties Burbank, LLC 49.0 % Burbank, California We also own 10.0% minority ownership interest in Dolby Properties, LP, which owns a facility in Wootton Bassett, England. As of September 30, 2022, we are no longer leasing the Wootton Bassett facility. The property leased to Dolby Laboratories through Dolby Properties Brisbane, LLC, located in Brisbane, California, was sold during fiscal 2021. We also lease from our principal stockholder a commercial office building located at 100 Potrero Avenue in San Francisco, California under a term that expires on October 31, 2024. Related party rent expense included in operating expenses in our consolidated statements of operations were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Related party rent expense included in operating expenses $ — $ (392) $ 126 Distributions. Distributions made by the jointly-owned real estate entities to our principal stockholder were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Distributions to principal stockholder $ (1,435) $ (7,362) $ (283)

Retirement Plans

Retirement Plans	12 Months Ended
	Sep. 30, 2022
Pension and Other Postretirement Benefits Cost (Reversal of Cost) [Abstract]
Retirement Plans	Retirement Plans We maintain a tax-qualified Section 401(k) retirement plan for employees in the U.S. and similar plans in foreign jurisdictions. Under the plan, employees are eligible to receive matching contributions and profit-sharing contributions. We also maintain a SERP, a non-qualified, employer-funded defined contribution retirement plan which was terminated in fiscal 2005. Retirement plan expenses, which are included in cost of products and services, R&D, S&M, and G&A expense in our consolidated statements of operations, were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Retirement plan expenses $ 27,378 $ 26,379 $ 25,257

Basis Of Presentation (Policies

Basis Of Presentation (Policies)	12 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Principles Of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of Dolby Laboratories, Inc. and our wholly owned subsidiaries. In addition, we have consolidated the financial results of jointly owned affiliated companies in which our principal stockholder has a controlling interest. We report these controlling interests as a separate line in our consolidated statements of operations as net income attributable to controlling interest and in our consolidated balance sheets as a controlling interest. We eliminate all intercompany accounts and transactions upon consolidation.
Use of Estimates	Use of Estimates The preparation of our financial statements in accordance with U.S. GAAP requires management to make certain estimates and assumptions that affect the amounts reported and disclosed in our consolidated financial statements and accompanying notes. Significant items subject to such estimates and assumptions include estimated shipments by our licensees for which we are owed a sales-based royalty. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Our estimates of royalty-based revenue also take into consideration the macroeconomic effect of global events that may impact our licensees' supply chain activities as well as demand for shipments. Additional significant items subject to such estimates and assumptions include ESPs for performance obligations within revenue arrangements; allowance for credit losses for accounts receivable; carrying values of inventories and certain PP&E, goodwill and intangible assets; fair values of investments; accrued liabilities including unrecognized tax benefits, deferred income tax assets and liabilities, and contingent liabilities: and stock-based compensation. Actual results could differ from our estimates.
Fiscal Year	Fiscal YearOur fiscal year is a 52 or 53 week period ending on the last Friday in September. The fiscal years presented herein include the 53 week period ended September 30, 2022 (fiscal 2022), and the 52 week periods ended September 24, 2021 (fiscal 2021) and September 25, 2020 (fiscal 2020). Our fiscal year ending September 29, 2023 (fiscal 2023) will consist of 52 weeks.

Summary Of Significant Accoun_2

Summary Of Significant Accounting Policies (Policies)	12 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Concentration of Credit Risk	Concentration of Credit Risk Our financial instruments that are exposed to concentrations of credit risk principally consist of cash, cash equivalents, investments, and accounts receivable. Our investment portfolio consists of investment grade securities diversified amongst security types, industries, and issuers. All our securities are held in custody by a recognized financial institution. Our policy limits the amount of credit exposure to a maximum of 5% to any one issuer, except for the U.S. Treasury, and we believe no significant concentration risk exists with respect to these investments. We also mitigate counterparty risk through entering into derivative contracts with high-credit-quality financial institutions. The majority of our licensing revenue is generated from customers outside of the U.S. We manage this risk by performing regular evaluations of the creditworthiness of our licensing customers. In fiscal 2022, revenue from one individual customer accounted for 10% of our total revenue. For fiscal 2021 and 2020, we did not have any individual customers whose revenue exceeded 10% of our total revenue.
Cash and Cash Equivalents	Cash and Cash Equivalents We consider all short-term highly liquid investments with original maturities of 90 days or less from the date of purchase to be cash equivalents. Cash and cash equivalents primarily consist of funds held in general checking accounts, money market accounts, and U.S. agency securities.
Restricted Cash	Restricted CashRestricted cash on our consolidated balance sheets consists of cash contributed by Dolby and third-party licensors to Via, our wholly-owned subsidiary, that may only be used for licensor enforcement actions or licensee compliance activities related to certain Via-administered patent pools, as well as to disperse costs associated with any audit of Via for the Wideband Code Division Multiple Access (W-CDMA) patent pool
Investments	Investments All of our investments are classified as AFS, with the exception of our mutual fund investments held in our SERP, which are classified as trading securities, and our equity securities. Investments that have an original maturity of 91 days or more at the date of purchase and a current maturity of less than one year are classified as short-term investments, while investments with a current maturity of more than one year are classified as long-term investments. Our AFS securities and trading securities are recorded at fair value in our consolidated balance sheets. Unrealized gains and losses on our AFS securities are reported as a component of AOCI, while realized gains and losses and credit losses are reported as a component of net income. Upon sale, gains and losses are reclassified from AOCI into earnings, and are determined based on specific identification of securities sold. We evaluate our investment portfolio for impairment by comparing the fair value with the cost basis for each of our investment securities. If the fair value of our AFS securities is less than amortized cost, such securities are considered impaired. If we have the intent to sell the debt security, or if it is more likely than not that we will be required to sell the debt security before recovery of its amortized cost, the difference between the amortized cost (net of allowance, if any) and the fair value of the securities is reported as an impairment loss in net income. Impaired AFS securities that we intend to hold are evaluated to determine whether we need to recognize an allowance for credit losses, limited to the difference between the fair value and amortized cost of the security. Equity Securities Equity securities for which we possess the ability to exercise significant influence, but not control, over operating and financing decisions are accounted for under the equity method. In applying the equity method, we record the investment at cost and subsequently increase or decrease the carrying amount by our proportionate share of the investee's net earnings or losses. We record dividends or other equity distributions as reductions in the carrying value of the investment. Our share of the equity method investee's net income or loss is included in other income/(expense), net in the consolidated statements of operations, and was $5.0 million, $4.7 million, and $2.4 million in fiscal 2022, fiscal 2021, and fiscal 2020, respectively. Our equity method investment is included within long-term investments in our consolidated balance sheets.
Allowance for Doubtful Accounts	Allowance for Credit Losses We maintain a provision for estimated credit losses on receivables resulting from our customers' inability to make required payments. In determining the provision, we pool receivables with similar risk characteristics to evaluate the collectability of our receivables. Risk characteristics considered in creating these risk pools include assessing historical or expected loss patterns, credit ratings, current macroeconomic conditions that could impact collectability of cash flows, and structure of customer agreements. In cases where circumstances have changed such that specific customers no longer share similar risk characteristics, customers are excluded from their current pool and their risk profiles are evaluated separately. We recognize allowances for credit losses based on our actual historical loss information, the current business environment, and reasonable and supportable forecasts. Actual future losses from uncollectible accounts may differ from our estimates.
Inventories	Inventories Inventories are accounted for using the first-in, first-out method, and are valued at the lower of cost and net realizable value. We evaluate our ending inventories for estimated excess quantities and obsolescence. Our evaluation includes the analysis of future sales demand by product within specific time horizons. Inventories in excess
Property, Plant, and Equipment	Property, Plant, and Equipment PP&E is stated at cost less accumulated depreciation. Depreciation expense is recognized on a straight-line basis according to estimated useful lives assigned to each of our different categories of PP&E as summarized within the following table: PP&E Category Useful Life Computer equipment and software 3 to 5 years Machinery and equipment 3 to 8 years Furniture and fixtures 5 to 8 years Leasehold improvements Lesser of useful life or related lease term Equipment provided under operating leases 15 years Buildings and building improvements 20 to 40 years We may encounter scenarios where assets we acquire may deviate from the established standard useful life provided above. Such occurrences are evaluated on a case by case basis, and are assigned a useful life commensurate with the facts and circumstances associated with the specific PP&E being acquired. We capitalize certain costs incurred during the construction phase of a project or asset into construction-in-progress until the construction process is complete. Once the related asset is placed into service, we transfer its carrying value into the appropriate fixed asset category and begin depreciating the value over its useful life. Equipment Provided Under Operating Leases. In arrangements that we assess as operating leases, we recognize our equipment installed at third-party sites as a fixed asset and depreciate the asset on a straight-line basis.
Internal Use Software	Internal Use Software. We capitalize qualifying internal-use software development costs, consisting primarily of external and internal labor, including stock based compensation, incurred during the application development stage. Costs incurred during the preliminary project and post-implementation stages are charged to expense. Capitalized costs are included in PP&E, net of accumulated amortization in our consolidated balance sheets. Our capitalized internal use software costs are amortized on a straight-line basis over estimated useful lives of three
Goodwill, Intangible Assets, and Long-Lived Assets	Goodwill, Intangible Assets, and Long-Lived Assets We perform an assessment of goodwill for potential impairment annually during our third fiscal quarter or more frequently if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. For our annual goodwill test as of the fiscal quarter ended July 1, 2022, a qualitative assessment was performed and we concluded that it was more likely than not that its fair value was in excess of its carrying amount. Accordingly, no quantitative assessment was performed and no impairment was recorded. We did not incur any goodwill impairment losses in any of the periods presented. Intangible assets are stated at their original cost less accumulated amortization, and those with definite lives are amortized over their estimated useful lives. Our intangible assets principally consist of acquired technology, patents, trademarks, customer relationships and contracts, the majority of which are amortized on a straight-line basis over their useful lives using a range from three We review long-lived assets, including intangible assets, for impairment whenever events or a change in circumstances indicate an asset’s carrying value may not be recoverable. Recoverability of an asset is measured by comparing its carrying value to the total future undiscounted cash flows that the asset is expected to generate. If it is determined that an asset is not recoverable, an impairment loss is recorded in the amount by which the carrying value of the asset exceeds its estimated fair value.
Revenue Recognition	Revenue Recognition We enter into revenue arrangements with our customers to license technologies, trademarks and patents for sound, imaging and voice solutions, and to sell products and services. We recognize revenue when we satisfy a performance obligation by transferring control over the use of a license, product, or service to a customer. For additional financial information and a summary of our accounting policy, refer to Note 3. "Revenue Recognition" to our consolidated financial statements.
Cost of Revenue	Cost of Revenue Cost of licensing. Cost of licensing primarily consists of amortization expenses associated with purchased intangible assets and intangible assets acquired in business combinations. Cost of licensing also includes IP royalty obligations to third parties, depreciation of our Dolby Cinema equipment provided under operating leases in collaborative arrangements, and direct fees incurred. Cost of products and services. Cost of products primarily consists of the cost of materials related to products sold, applied labor, and manufacturing overhead. Our cost of products also includes third party royalty obligations paid to license IP that we include in our products. Cost of services primarily consists of the personnel and personnel-related costs of employees performing our professional services, and those of outside consultants, and reimbursable expenses incurred on behalf of customers.
Stock-Based Compensation	Stock-Based Compensation We measure expenses associated with all employee stock-based compensation awards using a fair-value method and record such expense in our consolidated financial statements on a straight-line basis over the requisite service period.
Advertising and Promotional Costs	Advertising and Promotional Costs Advertising and promotional costs are charged to S&M expense as incurred. Our advertising and promotional costs were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Advertising and promotional costs $ 51,422 $ 52,253 $ 61,125
Income Taxes	Income Taxes We use the asset and liability method, under which deferred income tax assets and liabilities are determined based upon the difference between the financial statement carrying amounts and the tax bases of assets and liabilities, and NOL carryforwards are measured using the enacted tax rate expected to apply to taxable income in the years in which the differences are expected to be reversed. In assessing the realizability of deferred tax assets, we consider whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The realization of deferred tax assets is additionally dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. We consider the scheduled reversal of deferred tax liabilities and projected future taxable income in making this assessment, and we record a valuation allowance to reduce our deferred tax assets when it's more-likely-than-not that some portion or all of the deferred tax assets will not be realized. We record an unrecognized tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the tax authorities. We include interest and penalties related to gross unrecognized tax benefits within our provision for income taxes. To the extent accrued interest and penalties do not ultimately become payable, amounts accrued are reversed in the period that such determination is made and are reflected as a reduction of the overall income tax provision.
Recently Issued Accounting Standards	Recently Issued Accounting Standards We continually assess any ASUs or other new accounting pronouncements issued by the FASB to determine their applicability and impact on us. Where it is determined that a new accounting pronouncement will result in a change to our financial reporting, we take the appropriate steps to ensure that such changes are properly reflected in our consolidated financial statements or notes thereto. Adopted Standards Income Taxes. In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , which modifies and eliminates certain exceptions to the general principles of ASC 740, Income Taxes. We adopted this standard in the first quarter of fiscal 2022, and it did not have a material impact on our consolidated financial statements. Standards Not Yet Adopted
Revenue Recognition	Revenue Recognition We enter into revenue arrangements with our customers to license technologies, trademarks and patents for sound, imaging and voice solutions, and to sell products and services. We recognize revenue when we satisfy a performance obligation by transferring control over the use of a license, product, or service to a customer. A. Identification of the Contract or Contracts with Customers We generally determine that a contract with a customer exists upon the execution of an agreement and after consideration of collectability, which could include an evaluation of the customer's payment history, the existence of a standby letter-of-credit between the customer’s financial institution and our financial institution, public financial information, and other factors. At contract inception, we also evaluate whether two or more non-standard agreements with a customer should be combined and accounted for as a single contract. B. Identification of Performance Obligations in a Contract We generate revenue principally from the following sources, which represent performance obligations in our contracts with customers: • Licensing. We license our technologies, including patents, to a range of customers who incorporate them into their products for enhanced audio, imaging and voice functionality across broadcast, mobile, CE, PC, gaming, and other markets. • Product Sales. We design and provide audio and imaging products for the cinema, television, broadcast, communications, and entertainment industries. • Services. We provide various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment, including equipment training, mixing room alignment, equalization, as well as audio, color and light image calibration. We also offer a developer platform, Dolby.io, that enables developers to access our technologies through audio and video APIs for building high-quality communications, media, and streaming solutions. • PCS. We provide PCS for products sold and for equipment leased, and we support the implementation of our licensing technologies in our licensees’ products. • Equipment Leases. We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences by leasing equipment and licensing our IP. We also lease hardware that facilitates the Dolby conferencing experience, including the Dolby Conference Phone, and the Dolby Voice Room solution. • Licensing Administration Fees. We generate service fees for managing patent pools on behalf of third party patent owners through our wholly-owned subsidiary, Via. Some of our revenue arrangements include multiple performance obligations, such as hardware, software, support and maintenance, and extended warranty services. We evaluate whether promised products and services are distinct performance obligations. The majority of our arrangements with multiple performance obligations pertain to our digital cinema server and processor sales that include the following distinct performance obligations to which we allocate portions of the transaction price based on their stand-alone selling price: • Digital cinema server hardware and embedded software, which is dependent on and interrelated with the hardware. Accordingly, the hardware and embedded software represent a single performance obligation. • The right to support and maintenance, which is included with the purchase of the digital cinema server hardware, is a distinct performance obligation. • The right to receive commissioning services is a distinct performance obligation within the sale of the Dolby Atmos Cinema Processor. These services consist of the review of venue designs specifying proposed speaker placement as well as calibration services performed for installed speakers to ensure optimal playback. C. Determination of Transaction Price for Performance Obligations in a Contract After identifying the distinct performance obligations, we determine the transaction price in accordance with the terms of the underlying executed contract which may include variable consideration such as discounts, rebates, refunds, rights of returns, and incentives. We assess and update, if necessary, the amount of variable consideration to which we are entitled for each reporting period. At the end of each reporting period, we estimate and accrue a liability for returns and adjustments as a reduction to revenue based on several factors, including past returns history. With the exception of our sales-based royalties, we evaluate whether a significant financing component exists when we recognize revenue in advance of customer payments that occur over time. For example, some of our licensing arrangements include payment terms greater than one year from when we transfer control of our IP to a licensee and the receipt of the final payment for that IP. If a significant financing component exists, we classify a portion of the transaction price as interest income, instead of recognizing all of the transaction price as revenue. We do not adjust the transaction price for the effects of financing if, at contract inception, the period between the transfer of control to a customer and final payment is expected to be one year or less. D. Allocation of Transaction Price to Distinct Performance Obligations in a Contract For our sales-based royalties where the license is the predominant item to which the royalties relate, we present all revenue as licensing. For revenue arrangements that include multiple performance obligations, we determine the stand-alone selling price for each distinct performance obligation based on the actual selling prices made to customers. If the performance obligation is not sold separately, we estimate the stand-alone selling price. We do so by considering market conditions such as competitor pricing strategies, customer specific information and industry technology lifecycles, internal conditions such as cost and pricing practices, or applying the residual approach method when the selling price of the good, most commonly a license, is highly variable or uncertain. Once the transaction price, including any variable consideration, has been determined, we allocate the transaction price to the performance obligations identified in the contract and recognize revenue as or when control is transferred for each distinct performance obligation. E. Revenue Recognition as Control is Transferred to a Customer We generate our licensing revenue by licensing our technologies and patents to various types of licensees, such as chip manufacturers ("implementation licensees"), consumer product manufacturers, software vendors, and communications service providers. Our revenue recognition policies for each of these arrangements are summarized below. Initial fees from implementation licensees. Implementation licensees incorporate our technologies into their chipsets that, once approved by Dolby, are available for purchase by OEMs for use in end-user products. Implementation licensees only pay us a nominal initial fee on contract execution as consideration for the ongoing services that we provide to assist in their implementation process. Revenue from these initial fees are recognized ratably over the contractual term as a component of licensing revenue. Sales-based licensing fees. In our royalty bearing licensing agreements with OEMs, control is transferred upon the later of contract execution or the contract’s effective date. We apply the royalty exception, which requires that we recognize sales-based royalties when the sales occur based on our estimates. These estimates involve the use of historical data and judgment for several key attributes including industry estimates of expected shipments, the percentage of markets using our technologies, and average sale prices. Generally, our estimates represent the current period’s shipments to which we expect our licensees to submit royalty statements in the following quarter. Upon receipt of royalty statements from the licensees with the actual reporting of sales-based royalties that we estimated previously, we record a favorable or unfavorable adjustment based on the difference, if any, between estimated and actual sales. In the first quarter of fiscal 2022, we recorded an unfavorable adjustment of approximately $6 million, which was primarily related to shipments that occurred in our fourth quarter of fiscal 2021 (July through September) and largely based on actual royalty statements received from licensees. In the second quarter of fiscal 2022, we recorded an unfavorable adjustment of $3 million, and in the third and fourth quarter of fiscal 2022, we recorded a favorable adjustment of $3 million and $3 million, respectively, each primarily related to shipments that occurred in the preceding fiscal quarter, and largely based on actual royalty statements received from licensees. Fixed and guaranteed licensing fees. In certain cases, our arrangements require the licensee to pay fixed, non-refundable fees. In these cases, control is transferred and fees are recognized upon the later of contract execution or the effective date. Additionally and separate from initial fees from implementation licensees, our sales- and usage-based licensing agreements include a nominal fee, which is also recognized at a point in time in which control of the IP has been transferred. Revenue from these arrangements is included as a component of licensing revenue. Recoveries. Through compliance efforts, we identify misreported licensed activity related to non-current periods. We may record a favorable or unfavorable revenue adjustment in connection with the findings from these compliance efforts generally upon resolution with the licensee through agreement of the findings, or upon receipt of the licensee’s correction statement. Revenue from these arrangements is included as a component of licensing revenue. We undertake activities aimed at identifying potential unauthorized uses of our technologies, which when successful result in the recognition of revenue. Recoveries stem from third parties who agree to remit payments to us based on past use of our technology. In these scenarios, a legally binding contract did not exist at time of use of our technology, and therefore, we recognize revenue recoveries upon execution of the agreement as that is the point in time to which a contract exists and control is transferred. This revenue is classified as licensing revenue. In general, we classify legal costs associated with activities aimed at identifying potential unauthorized uses of our technologies, auditing existing licensees, and on occasion, pursuing litigation as S&M in our consolidated statements of operations. We recognize licensing revenue gross of withholding taxes, which our licensees remit directly to their local tax authorities, and for which we receive a partial foreign tax credit in our income tax provision. In addition to our licensing arrangements, we also enter into arrangements to deliver products and services. Product Sales. Revenue from the sale of products is recognized when the customer obtains control of the promised good or service, which is generally upon shipment. Payments are generally made within 90 days of sale. Services. We provide various services, such as engineering services related to movie soundtrack print mastering, equipment training and maintenance, mixing room alignment, equalization, and image calibration, which we bill on a fixed fee and time and materials basis. Most of these services are of a short duration and are recognized as control of the performance obligations are transferred which is when the related services are performed. Cloud Services. We provide access to audio and video APIs through our developer platform as well as cloud encoding services, generally, on either a consumption or subscription basis. Revenue related to cloud services provided on a consumption basis is recognized when the customer utilizes the services, based on the quantity of services consumed. Revenue related to cloud services provided on a subscription basis is recognized ratably over the contract term as the customer receives and consumes the benefits of the cloud services. Collaborative Arrangements. We collaborate with established cinema exhibitors to offer Dolby Cinema, a branded premium cinema offering for movie audiences. Under such collaborations, Dolby and the exhibitor are both active participants, and share the risks and rewards associated with the business. Accordingly, these collaborations are governed by revenue sharing arrangements under which Dolby receives revenue based on box office receipts, reported to Dolby by exhibitor partners on a monthly or quarterly basis, our proprietary designs and trademarks as well as for the use of our equipment at the exhibitor's venue. The use of our product solution meets the definition of a lease, and for the related portion of Dolby's share of revenue, we apply ASC 842, Leases , and recognize revenue based on monthly box office reports from exhibitors. Our revenue share is recognized as licensing revenue in our consolidated statements of operations. In addition, we also enter into hybrid agreements where a portion of our revenue share involves guaranteed payments, which in some cases result in classifying the arrangement as a sales-type lease. In such arrangements, we consider control to transfer at the point in time to which we have installed and tested the equipment, at which point we record such guaranteed payments as product revenue. Via Administration Fee. We generate service fees for managing patent pools on behalf of third party patent owners through our wholly-owned subsidiary, Via. As an agent to licensors in the patent pool, Via receives a share of the sales-based royalty that the patent pool licensors earn from licensees. As such, we apply the sales-based royalty exception as the service provided is directly related to the patent pool licensors’ provision of IP, which results in recognition based on estimates of the licensee’s quarter shipments that use the pool’s patents. In addition to sales-based royalties, Via also has contracts where the fees are fixed. The revenue share Via receives from licensors on fixed fee contracts is recognized over the term in which we are providing services associated with the fixed fee contract. We recognize our administrative fees net of the consideration paid to the patent licensors in the pool as licensing revenue.

Summary Of Significant Accoun_3

Summary Of Significant Accounting Policies (Tables)	12 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Schedule Of Property, Plant, And Equipment, Estimated Useful Life	PP&E is stated at cost less accumulated depreciation. Depreciation expense is recognized on a straight-line basis according to estimated useful lives assigned to each of our different categories of PP&E as summarized within the following table: PP&E Category Useful Life Computer equipment and software 3 to 5 years Machinery and equipment 3 to 8 years Furniture and fixtures 5 to 8 years Leasehold improvements Lesser of useful life or related lease term Equipment provided under operating leases 15 years Buildings and building improvements 20 to 40 years
Advertising and Promotional Costs	Advertising and promotional costs are charged to S&M expense as incurred. Our advertising and promotional costs were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Advertising and promotional costs $ 51,422 $ 52,253 $ 61,125
Schedule of Foreign Currency Translation Gains (Losses)	These losses were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Foreign currency transaction losses $ (1,283) $ (749) $ (1,361)

Revenue Recognition (Tables)

Revenue Recognition (Tables)	12 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table presents a summary of the composition of our revenue for all periods presented (in thousands, except percentage amounts): Fiscal Year Ended Revenue September 30, 2022 September 24, 2021 September 25, 2020 Licensing $ 1,164,533 93 % $ 1,214,147 95 % $ 1,078,577 93 % Products and services 89,260 7 % 67,109 5 % 83,215 7 % Total revenue $ 1,253,793 100 % $ 1,281,256 100 % $ 1,161,792 100 % The following table presents the composition of our licensing revenue for all periods presented (in thousands, except percentage amounts): Fiscal Year Ended Licensing Revenue By Market September 30, 2022 September 24, 2021 September 25, 2020 Broadcast $ 433,992 37 % $ 475,648 39 % $ 439,415 41 % Mobile 238,735 21 % 261,232 22 % 226,972 21 % CE 186,285 16 % 181,944 15 % 152,608 14 % PC 151,079 13 % 141,919 12 % 132,302 12 % Other 154,442 13 % 153,404 12 % 127,280 12 % Total licensing revenue $ 1,164,533 100 % $ 1,214,147 100 % $ 1,078,577 100 % Fiscal Year Ended Revenue By Geographic Location September 30, 2022 September 24, 2021 September 25, 2020 United States $ 468,246 37 % $ 419,901 33 % $ 460,972 40 % International 785,547 63 % 861,355 67 % 700,820 60 % Total revenue $ 1,253,793 100 % $ 1,281,256 100 % $ 1,161,792 100 %
Contract with Customer, Asset and Liability	The following table presents a summary of the balances to which contract assets and liabilities related to revenue are recorded for all periods presented (in thousands, except percentage amounts): September 30, 2022 September 24, 2021 Change ($) Change (%) Accounts receivable, net $ 243,593 $ 232,609 $ 10,984 5 % Contract assets, net 176,093 182,316 (6,223) (3) % Contract liabilities - current 18,588 18,473 115 1 % Contract liabilities - non-current 23,203 23,713 (510) (2) %

Composition Of Certain Financ_2

Composition Of Certain Financial Statement Captions (Tables)	12 Months Ended
	Sep. 30, 2022
Composition Of Certain Financial Statement Captions [Abstract]
Schedule Of Accounts Receivable	September 30, September 24, Trade accounts receivable $ 162,531 $ 160,112 Accounts receivable from patent administration program licensees 92,896 81,241 Contract assets 176,218 182,524 Accounts receivable and contract assets, gross 431,645 423,877 Less: allowance for credit losses on accounts receivable and contract assets (11,959) (8,952) Total accounts receivable and contract assets, net $ 419,686 $ 414,925
Schedule Of Allowance For Doubtful Accounts	Allowance for Credit Losses Beginning Balance Charges/(Credits) Additions/(Deductions) Ending Balance For fiscal year ended: September 25, 2020 $ 9,775 $ 7,689 $ (1,556) $ 15,908 September 24, 2021 15,908 (2,889) (4,067) 8,952 September 30, 2022 8,952 5,460 (7) 14,405
Schedule Of Inventories	Inventories September 30, September 24, Raw materials $ 10,026 $ 2,792 Work in process 4,955 3,461 Finished goods 8,568 4,712 Total inventories $ 23,549 $ 10,965
Schedule Of Prepaid Expenses And Other Current Assets	September 30, September 24, Prepaid expenses $ 26,851 $ 29,964 Other current assets 23,224 32,773 Total prepaid expenses and other current assets $ 50,075 $ 62,737
Schedule Of Accrued Liabilities	September 30, September 24, Amounts payable to patent administration program partners $ 63,106 $ 72,847 Accrued compensation and benefits 84,111 107,322 Accrued professional fees 13,057 11,737 Unpaid property, plant, and equipment additions 15,428 17,839 Accrued customer refunds 3,674 14,151 Accrued market development funds 7,206 7,777 Other accrued liabilities 43,655 31,055 Total accrued liabilities $ 230,237 $ 262,728
Schedule Of Other Non-Current Liabilities	September 30, September 24, Supplemental retirement plan obligations $ 4,127 $ 4,877 Non-current tax liabilities (1) 83,758 85,063 Other liabilities 12,237 15,370 Total other non-current liabilities $ 100,122 $ 105,310

Investments and Fair Value Meas

Investments and Fair Value Measurements (Tables)	12 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured on Recurring Basis	Our cash and investment portfolio consisted of the following (in thousands): September 30, 2022 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 474,813 $ — $ — $ 474,813 $ 474,813 $ — $ — Cash equivalents: Money market funds 134,987 — — 134,987 134,987 — — U.S. agency securities 10,328 — (1) 10,327 — 10,327 — Cash and cash equivalents 620,128 — (1) 620,127 609,800 10,327 — Short-term investments: Certificate of deposit 23,033 8 (47) 22,994 — 22,994 — U.S. agency securities 3,412 — (21) 3,391 — 3,391 — Government bonds 57,417 — (705) 56,712 52,833 3,879 — Commercial paper 8,786 1 (15) 8,772 — 8,772 — Corporate bonds 72,730 — (734) 71,996 — 71,996 — Municipal debt securities 25,589 — (241) 25,348 — 25,348 — Short-term investments 190,967 9 (1,763) 189,213 52,833 136,380 — Long-term investments: U.S. agency securities 861 — (39) 822 — 822 — Government bonds 43,816 — (2,222) 41,594 38,055 3,539 — Corporate bonds 29,684 4 (1,349) 28,339 — 28,339 — Municipal debt securities 21,483 — (626) 20,857 — 20,857 — Other investments (1) 10,902 — — 10,902 — — — Long-term investments 106,746 4 (4,236) 102,514 38,055 53,557 — Total cash, cash equivalents, and investments $ 917,841 $ 13 $ (6,000) $ 911,854 $ 700,688 $ 200,264 $ — Investments held in supplemental retirement plan: Assets $ 4,225 $ — $ — $ 4,225 $ 4,225 $ — $ — Included in prepaid expenses and other current assets and other non-current assets Liabilities $ 4,225 $ — $ — $ 4,225 $ 4,225 $ — $ — Included in accrued liabilities and other non-current liabilities Currency derivatives as hedge instruments: Liabilities: Included in other accrued liabilities $ — $ — $ (4,882) $ (4,882) $ — $ (4,882) $ — Liabilities: Included in other non-current liabilities — — (420) (420) — (420) — (1) Other investments as of September 30, 2022 is comprised of an equity method investment of $5.9 million and an equity security without a readily determinable fair value of $5.0 million. September 24, 2021 Cost Unrealized Estimated Fair Value Gains Losses Total Level 1 Level 2 Level 3 Cash and cash equivalents: Cash $ 990,182 $ — $ — $ 990,182 $ 990,182 $ — $ — Cash equivalents: Money market funds 235,198 — — 235,198 235,198 — — Cash and cash equivalents 1,225,380 — — 1,225,380 1,225,380 — — Short-term investments: Certificate of deposit 1,795 — — 1,795 — 1,795 — U.S. agency securities 1,096 6 — 1,102 — 1,102 — Government bonds 100 2 — 102 102 — — Commercial paper 5,184 2 — 5,186 — 5,186 — Corporate bonds 18,850 116 — 18,966 — 18,966 — Municipal debt securities 11,660 29 (1) 11,688 — 11,688 — Short-term investments 38,685 155 (1) 38,839 102 38,737 — Long-term investments: U.S. agency securities 2,264 13 (2) 2,275 — 2,275 — Government bonds 11,784 38 (16) 11,806 4,966 6,840 — Corporate bonds 32,116 61 (25) 32,152 — 32,152 — Municipal debt securities 10,080 58 (8) 10,130 — 10,130 — Other investments (1) 6,456 — — 6,456 — — — Long-term investments 62,700 170 (51) 62,819 4,966 51,397 — Total cash, cash equivalents, and investments $ 1,326,765 $ 325 $ (52) $ 1,327,038 $ 1,230,448 $ 90,134 $ — Investments held in supplemental retirement plan: Assets $ 4,975 $ — $ — $ 4,975 $ 4,975 $ — $ — Included in prepaid expenses and other current assets and other non-current assets Liabilities $ 4,975 $ — $ — $ 4,975 $ 4,975 $ — $ — Included in accrued liabilities and other non-current liabilities Currency derivatives as hedge instruments: Assets: Included in other current assets $ — $ 689 $ — $ 689 $ — $ 689 $ — Liabilities: Included in other accrued liabilities — — (197) (197) — (197) —
Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value	The following table presents the gross unrealized losses and fair value for those AFS securities that were in an unrealized loss position for less than twelve months and for greater than twelve months as of September 30, 2022 and September 24, 2021 (in thousands): September 30, 2022 September 24, 2021 Less Than 12 Months Greater Than 12 Months Less Than 12 Months Investment Type Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Certificate of deposit $ 10,352 $ (47) $ — $ — $ 600 $ — U.S. agency securities 13,144 (5) 1,395 (55) 1,449 (2) Government bonds 89,741 (2,593) 8,566 (332) 8,940 (16) Commercial paper 5,770 (15) — — — — Corporate bonds 81,044 (1,523) 18,306 (561) 22,964 (25) Municipal debt securities 40,119 (712) 3,336 (156) 7,031 (9) Total $ 240,170 $ (4,895) $ 31,603 $ (1,104) $ 40,984 $ (52)
Debt Securities, Available-for-sale	Investment Maturities. The following table summarizes the amortized cost and estimated fair value of the AFS securities within our investment portfolio based on stated maturities as of September 30, 2022 and September 24, 2021, which are recorded within cash equivalents and both short and long-term investments in our consolidated balance sheets (in thousands): September 30, 2022 September 24, 2021 Range of maturity Amortized Cost Fair Value Amortized Cost Fair Value Due within 1 year $ 336,291 $ 334,537 $ 273,884 $ 274,037 Due in 1 to 2 years 53,721 51,332 40,739 40,874 Due in 2 to 5 years 42,122 40,280 15,506 15,490 Total $ 432,134 $ 426,149 $ 330,129 $ 330,401

Property, Plant & Equipment (Ta

Property, Plant & Equipment (Tables)	12 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment	As of September 30, 2022 and September 24, 2021, PP&E consisted of the following (in thousands): Property, Plant, and Equipment September 30, September 24, Land $ 41,774 $ 42,041 Buildings and building improvements 287,544 284,146 Leasehold improvements 86,793 88,549 Machinery and equipment 136,995 128,008 Computer equipment and software 232,108 258,981 Furniture and fixtures 33,797 33,565 Equipment provided under operating leases 229,177 214,109 Construction-in-progress 23,037 22,923 Property, plant, and equipment, gross 1,071,225 1,072,322 Less: accumulated depreciation (557,744) (537,941) Property, plant, and equipment, net $ 513,481 $ 534,381

Leases (Tables)

Leases (Tables)	12 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Lease Cost Components, Supplemental Cash Flow Information and Supplemental Balance Sheet Information Schedules	The components of lease expense were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Lease cost Operating lease cost $ 17,260 $ 19,261 $ 23,570 Variable lease cost 1,560 755 1,175 Total lease cost $ 18,820 $ 20,016 $ 24,745 Supplemental cash flow information related to leases was as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Other information Cash paid for amounts included in the measurement of operating lease liabilities $ 16,957 $ 19,173 $ 22,043 Right-of-use assets obtained in exchange for operating lease obligations 1,737 5,225 34,198 Supplemental balance sheet information related to leases was as follows: September 30, September 24, Operating Leases Weighted-average remaining lease term 5.5 years 5.8 years Weighted-average discount rate 3.2 % 3.1 % Fiscal Year Ended September 30, September 24, September 25, Operating Lease Income Variable operating lease income $ 31.6 $ 9.5 $ 10.4 Fixed operating lease income 3.0 4.2 3.7
Maturities of Lessee Lease Liabilities after Adoption of 842 Schedule	The following tables presents the maturity analysis of lease liabilities (in thousands): September 30, 2022 Operating Leases Fiscal 2023 $ 15,995 Fiscal 2024 12,529 Fiscal 2025 9,097 Fiscal 2026 5,957 Fiscal 2027 4,638 Thereafter 12,240 Total undiscounted lease payments 60,456 Less: imputed interest (9,514) Total lease liabilities $ 50,942
Maturities of Lessor Operating Lease Payments Schedule	The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): September 30, 2022 Operating Leases Sales-Type Leases Fiscal 2023 $ 767 $ 1,595 Fiscal 2024 787 795 Fiscal 2025 807 395 Fiscal 2026 732 395 Fiscal 2027 — — Thereafter — — Total undiscounted cash flows $ 3,093 3,180 Less: present value of lease payments (recognized as lease receivables) (2,801) Difference $ 379
Maturities of Lessor Sales-Type Lease Payments Schedule	The following table presents the maturity analysis of fixed lease payments due to Dolby (in thousands): September 30, 2022 Operating Leases Sales-Type Leases Fiscal 2023 $ 767 $ 1,595 Fiscal 2024 787 795 Fiscal 2025 807 395 Fiscal 2026 732 395 Fiscal 2027 — — Thereafter — — Total undiscounted cash flows $ 3,093 3,180 Less: present value of lease payments (recognized as lease receivables) (2,801) Difference $ 379

Goodwill & Intangible Assets (T

Goodwill & Intangible Assets (Tables)	12 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The following table outlines changes to the carrying amount of goodwill (in thousands): Goodwill Balance at September 25, 2020 $ 336,945 Acquired goodwill 3,345 Translation adjustments 404 Balance at September 24, 2021 $ 340,694 Acquired goodwill (1) 31,695 Translation adjustments (7,185) Measurement period adjustments (57) Balance at September 30, 2022 $ 365,147
Schedule of Finite-Lived Intangible Assets	Intangible assets are stated at their original cost less accumulated amortization, and principally consist of acquired patents, technology, customer relationships and contracts, and trademarks. Intangible assets subject to amortization consisted of the following (in thousands): September 30, 2022 September 24, 2021 Intangible Assets, Net Cost Accumulated Net Cost Accumulated Net Acquired patents and technology $ 355,622 $ (253,080) $ 102,542 $ 343,280 $ (233,789) $ 109,491 Customer relationships 66,142 (56,572) 9,570 65,822 (52,730) 13,092 Other intangible assets 22,973 (22,820) 153 22,972 (22,665) 307 Total $ 444,737 $ (332,472) $ 112,265 $ 432,074 $ (309,184) $ 122,890
Future Amortization Expense	As of September 30, 2022, expected amortization expense of our intangible assets in future periods was as follows (in thousands): Fiscal Year Amortization Expense 2023 $ 26,057 2024 23,930 2025 8,860 2026 7,969 2027 7,285 Thereafter 38,164 Total $ 112,265

Stockholders' Equity And Stoc_2

Stockholders' Equity And Stock-Based Compensation (Tables)	12 Months Ended
	Sep. 30, 2022
Stockholders' Equity And Stock-Based Compensation [Abstract]
Summary Of Restricted Stock Units Issued To Officers, Directors And Employees Under 2005 Stock Incentive Plan	The following table summarizes information about RSUs, including PSUs, issued under our 2020 Stock Plan: Shares Weighted-Average (in thousands) Non-vested at September 24, 2021 3,335 $ 77.46 Granted 1,737 86.42 Vested (1,205) 72.92 Forfeitures (365) 81.10 Non-vested at September 30, 2022 3,502 $ 83.09
Schedule of Share-Based Payment Fair Value by Vesting Date	The fair value as of the respective vesting dates of RSUs were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Restricted stock units - vest date fair value $ 106,919 $ 101,108 $ 72,426
Schedule Of Fair Value Of Stock-Based Awards Estimated Using Weighted-Average Assumptions	The weighted-average assumptions used in the determination of the fair value of our stock options were as follows: Fiscal Year Ended September 30, September 24, September 25, Expected term (in years) 4.78 4.88 4.91 Risk-free interest rate 1.5 % 0.4 % 1.6 % Expected stock price volatility 28.8 % 28.5 % 24.2 % Dividend yield 1.1 % 1.1 % 1.3 %
Summary Of Weighted-Average Fair Value Of Stock Options Granted And Total Intrinsic Value Of Stock Options Exercised	The weighted-average assumptions used in the determination of the fair value of our stock options were as follows: Fiscal Year Ended September 30, September 24, September 25, Expected term (in years) 4.78 4.88 4.91 Risk-free interest rate 1.5 % 0.4 % 1.6 % Expected stock price volatility 28.8 % 28.5 % 24.2 % Dividend yield 1.1 % 1.1 % 1.3 % The following table summarizes the weighted-average fair value (per share) of stock options granted and the total intrinsic value of stock options exercised (in thousands): Fiscal Year Ended September 30, September 24, September 25, Stock options granted - weighted-average grant date fair value $ 21.17 $ 20.93 $ 13.76 Stock options exercised - intrinsic value 22,885 102,812 47,267
Schedule Of Stock-Based Compensation Expense By Plan	The following two tables separately present stock-based compensation expense both by award type and classification in our consolidated statements of operations (in thousands): Expense - By Award Type Fiscal Year Ended September 30, September 24, September 25, Compensation expense Stock options $ 10,244 $ 13,724 $ 16,718 Restricted stock units (1) (2) 98,433 80,705 65,235 Employee stock purchase plan 6,248 5,269 4,675 Total stock-based compensation 114,925 99,698 86,628 Estimated benefit from income taxes (17,581) (15,790) (14,090) Total stock-based compensation, net of tax $ 97,344 $ 83,908 $ 72,538 (1) Stock-based compensation expense incurred by restricted stock units includes expense from PSUs. (2) Excludes $0.7 million of capitalized stock-based compensation related to internal use software in fiscal 2022.
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs	Expense - By Income Statement Line Item Classification Fiscal Year Ended September 30, September 24, September 25, Compensation expense Cost of products and services $ 1,819 $ 2,033 $ 2,072 Research and development 37,061 29,733 25,634 Sales and marketing 41,326 36,432 31,915 General and administrative 34,719 31,500 27,007 Total stock-based compensation 114,925 99,698 86,628 Estimated benefit from income taxes (17,581) (15,790) (14,090) Total stock-based compensation, net of tax $ 97,344 $ 83,908 $ 72,538
Schedule of Tax Benefit from Exercise of Options	Expense - By Income Statement Line Item Classification Fiscal Year Ended September 30, September 24, September 25, Compensation expense Cost of products and services $ 1,819 $ 2,033 $ 2,072 Research and development 37,061 29,733 25,634 Sales and marketing 41,326 36,432 31,915 General and administrative 34,719 31,500 27,007 Total stock-based compensation 114,925 99,698 86,628 Estimated benefit from income taxes (17,581) (15,790) (14,090) Total stock-based compensation, net of tax $ 97,344 $ 83,908 $ 72,538
Schedule of Treasury Stock Authorizations	The following table summarizes the initial amount of authorized repurchases as well as additional repurchases approved by our Board of Directors as of September 30, 2022 (in thousands): Authorization Period Authorization Amount Fiscal 2010: November 2009 $ 250,000 Fiscal 2010: July 2010 300,000 Fiscal 2011: July 2011 250,000 Fiscal 2012: February 2012 100,000 Fiscal 2015: October 2014 200,000 Fiscal 2017: January 2017 200,000 Fiscal 2018: July 2018 350,000 Fiscal 2019: July 2019 350,000 Fiscal 2021: July 2021 350,000 Fiscal 2022: February 2022 250,000 Fiscal 2022: August 2022 350,000 Total $ 2,950,000
Schedule of Stock Repurchase Activity	The following table provides information regarding share repurchase activity under the program during fiscal 2022: Quarterly Repurchase Activity Shares Cost (1) Average Price Paid Per Share (2) (in thousands) Q1 - Quarter ended December 31, 2021 408,508 $ 35,573 $ 87.08 Q2 - Quarter ended April 1, 2022 1,116,032 84,913 76.08 Q3 - Quarter ended July 1, 2022 2,549,474 190,000 74.53 Q4 - Quarter ended September 30, 2022 2,928,536 220,000 75.12 Total 7,002,550 $ 530,486 (1) Cost of share repurchases includes the price paid per share, and excludes commission costs. (2) Average price paid per share excludes commission costs.
Dividends Declared	The following table summarizes dividends declared under the program during fiscal 2022: Fiscal Period Announcement Date Record Date Payment Date Cash Dividend Per Common Share Dividend Payment Q1 - Quarter ended December 31, 2021 February 3, 2022 February 16, 2022 February 23, 2022 $ 0.25 $25.3 million Q2 - Quarter ended April 1, 2022 May 5, 2022 May 17, 2022 May 25, 2022 $ 0.25 $25.1 million Q3 - Quarter ended July 1, 2022 August 9, 2022 August 23, 2022 August 31, 2022 $ 0.25 $24.3 million Q4 - Quarter ended September 30, 2022 November 17, 2022 November 30, 2022 December 8, 2022 $ 0.27 $25.9 million (1) (1) The dividend payment amount for the dividend declared in the fourth quarter of fiscal 2022 is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Tables)	12 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The following table summarizes the changes in the accumulated balances during the period, and includes information regarding the manner in which the reclassifications out of AOCI into earnings affect our consolidated statements of operations (in thousands): Fiscal Year Ended Fiscal Year Ended September 30, 2022 September 24, 2021 Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Investment Securities Cash Flow Hedges Currency Translation Adjustments Total Beginning Balance $ 220 $ (122) $ (10,128) $ (10,030) $ 818 $ 3,969 $ (15,381) $ (10,594) Other comprehensive income before reclassifications: Unrealized gains/(losses) (6,783) (2,588) — (9,371) (917) (12,704) — (13,621) Foreign currency translation gains/(losses) (1) — — (30,799) (30,799) — — 5,754 5,754 Income tax effect - benefit/(expense) 52 (8) (245) (201) 120 415 (501) 34 Net of tax (6,731) (2,596) (31,044) (40,371) (797) (12,289) 5,253 (7,833) Amounts reclassified from AOCI into earnings: Realized gains/(losses) (2) 527 (2,097) — (1,570) 211 9,032 — 9,243 Income tax effect - benefit/(expense) (3) (2) 332 — 330 (12) (834) — (846) Net of tax 525 (1,765) — (1,240) 199 8,198 — 8,397 Net current-period other comprehensive income/(loss) (6,206) (4,361) (31,044) (41,611) (598) (4,091) 5,253 564 Ending Balance $ (5,986) $ (4,483) $ (41,172) $ (51,641) $ 220 $ (122) $ (10,128) $ (10,030) (1) The foreign currency translation losses during fiscal 2022 were primarily due the strengthening of the U.S. dollar compared to other foreign currencies. (2) Realized gains or losses, if any, from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/(expense), net in our consolidated statements of operations. Realized gains or losses on foreign currency contracts designated as cash flow hedges are included in operating expenses in the consolidated statements of operations. (3) The income tax benefit or expense is included within provision for income taxes in our consolidated statements of operations.

Per Share Data (Tables)

Per Share Data (Tables)	12 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth the computation of basic and diluted EPS attributable to Dolby Laboratories, Inc. (in thousands, except per share amounts): Fiscal Year Ended September 30, September 24, September 25, Numerator: Net income attributable to Dolby Laboratories, Inc. $ 184,087 $ 310,227 $ 231,363 Denominator: Weighted-average shares outstanding—basic 99,990 101,190 100,564 Potential common shares from options to purchase common stock 958 1,994 1,400 Potential common shares from restricted stock units 912 1,376 941 Potential common shares from employee stock purchase plan 123 62 39 Weighted-average shares outstanding—diluted 101,983 104,622 102,944 Net income per share attributable to Dolby Laboratories, Inc.: Basic $ 1.84 $ 3.07 $ 2.30 Diluted $ 1.81 $ 2.97 $ 2.25 Antidilutive awards excluded from calculation: Stock options 587 235 3,209 Restricted stock units 1,158 48 2 Employee stock purchase plan — 2 1

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Components Of Income Before Provision For Income Taxes	The following two tables present the components of our income before provision for income taxes by geographic region and the portion of our provision for income taxes classified as current and deferred (in thousands): Fiscal Year Ended September 30, September 24, September 25, United States $ 33,318 $ 104,741 $ 32,426 Foreign 181,961 249,771 207,289 Total income before income taxes $ 215,279 $ 354,512 $ 239,715
Schedule Of Provision For Income Taxes	Fiscal Year Ended September 30, September 24, September 25, Current: Federal $ 2,008 $ 7,216 $ (48,517) State 553 953 735 Foreign 58,285 65,568 61,153 Total current 60,846 73,737 13,371 Deferred: Federal (29,990) (36,035) (4,674) State 8 (63) (111) Foreign 517 (950) (490) Total deferred (29,465) (37,048) (5,275) Provision for income taxes $ 31,381 $ 36,689 $ 8,096
Summary Of Tax Effects Of The Temporary Differences Between Carrying Amounts And Amounts Used For Tax	A summary of the tax effects of the temporary differences were as follows (in thousands): Fiscal Year Ended September 30, September 24, Deferred income tax assets: Investments $ 1,339 $ 1,439 Inventories 6,851 6,551 Net operating loss 2,507 3,305 Accrued expenses 11,536 17,686 Stock-based compensation 17,295 16,926 Revenue recognition 4,275 4,245 Depreciation and amortization 105,114 81,963 Lease liability 10,589 15,377 Research and development credits 40,149 31,635 Foreign tax credits 21,244 12,793 Deemed repatriated earnings tax benefit 10,724 9,788 Other 5,657 4,801 Total gross deferred income tax assets 237,280 206,509 Less: valuation allowance (41,087) (33,284) Total deferred income tax assets 196,193 173,225 Deferred income tax liabilities: Right of use asset (10,046) (14,288) Intangible assets (2,579) (2,917) Deferred income tax assets, net $ 183,568 $ 156,020
Reconciliation Of Federal Statutory Tax Rate To Our Effective Tax Rate	A reconciliation of the federal statutory tax rate to our effective tax rate on income from continuing operations was as follows: Fiscal Year Ended September 30, September 24, September 25, Federal statutory rate 21.0 % 21.0 % 21.0 % State income taxes, net of federal effect 0.2 0.2 0.2 Stock-based compensation (0.1) (5.1) (2.2) Research and development tax credits (5.0) (2.6) (3.0) Foreign-derived intangible income deduction (2.3) (2.2) (2.2) U.S. tax on foreign entities 1.8 0.8 3.1 Foreign rate differential (1.8) (3.4) (1.8) Increase (decrease) unrecognized tax benefit 2.8 2.0 (12.9) Other (2.0) (0.4) 1.2 Effective tax rate 14.6 % 10.3 % 3.4 %
Aggregate Changes In Balance Of Gross Unrecognized Tax Benefits, Excluding Interest And Penalties	Aggregate changes in the balance of gross unrecognized tax benefits, excluding interest and penalties, were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Beginning Balance $ 66,106 $ 60,691 $ 108,539 Gross increases - tax positions taken during prior years 822 220 5,504 Gross decreases - tax positions taken during prior years (178) (247) — Gross increases - tax positions taken during current year 7,784 6,979 7,509 Gross decreases - settlements with tax authorities during current year — (875) (37) Lapse of statute of limitations (4,852) (662) (60,824) Ending Balance $ 69,682 $ 66,106 $ 60,691
Schedule of Accrued Interest and Penalties on Unrecognized Tax Benefits	Our accrued interest and penalties on unrecognized tax benefits as of September 30, 2022 and September 24, 2021 were as follows (in thousands): Fiscal Year Ended September 30, September 24, Accrued interest $ 6,748 $ 5,030 Accrued penalties 119 47 Total $ 6,867 $ 5,077

Restructuring (Tables)

Restructuring (Tables)	12 Months Ended
	Sep. 30, 2022
Restructuring Charges [Abstract]
Restructuring and Related Costs	The table presented below summarizes the changes in our restructuring accruals (in thousands): Severance Leased facility exit costs and other costs Total Balance at September 25, 2020 $ — $ — $ — Restructuring charges 9,522 718 10,240 Cash payments and adjustments (9,359) (714) (10,073) Balance at September 24, 2021 $ 163 $ 4 $ 167 Restructuring charges 8,874 1,749 10,623 Cash payments and adjustments (3,256) (1,753) (5,009) Balance at September 30, 2022 $ 5,781 $ — $ 5,781

Commitments And Contingencies (

Commitments And Contingencies (Tables)	12 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Schedule Of Contractual Obligations And Commitments	The following table presents a summary of our contractual obligations and commitments as of September 30, 2022 (in thousands): Payments Due By Fiscal Period Fiscal 2023 Fiscal Fiscal Fiscal Fiscal Thereafter Total Naming rights $ 12,474 $ 12,794 $ 13,126 $ 13,472 $ 8,534 $ 44,316 $ 104,716 Purchase obligations 28,228 8,425 1,270 252 — — 38,175 Donation commitments 1,797 116 116 116 86 417 2,648 Total $ 42,499 $ 21,335 $ 14,512 $ 13,840 $ 8,620 $ 44,733 $ 145,539

Operating Segments and Geogra_2

Operating Segments and Geographic Data (Tables)	12 Months Ended
	Sep. 30, 2022
Segments, Geographical Areas [Abstract]
Revenue By Geographic Region	Revenue Category Basis For Determining Geographic Location Licensing Region in which our licensees’ headquarters are located Products Destination to which our products are shipped Services Location in which the relevant services are performed The following tables present selected information regarding total revenue by geographic location (amounts presented in thousands). Revenue Composition—U.S . and International Fiscal Year Ended Location September 30, September 24, September 25, United States $ 468,246 $ 419,901 $ 460,972 International 785,547 861,355 700,820 Total revenue $ 1,253,793 $ 1,281,256 $ 1,161,792
Schedule Of Concentration Of Revenue From Individual Geographic Regions	Revenue Concentration—Significant Individual Geographic Regions Fiscal Year Ended Location September 30, September 24, September 25, United States 37 % 33 % 40 % South Korea 13 % 14 % 12 % China 20 % 23 % 20 % Japan 8 % 11 % 9 % Europe 10 % 10 % 10 % Other 12 % 9 % 9 % Total 100 % 100 % 100 %
Schedule Of Long-Lived Tangible Assets, Net Of Accumulated Depreciation, By Geographic Region	Long-lived tangible assets, net of accumulated depreciation, by geographic region were as follows (in thousands): Location September 30, September 24, United States $ 415,493 $ 432,968 International 97,988 101,413 Total long-lived tangible assets, net of accumulated depreciation $ 513,481 $ 534,381

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Schedule Of Ownership Interest In The Consolidated Affiliated Entities	Our interests in these consolidated affiliated entities and the location of the properties leased to Dolby Laboratories as of September 30, 2022 were as follows: Entity Name Minority Ownership Interest Location Of Properties Dolby Properties Burbank, LLC 49.0 % Burbank, California We also own 10.0% minority ownership interest in Dolby Properties, LP, which owns a facility in Wootton Bassett, England. As of September 30, 2022, we are no longer leasing the Wootton Bassett facility. The property leased to Dolby Laboratories through Dolby Properties Brisbane, LLC, located in Brisbane, California, was sold during fiscal 2021. We also lease from our principal stockholder a commercial office building located at 100 Potrero Avenue in San Francisco, California under a term that expires on October 31, 2024. Related party rent expense included in operating expenses in our consolidated statements of operations were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Related party rent expense included in operating expenses $ — $ (392) $ 126 Distributions. Distributions made by the jointly-owned real estate entities to our principal stockholder were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Distributions to principal stockholder $ (1,435) $ (7,362) $ (283)

Retirement Plans Retirement Pla

Retirement Plans Retirement Plans (Tables)	12 Months Ended
	Sep. 30, 2022
Pension and Other Postretirement Benefits Cost (Reversal of Cost) [Abstract]
Schedule of Costs of Retirement Plans	Retirement plan expenses, which are included in cost of products and services, R&D, S&M, and G&A expense in our consolidated statements of operations, were as follows (in thousands): Fiscal Year Ended September 30, September 24, September 25, Retirement plan expenses $ 27,378 $ 26,379 $ 25,257

Summary Of Significant Accoun_4

Summary Of Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Thousands		12 Months Ended
		Sep. 30, 2022		Sep. 24, 2021	Sep. 25, 2020
Summary Of Significant Accounting Policies [Line Items]
Maximum credit exposure (percent)		5%
Income (Loss) from Equity Method Investments		$ 5,000		$ 4,700	$ 2,400
Advertising expense		51,422		52,253	61,125
Transaction and re-measurement gains/losses		(1,283)		(749)	$ (1,361)
Derivative, Notional Amount		74,100
Operating lease right-of-use assets		46,530		67,128
Operating lease liabilities		50,942
Other Comprehensive Income (Loss), before Reclassifications, before Tax		9,371		13,621
Realized gains/(losses)	[1]	1,570		(9,243)
Cash Flow Hedges
Summary Of Significant Accounting Policies [Line Items]
Other Comprehensive Income (Loss), before Reclassifications, before Tax		2,588		12,704
Realized gains/(losses)		$ 2,097	[1]	$ (9,032)
Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Intangible assets with definite lives, useful life, minimum years		3 years
Minimum [Member] | Internal Use Software [Member]
Summary Of Significant Accounting Policies [Line Items]
Intangible assets with definite lives, useful life, minimum years		3 years
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Intangible assets with definite lives, useful life, minimum years		18 years
Foreign Exchange Forward [Member]
Summary Of Significant Accounting Policies [Line Items]
Derivative, Remaining Maturity		31 days		38 days
Notional amount of derivative		$ 56,600		$ 35,300
Foreign Exchange Forward [Member] | Cash Flow Hedging
Summary Of Significant Accounting Policies [Line Items]
Derivative, Notional Amount				$ 15,700
[1]Realized gains or losses, if any, from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/(expense), net in our consolidated statements of operations

Summary Of Significant Accoun_5

Summary Of Significant Accounting Policies (Schedule Of Property, Plant, And Equipment, Estimated Useful Life) (Details)	12 Months Ended
	Sep. 30, 2022
Minimum [Member] | Systems And Software [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life, years	3 years
Minimum [Member] | Machinery And Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life, years	3 years
Minimum [Member] | Furniture And Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life, years	5 years
Minimum [Member] | Buildings [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life, years	20 years
Maximum [Member] | Systems And Software [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life, years	5 years
Maximum [Member] | Machinery And Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life, years	8 years
Maximum [Member] | Furniture And Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life, years	8 years
Maximum [Member] | Buildings [Member]
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life, years	40 years
Maximum [Member] | Leased Equipment
Property, Plant and Equipment [Line Items]
Property, plant, and equipment, useful life, years	15 years

Revenue Recognition (Narrative)

Revenue Recognition (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended				12 Months Ended
	Sep. 30, 2022	Jul. 01, 2022	Apr. 01, 2022	Dec. 31, 2021	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Expected timing of satisfaction period, or less					1 year
Revenue adjustment	$ 3	$ 3	$ 3	$ 6
Revenue recognized					$ 16.8

Revenue Recognition (Performanc

Revenue Recognition (Performance Obligation) (Details) $ in Millions	12 Months Ended
	Sep. 30, 2022 USD ($) country
Revenue from Contract with Customer [Abstract]
Remaining performance obligation | $	$ 41.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Countries technologies are licensed in | country	70
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected timing of satisfaction period	1 year
Remaining performance obligation, percent	45%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected timing of satisfaction period	1 year
Remaining performance obligation, percent	18%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected timing of satisfaction period	1 year
Remaining performance obligation, percent	37%

Revenue Recognition (Schedule o

Revenue Recognition (Schedule of Disaggregation of Revenue) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 1,253,793	$ 1,281,256	$ 1,161,792
Revenue from contract with customer, percent	100%	100%	100%
United States
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 468,246	$ 419,901	$ 460,972
Revenue from contract with customer, percent	37%	33%	40%
International
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 785,547	$ 861,355
Revenue from contract with customer, percent	63%	67%	60%
Licensing
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 1,164,533	$ 1,214,147	$ 1,078,577
Revenue from contract with customer, percent	93%	95%	93%
Revenue from contract with customer, licensing percent	100%	100%	100%
Products and services
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 89,260	$ 67,109	$ 83,215
Revenue from contract with customer, percent	7%	5%	7%
Broadcast
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 433,992	$ 475,648	$ 439,415
Revenue from contract with customer, licensing percent	37%	39%	41%
Mobile
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 238,735	$ 261,232	$ 226,972
Revenue from contract with customer, licensing percent	21%	22%	21%
CE
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 186,285	$ 181,944	$ 152,608
Revenue from contract with customer, licensing percent	16%	15%	14%
PC
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 151,079	$ 141,919	$ 132,302
Revenue from contract with customer, licensing percent	13%	12%	12%
Other
Revenue from External Customer [Line Items]
Revenue from contract with customer	$ 154,442	$ 153,404	$ 127,280
Revenue from contract with customer, licensing percent	13%	12%	12%

Revenue Recognition (Summary of

Revenue Recognition (Summary of Contract Assets and Liabilities) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021
Revenue from Contract with Customer [Abstract]
Accounts receivable, net	$ 243,593	$ 232,609
Other non-current assets	55,149	61,257
Contract liabilities	18,588	18,473
Non-current contract liabilities	23,203	23,713
Other non-current liabilities	100,122	$ 105,310
Change ($)
Accounts receivable, net	10,984
Contract assets	(6,223)
Contract liabilities - current	115
Contract liabilities - non-current	$ (510)
Change (%)
Accounts receivable, net	5%
Contract assets	(3.00%)
Contract liabilities - current	1%
Contract liabilities - non-current	(2.00%)

Composition Of Certain Financ_3

Composition Of Certain Financial Statement Captions (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Composition Of Certain Financial Statement Captions [Line Items]
Trade accounts receivable	$ 162,531	$ 160,112
Unbilled accounts receivable	106,900	97,500
Raw materials	10,026	2,792
Gain on sale of assets	0	13,871	$ 0
Other Noncurrent Assets
Composition Of Certain Financial Statement Captions [Line Items]
Raw materials	$ 2,800	$ 1,900

Composition Of Certain Financ_4

Composition Of Certain Financial Statement Captions (Schedule Of Accounts Receivable) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Composition Of Certain Financial Statement Captions [Abstract]
Trade accounts receivable	$ 162,531	$ 160,112
Accounts receivable from patent administration program partners	92,896	81,241
Contract with Customer, Asset, after Allowance for Credit Loss, Current	176,218	182,524
Accounts receivable and contract assets, gross	431,645	423,877
Accounts Receivable And Contract With Customer, Asset, Allowance For Credit Loss, Current	(11,959)	(8,952)
Total accounts receivable and contract assets, net	$ 419,686	$ 414,925

Composition Of Certain Financ_5

Composition Of Certain Financial Statement Captions (Schedule Of Allowance For Doubtful Accounts) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Fiscal Year	$ 8,952	$ 15,908	$ 9,775
Charged to Operations	5,460	(2,889)	7,689
Deductions	(7)	(4,067)	(1,556)
Balance at End of Fiscal Year	$ 14,405	$ 8,952	$ 15,908

Composition Of Certain Financ_6

Composition Of Certain Financial Statement Captions (Schedule Of Inventories) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Composition Of Certain Financial Statement Captions [Abstract]
Raw materials	$ 10,026	$ 2,792
Work in process	4,955	3,461
Finished goods	8,568	4,712
Inventories	$ 23,549	$ 10,965

Composition Of Certain Financ_7

Composition Of Certain Financial Statement Captions (Schedule Of Prepaid Expenses And Other Current Assets) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Composition Of Certain Financial Statement Captions [Abstract]
Prepaid assets	$ 26,851	$ 29,964
Other current assets	23,224	32,773
Prepaid expenses and other current assets	$ 50,075	$ 62,737

Composition Of Certain Financ_8

Composition Of Certain Financial Statement Captions (Schedule Of Accrued Liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Composition Of Certain Financial Statement Captions [Abstract]
Amounts payable to joint licensing program partners	$ 63,106	$ 72,847
Accrued compensation and benefits	84,111	107,322
Accrued professional fees	13,057	11,737
Unpaid property, plant, and equipment additions	15,428	17,839
Accrued customer refunds	3,674	14,151
Accrued market development funds	7,206	7,777
Other accrued liabilities	43,655	31,055
Accrued liabilities	$ 230,237	$ 262,728

Composition Of Certain Financ_9

Composition Of Certain Financial Statement Captions (Schedule Of Other Non-Current Liabilities) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Composition Of Certain Financial Statement Captions [Abstract]
Supplemental retirement plan obligations	$ 4,127	$ 4,877
Non-current tax liabilities	83,758	85,063
Other liabilities	12,237	15,370
Other non-current liabilities	$ 100,122	$ 105,310

Investments and Fair Value Me_2

Investments and Fair Value Measurements (Schedule Of Financial Assets Carried At Fair Value) (Details) - USD ($) $ in Thousands		12 Months Ended
		Sep. 30, 2022		Sep. 24, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents, at Carrying Value		$ 620,128
Cash				$ 1,225,380
Short-term investments, cost		432,134		330,129
Short-term investments, unrealized gains		0
Short-term investments, unrealized losses		(1)		0
Short-term investments, total		426,149		330,401
Long-term investments, Total				62,819
Total cash, cash equivalents, and investments, cost		917,841		1,326,765
Total cash, cash equivalents, and investments, unrealized gains		13		325
Total cash, cash equivalents, and investments, unrealized losses		(6,000)		(52)
Total cash, cash equivalents, and investments, total		911,854		1,327,038
Assets		$ 620,127		$ 1,225,380
Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]		Accrued liabilities		Accrued liabilities
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]		Other non-current liabilities
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]				Prepaid expenses and other current assets
Equity Method Investments		$ 5,900
Government bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments, Cost		57,417		$ 100
Short-term investments, Unrealized Gains		0		2
Short-term investments, Unrealized Losses		(705)		0
Short-term investments, Total		56,712		102
Long-term investments, Cost		43,816		11,784
Long-term investments, Unrealized Gains		0		38
Long-term investments, Unrealized Losses		(2,222)		16
Long-term investments, Total		41,594		11,806
U.S. agency securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments, Cost				1,096
Long-term investments, Cost		861		2,264
Long-term investments, Unrealized Gains		0		13
Long-term investments, Unrealized Losses		(39)		2
Long-term investments, Total		822		2,275
Commercial paper
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments, Cost		8,786		5,184
Short-term investments, Unrealized Gains		1		2
Short-term investments, Unrealized Losses		(15)		0
Short-term investments, Total		8,772		5,186
Total cash, cash equivalents, and investments, cost		5,770		0
Total cash, cash equivalents, and investments, unrealized gains		15		0
Corporate bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments, Cost		72,730		18,850
Short-term investments, Unrealized Gains		0		116
Short-term investments, Unrealized Losses		(734)		0
Short-term investments, Total		71,996		18,966
Long-term investments, Cost		29,684		32,116
Long-term investments, Unrealized Gains		4		61
Long-term investments, Unrealized Losses		(1,349)		25
Long-term investments, Total		28,339		32,152
Municipal debt securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments, Cost		25,589		11,660
Short-term investments, Unrealized Gains		0		29
Short-term investments, Unrealized Losses		(241)		1
Short-term investments, Total		25,348		11,688
Long-term investments, Cost		21,483		10,080
Long-term investments, Unrealized Gains		0		58
Long-term investments, Unrealized Losses		(626)		8
Long-term investments, Total		20,857		10,130
Total cash, cash equivalents, and investments, cost		40,119		7,031
Other long-term investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term investments, Cost		10,902	[1]	6,456	[2]
Long-term investments, Unrealized Gains		0	[1]	0	[2]
Long-term investments, Unrealized Losses		0	[1]	0	[2]
Long-term investments, Total		10,902	[1]	6,456	[2]
Long-term investments		5,000
Short-term investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments, Cost		190,967		38,685
Short-term investments, Unrealized Gains		9		155
Short-term investments, Unrealized Losses		(1,763)		1
Short-term investments, Total		189,213		38,839
Long-term investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term investments, Cost		106,746		62,700
Long-term investments, Unrealized Gains		4		170
Long-term investments, Unrealized Losses		(4,236)		51
Long-term investments, Total		102,514
Certificates of Deposit
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments, Cost		23,033		1,795
Short-term investments, Unrealized Gains		8		0
Short-term investments, Unrealized Losses		(47)		0
Short-term investments, Total		22,994		1,795
U.S. agency securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments, Cost		3,412
Short-term investments, Unrealized Gains		0		6
Short-term investments, Unrealized Losses		(21)		0
Short-term investments, Total		3,391		1,102
Cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents, at Carrying Value		474,813
Cash		474,813		990,182
Money market funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash Equivalents, at Carrying Value		134,987
Cash		134,987		235,198
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash		609,800		1,225,380
Short-term investments		52,833		102
Long-term investments		38,055		4,966
Assets		700,688		1,230,448
Derivative Liability, Current		0		0
Derivative Liability, Noncurrent		0
Derivative Asset, Current				0
Level 1 | Government bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments		52,833		102
Long-term investments		38,055		4,966
Level 1 | Other long-term investments
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term investments	[2]			0
Level 1 | Investments held in supplemental retirement plan:
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets		4,225		4,975
Liabilities		4,225		4,975
Level 1 | Cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash		474,813		990,182
Level 1 | Money market funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash		134,987		235,198
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash		10,327		0
Short-term investments		136,380		38,737
Long-term investments		53,557		51,397
Assets		200,264		90,134
Derivative Liability, Current		(4,882)		(197)
Derivative Liability, Noncurrent		(420)
Derivative Asset, Current				689
Level 2 | Government bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments		3,879		0
Long-term investments		3,539		6,840
Level 2 | U.S. agency securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term investments		822		2,275
Level 2 | Commercial paper
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments		8,772		5,186
Level 2 | Corporate bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments		71,996		18,966
Long-term investments		28,339		32,152
Level 2 | Municipal debt securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments		25,348		11,688
Long-term investments		20,857		10,130
Level 2 | Certificates of Deposit
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments		22,994		1,795
Level 2 | U.S. agency securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Short-term investments		3,391		1,102
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets		0		0
Derivative Liability, Current		0		0
Derivative Liability, Noncurrent		0
Derivative Asset, Current				0
Derivative Financial Instruments, Liabilities, Current
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Currency derivatives as hedge instruments, liabilities, cost				0
Currency derivatives as hedge instruments, unrealized gains		0		0
Currency derivatives as hedge instruments, unrealized loss		(4,882)		(197)
Derivative Financial Instruments, Liabilities, Current, Amortized Cost Basis		0
Derivative Liability, Current		(4,882)		(197)
us-Derivative Financial Instruments, Liabilities, Noncurrent
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Currency derivatives as hedge instruments, unrealized gains		0
Currency derivatives as hedge instruments, unrealized loss		(420)
Derivative Liability, Noncurrent		(420)
Derivative Financial Instruments, Liabilities, Noncurrent, Amortized Cost Basis		$ 0
Derivative Financial Instruments, Assets, Current
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Currency derivatives as hedge instruments, assets, cost				0
Currency derivatives as hedge instruments, unrealized gains				689
Currency derivatives as hedge instruments, unrealized loss				0
Derivative Asset, Current				$ 689
[1]Other investments as of September 30, 2022 is comprised of an equity method investment of $5.9 million and an equity security without a readily determinable fair value of $5.0 million.[2]Other investments as of September 24, 2021 is comprised of one equity method investment.

Investments and Fair Value Me_3

Investments and Fair Value Measurements (Unrealized Loss Position) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	$ 240,170	$ 40,984
Less Than 12 Months, Fair Value	917,841	1,326,765
Less Than 12 Months, Gross Unrealized Losses	(4,895)	(52)
Less Than 12 Months, Gross Unrealized Losses	(13)	(325)
Greater than 12 months, Fair Value	31,603
Greater than 12 months, Gross Unrealized Losses	(1,104)
Certificates of Deposit
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	10,352	600
Less Than 12 Months, Gross Unrealized Losses	(47)	0
Greater than 12 months, Fair Value	0
Greater than 12 months, Gross Unrealized Losses	0
U.S. agency securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	13,144	1,449
Less Than 12 Months, Gross Unrealized Losses	(5)	(2)
Greater than 12 months, Fair Value	1,395
Greater than 12 months, Gross Unrealized Losses	(55)
Corporate bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	81,044	22,964
Less Than 12 Months, Gross Unrealized Losses	(1,523)	(25)
Greater than 12 months, Fair Value	18,306
Greater than 12 months, Gross Unrealized Losses	(561)
Municipal debt securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	40,119	7,031
Less Than 12 Months, Gross Unrealized Losses	(712)	(9)
Greater than 12 months, Fair Value	3,336
Greater than 12 months, Gross Unrealized Losses	(156)
Government bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	89,741	8,940
Less Than 12 Months, Gross Unrealized Losses	(2,593)	(16)
Greater than 12 months, Fair Value	8,566
Greater than 12 months, Gross Unrealized Losses	(332)
Commercial paper
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Less Than 12 Months, Fair Value	5,770	0
Less Than 12 Months, Gross Unrealized Losses	(15)	$ 0
Greater than 12 months, Fair Value	0
Greater than 12 months, Gross Unrealized Losses	$ 0

Investments and Fair Value Me_4

Investments and Fair Value Measurements Investments and Fair Value Measurements (Investment Maturities) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Amortized Cost
Due within 1 year	$ 336,291	$ 273,884
Due in 1 to 2 years	53,721	40,739
Due in 2 to 3 years	42,122	15,506
Total	432,134	330,129
Fair Value
Due within 1 year	334,537	274,037
Due in 1 to 2 years	51,332	40,874
Due in 2 to 3 years	40,280	15,490
Total	$ 426,149	$ 330,401

Property, Plant & Equipment (De

Property, Plant & Equipment (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 1,071,225	$ 1,072,322
Less: accumulated depreciation	(557,744)	(537,941)
Property, Plant And Equipment, Net	513,481	534,381
Depreciation	59,500	66,400	$ 61,400
Land [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	41,774	42,041
Building [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	287,544	284,146
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	86,793	88,549
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	136,995	128,008
Computer Systems and Software [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	232,108	258,981
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	33,797	33,565
Construction in Progress [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	23,037	22,923
Leased Equipment
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 229,177	$ 214,109

Leases (Narrative) (Details)

Leases (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Lessor, Lease, Description [Line Items]
Lesse lease term	10 years
Lessee lease renewal term	5 years
Lessee lease termination period	1 year
Variable operating lease income	$ 31.6	$ 9.5	$ 10.4
Fixed operating lease income	3	4.2	$ 3.7
Unguaranteed residual value of sales-type leases	$ 1.1	$ 0.8
Minimum [Member]
Lessor, Lease, Description [Line Items]
Lessor lease term	4 years
Lessor lease renewal term	1 year
Maximum [Member]
Lessor, Lease, Description [Line Items]
Lessor lease term	10 years
Lessor lease renewal term	5 years

Leases (Lease Cost Components)

Leases (Lease Cost Components) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Leases [Abstract]
Operating lease cost	$ 17,260	$ 19,261	$ 23,570
Variable lease cost	1,560	755	1,175
Total lease cost	$ 18,820	$ 20,016	$ 24,745

Leases (Supplemental Cash Flow

Leases (Supplemental Cash Flow Information Schedule) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 16,957	$ 19,173	$ 22,043
Right-of-use assets obtained in exchange for lease obligations:
Operating lease liabilities	$ 1,737	$ 5,225	$ 34,198

Leases (Supplemental Balance Sh

Leases (Supplemental Balance Sheet Information Schedule) (Details)	Sep. 30, 2022	Sep. 24, 2021
Operating Leases
Weighted-average remaining lease term	5 years 6 months	5 years 9 months 18 days
Weighted-average discount rate	3.20%	3.10%

Leases (Maturities of Lessee Le

Leases (Maturities of Lessee Lease Liabilities Schedule) (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Operating Lease After Adoption of 842
Fiscal 2023	$ 15,995
Fiscal 2024	12,529
Fiscal 2025	9,097
Fiscal 2026	5,957
Fiscal 2027	4,638
Thereafter	12,240
Total undiscounted lease payments	60,456
Less: imputed interest	(9,514)
Total lease liabilities	$ 50,942

Leases (Maturities of Lessor Le

Leases (Maturities of Lessor Lease Payments Schedule) (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Lessor, Operating Lease, Payments, Fiscal Year Maturity [Abstract]
Fiscal 2023	$ 767
Fiscal 2024	787
Fiscal 2025	807
Fiscal 2026	732
Fiscal 2027	0
Thereafter	0
Total undiscounted cash flows	3,093
Sales-type and Direct Financing Leases, Lease Receivable, Fiscal Year Maturity [Abstract]
Fiscal 2023	1,595
Fiscal 2024	795
Fiscal 2025	395
Fiscal 2026	395
Fiscal 2027	0
Thereafter	0
Total undiscounted cash flows	3,180
Less: present value of lease payments (recognized as lease receivables)	(2,801)
Difference	$ 379

Goodwill & Intangible Assets (D

Goodwill & Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Finite-Lived Intangible Assets [Line Items]
Goodwill, Acquired During Period	$ 31,695	$ 3,345
Goodwill [Roll Forward]
Goodwill	340,694	336,945
Goodwill, Translation and Purchase Accounting Adjustments	(7,185)	404
Measurement period adjustments	(57)
Goodwill	365,147	340,694	$ 336,945
Finite-Lived Intangible Assets, Net [Abstract]
Cost	444,737	432,074
Accumulated Amortization	(332,472)	(309,184)
Net	112,265	122,890
Payments to acquire intangible assets	11,500
Amortization of intangible assets	29,000	29,500	$ 29,500
Acquired patents and technology
Finite-Lived Intangible Assets, Net [Abstract]
Cost	355,622	343,280
Accumulated Amortization	(253,080)	(233,789)
Net	102,542	109,491
Customer relationships
Finite-Lived Intangible Assets, Net [Abstract]
Cost	66,142	65,822
Accumulated Amortization	(56,572)	(52,730)
Net	9,570	13,092
Other intangibles
Finite-Lived Intangible Assets, Net [Abstract]
Cost	22,973	22,972
Accumulated Amortization	(22,820)	(22,665)
Net	$ 153	$ 307

Goodwill & Intangible Assets -

Goodwill & Intangible Assets - Future Amortization of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2016	$ 26,057
2017	23,930
2018	8,860
2019	7,969
2020	7,285
Thereafter	38,164
Net	$ 112,265	$ 122,890

Stockholders' Equity And Stoc_3

Stockholders' Equity And Stock-Based Compensation (Narrative) (Details) - USD ($)

12 Months Ended

41 Months Ended

Dec. 15, 2020

Dec. 16, 2019

Dec. 15, 2018

Dec. 15, 2017

Dec. 15, 2016

Sep. 30, 2022

Sep. 24, 2021

Sep. 25, 2020

Mar. 28, 2014

Aug. 31, 2022

Feb. 28, 2022

Dec. 15, 2021

Jul. 29, 2021

Jul. 31, 2019

Jul. 25, 2018

Jan. 25, 2017

Oct. 31, 2014

Feb. 29, 2012

Jul. 31, 2011

Jul. 31, 2010

Nov. 30, 2009

Stockholders' Equity And Stock-Based Compensation [Line Items]

Options outstanding to purchase

4,577,000

Estimated forfeiture rate, percent

8.63%

8.85%

9.74%

Tax benefit

$ 17,581,000

$ 15,790,000

$ 14,090,000

Stock authorized for repurchase

2,950,000,000

$ 250,000,000

Remaining authorization to purchase additional shares

$ 360,900,000

Class A Common Stock [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Common stock, shares authorized (shares)

500,000,000

500,000,000

Common stock, shares issued (shares)

59,798,862

64,986,316

Class B Common Stock [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Common stock, shares authorized (shares)

500,000,000

500,000,000

Common stock, shares issued (shares)

36,085,779

36,086,779

2005 Stock Plan. [Member] | Class A Common Stock [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Shares authorized under plan

55,000,000

Options vested and exercisable

3,091,000

Options outstanding to purchase

4,059,000

Awards Granted Under 2005 Stock Plan Prior To February 2011 [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Terms for issuance of stock

2

Awards Granted Under 2005 Stock Plan From February 2011 [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Terms for issuance of stock

1.6

Employee Stock Purchase Plan [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Percentage of compensation withheld by employees to purchase common stock

10%

Common stock purchase price determined over percentage of closing price

15%

Employee Stock Purchase Plan [Member] | Class A Common Stock [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Maximum value of common stock available for eligible employees

$ 25,000

Maximum number of common stock available for eligible employees

1,000

Share-based Compensation Arrangement by Share-based Payment Award, Purchase Period

6 months

Share-based Compensation Arrangement by Share-based Payment Award, Look Back Commencement Period

1 year

Additional Stock Approved [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Stock authorized for repurchase

$ 350,000,000

$ 250,000,000

$ 350,000,000

$ 350,000,000

$ 350,000,000

$ 200,000,000

$ 200,000,000

$ 100,000,000

$ 250,000,000

$ 300,000,000

Employee Stock Option [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Stock options expected to vest

$ 13,400,000

Employee stock options expected to be recognized over a weighted-average period

2 years 3 months 18 days

Employee Stock Option [Member] | Options Granted From June 2008 [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Options vesting period

4 years

Percentage of stock option becoming exercisable subjected to date of grant

25%

Performance-Based Stock Options [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Options vesting period

3 years

Performance-Based Stock Options [Member] | Minimum [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Percentage Of target award

0%

Performance-Based Stock Options [Member] | Maximum [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Percentage Of target award

125%

Restricted Stock Units [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Stock options expected to vest

$ 190,800,000

Employee stock options expected to be recognized over a weighted-average period

2 years 4 months 24 days

Performance-Based Restricted Stock Units [Member] | Minimum [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Percentage Of target award

0%

Performance-Based Restricted Stock Units [Member] | Maximum [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Percentage Of target award

200%

Employee Stock [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Tax benefit

$ 0

$ 1,200,000

$ 0

Executive Officer [Member] | Performance-Based Stock Options [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Percentage Of target award

75%

96%

95%

Grants in Period, Gross

241,100

264,000

276,199

Number of Exercisable Options

158,700

253,440

240,539

Options outstanding to purchase

424,249

Executive Officer [Member] | Performance-Based Restricted Stock Units [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Percentage Of target award

200%

200%

200%

Number of Exercisable Options

132,276

124,000

Options outstanding to purchase

66,138

62,000

162,846

60,301

Employee and Officer [Member] | Restricted Stock Units [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Options vesting period

4 years

Awards Granted Prior to November 2010 [Member] | Director [Member] | Restricted Stock Units [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Options vesting period

1 year

Share-based Payment Arrangement, Tranche Two | Employee Stock Option [Member] | Options Granted From June 2008 [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Options vesting period

36 months

Vesting Shares At 200% Of The Target Award Amount | Executive Officer [Member] | Performance-Based Restricted Stock Units [Member]

Stockholders' Equity And Stock-Based Compensation [Line Items]

Options outstanding to purchase

325,692

Stockholders' Equity And Stoc_4

Stockholders' Equity And Stock-Based Compensation (Summary Of Stock Options Issued To Officers, Directors, And Employees Under 2000 Stock Incentive Plan And 2005 Stock Plan) (Details) - USD ($) $ / shares in Units, $ in Thousands				12 Months Ended
	Dec. 15, 2018	Dec. 15, 2017	Dec. 15, 2016	Sep. 30, 2022
Shares
Options outstanding at September 25, 2021				4,577,000
Grants				369,000
Exercises				(766,000)
Forfeitures and cancellations				(121,000)
Options vested and expected to vest at September 30, 2022				3,912,000
Weighted-Average Exercise Price
Options outstanding at September 25, 2021				$ 59.18
Grants				88.37
Exercises				52.88
Forfeitures and cancellations				73.58
Options outstanding at September 30, 2022				62.59
Options vested and expected to vest at September 30, 2022				62.15
Options exercisable at September 30, 2022				$ 57.16
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Contractual Life, Options vested and expected to vest at September 28, 2012				5 years 4 months 9 days
Weighted Average Remaining Contractual Life, Options exercisable				4 years 7 months 6 days
Aggregate Intrinsic Value, Options outstanding				$ 29,902
Aggregate Intrinsic Value, Options vested and expected to vest				29,896
Aggregate Intrinsic Value, Options exercisable				$ 29,690
Year End Stock Price				$ 65.15
Two Thousand Five Stock Plan Member | Common Class A [Member]
Shares
Options outstanding at September 30, 2022				4,059,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Remaining Contractual Life, Options outstanding				5 years 5 months 1 day
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number				3,091,000
Awards Granted Under 2005 Stock Plan Prior To February 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Terms for issuance of stock				2
Awards Granted Under 2005 Stock Plan From February 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Terms for issuance of stock				1.6
Employee Stock Option [Member] | Options Granted From June 2008 [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options maximum vesting period, months				4 years
Share Based Compensation Arrangement By Share Based Payment Award Options Becoming Exercisable				25%
Performance-Based Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options maximum vesting period, months				3 years
Performance-Based Stock Options [Member] | Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grants in Period, Gross	241,100	264,000	276,199
Shares
Options outstanding at September 30, 2022				424,249

Stockholders' Equity And Stoc_5

Stockholders' Equity And Stock-Based Compensation (Summary Of Restricted Stock Units Issued To Officers, Directors, And Employees Under 2005 Stock Incentive Plan) (Details) shares in Thousands	12 Months Ended
	Sep. 30, 2022 $ / shares shares
Shares
Non-vested at September 24, 2021 | shares	3,335
Granted | shares	1,737
Vested | shares	(1,205)
Forfeitures | shares	(365)
Non-vested at September 30, 2022 | shares	3,502
Weighted-Average Grant Date Fair Value
Non-vested at September 24, 2021 | $ / shares	$ 77.46
Granted | $ / shares	86.42
Vested | $ / shares	72.92
Forfeitures | $ / shares	81.10
Non-vested at September 30, 2022 | $ / shares	$ 83.09

Stockholders' Equity And Stoc_6

Stockholders' Equity And Stock-Based Compensation (RSU Vest Date Fair Value) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Stockholders' Equity And Stock-Based Compensation [Abstract]
Restricted stock units - vest date fair value	$ 106,919	$ 101,108	$ 72,426

Stockholders' Equity And Stoc_7

Stockholders' Equity And Stock-Based Compensation (Schedule Of Fair Value Of Stock-Based Awards Estimated Using Weighted-Average Assumptions) (Details)	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Stockholders' Equity And Stock-Based Compensation [Abstract]
Expected life (in years)	4 years 9 months 10 days	4 years 10 months 17 days	4 years 10 months 28 days
Risk-free interest rate	1.50%	0.40%	1.60%
Expected stock price volatility	28.80%	28.50%	24.20%
Dividend yield	1.10%	1.10%	1.30%

Stockholders' Equity And Stoc_8

Stockholders' Equity And Stock-Based Compensation (Summary Of Weighted-Average Fair Value Of Stock Options Granted And Total Intrinsic Value Of Stock Options Exercised) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Stockholders' Equity And Stock-Based Compensation [Abstract]
Weighted-average fair value at date of grant	$ 21.17	$ 20.93	$ 13.76
Intrinsic value of options exercised	$ 22,885	$ 102,812	$ 47,267

Stockholders' Equity And Stoc_9

Stockholders' Equity And Stock-Based Compensation (Forfeiture Rates) (Details)	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Stockholders' Equity And Stock-Based Compensation [Abstract]
Estimated forfeiture rate, percent	8.63%	8.85%	9.74%

Stockholders' Equity And Sto_10

Stockholders' Equity And Stock-Based Compensation (Schedule Of Stock-Based Compensation Expense By Plan) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Stockholders' Equity And Stock-Based Compensation [Line Items]
Allocated Share-based Compensation Expense	$ 114,925	$ 99,698	$ 86,628
Share based compensation expense	114,925	99,698	86,628
Benefit from income taxes	(17,581)	(15,790)	(14,090)
Allocated Share-based Compensation Expense, Net of Tax	97,344	83,908	72,538
Stock Option [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share based compensation expense	10,244	13,724	16,718
Restricted Stock Units [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share based compensation expense	98,433	80,705	65,235
Capitalized stock-based compensation	700
Employee Stock Purchase Plan [Member]
Stockholders' Equity And Stock-Based Compensation [Line Items]
Share based compensation expense	$ 6,248	$ 5,269	$ 4,675

Stockholders' Equity And Sto_11

Stockholders' Equity And Stock-Based Compensation (Schedule of Stock-Based Compensation By Classification) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 114,925	$ 99,698	$ 86,628
Benefit from income taxes	(17,581)	(15,790)	(14,090)
Allocated Share-based Compensation Expense, Net of Tax	97,344	83,908	72,538
Cost of products and services [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	1,819	2,033	2,072
Research and development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	37,061	29,733	25,634
Sales and marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	41,326	36,432	31,915
General and administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 34,719	$ 31,500	$ 27,007

Stockholders' Equity And Sto_12

Stockholders' Equity And Stock-Based Compensation (Stock Repurchase) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended				12 Months Ended
	Sep. 30, 2022	Jul. 01, 2022	Apr. 01, 2022	Dec. 31, 2021	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020	Aug. 31, 2022	Feb. 28, 2022	Jul. 29, 2021	Jul. 31, 2019	Jul. 25, 2018	Jan. 25, 2017	Oct. 31, 2014	Feb. 29, 2012	Jul. 31, 2011	Jul. 31, 2010	Nov. 30, 2009
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Repurchase Program, Authorized Amount	$ 2,950,000				$ 2,950,000													$ 250,000
Shares repurchased (in shares)	2,928,536	2,549,474	1,116,032	408,508	7,002,550
Cost	$ 220,000	$ 190,000	$ 84,913	$ 35,573	$ 530,486	$ 245,864	$ 173,742
Average Price Paid per Share (in dollars per share)	$ 75.12	$ 74.53	$ 76.08	$ 87.08	$ 75.12
Additional Stock Approved [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Repurchase Program, Authorized Amount								$ 350,000	$ 250,000	$ 350,000	$ 350,000	$ 350,000	$ 200,000	$ 200,000	$ 100,000	$ 250,000	$ 300,000

Stockholders' Equity And Sto_13

Stockholders' Equity And Stock-Based Compensation Stockholders' Equity And Stock- Based Compensation - Dividends Declared (Details) - USD ($) $ / shares in Units, $ in Millions

12 Months Ended

Dec. 08, 2022

Nov. 17, 2022

Aug. 31, 2022

Aug. 09, 2022

May 25, 2022

May 05, 2022

Feb. 23, 2022

Feb. 03, 2022

Sep. 30, 2022

Sep. 24, 2021

Sep. 25, 2020

Dividends Payable [Line Items]

Cash dividend declared per common share

$ 0.25

$ 0.25

$ 0.25

$ 1.02

$ 0.91

$ 0.88

Dividends

$ 24.3

$ 25.1

$ 25.3

Subsequent Event [Member]

Dividends Payable [Line Items]

Cash dividend declared per common share

[1]

$ 0.27

Dividends

[1]

$ 25.9

[1]The dividend payment amount for the dividend declared in the fourth quarter of fiscal 2022 is estimated based on the number of shares of our Class A and Class B common stock that we estimate will be outstanding as of the Record Date.

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands		12 Months Ended
		Sep. 30, 2022		Sep. 24, 2021
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance		$ (10,030)		$ (10,594)
Other Comprehensive Income (Loss), before Reclassifications, before Tax		(9,371)		(13,621)
Income tax effect - benefit/(expense)		201		34
Net of tax		(40,371)		(7,833)
Realized gains/(losses)	[1]	(1,570)		9,243
Income tax effect - benefit/(expense)	[2]	330		(846)
Net of tax		(1,240)		8,397
Net current-period other comprehensive income/(loss)		(41,611)		564
Ending Balance		(51,641)		(10,030)
Investment Securities
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance		220		818
Other Comprehensive Income (Loss), before Reclassifications, before Tax		(6,783)		(917)
Income tax effect - benefit/(expense)		52		120
Net of tax		(6,731)		(797)
Realized gains/(losses)	[1]	527		211
Income tax effect - benefit/(expense)	[2]	(2)		(12)
Net of tax		525		199
Net current-period other comprehensive income/(loss)		(6,206)		(598)
Ending Balance		(5,986)		220
Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance		(122)
Other Comprehensive Income (Loss), before Reclassifications, before Tax		(2,588)		(12,704)
Income tax effect - benefit/(expense)		(8)		415
Net of tax		(2,596)		(12,289)
Realized gains/(losses)		(2,097)	[1]	9,032
Income tax effect - benefit/(expense)		332		(834)
Net of tax		(1,765)		8,198
Net current-period other comprehensive income/(loss)		(4,361)		(4,091)
Ending Balance		(4,483)		(122)
Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax [Roll Forward]
Beginning Balance		(10,128)		(15,381)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	[1]	(30,799)		5,754
Income tax effect - benefit/(expense)		(245)		(501)
Net of tax		(31,044)		5,253
Net current-period other comprehensive income/(loss)		(31,044)		5,253
Ending Balance		$ (41,172)		$ (10,128)
[1]Realized gains or losses, if any, from the sale of our AFS investment securities or from foreign currency translation adjustments are included within other income/(expense), net in our consolidated statements of operations[2]The income tax benefit or expense is included within provision for income taxes in our consolidated statements of operations.

Per Share Data (Details)

Per Share Data (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Net income attributable to Dolby Laboratories, Inc.	$ 184,087	$ 310,227	$ 231,363
Weighted Average Number of Shares Outstanding, Basic	99,990	101,190	100,564
Potential common shares from options to purchase Class A and Class B common stock	958	1,994	1,400
Potential common shares from restricted stock units	912	1,376	941
Weighted Average Number of Shares Outstanding, Diluted	101,983	104,622	102,944
Basic (usd per share)	$ 1.84	$ 3.07	$ 2.30
Net income per share attributable to Dolby Laboratories, Inc. - Diluted	$ 1.81	$ 2.97	$ 2.25
Incremental Common Shares Attributable To Employee Stock Purchase Plan	123	62	39
Employee Stock [Member]
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Anti-dilutive securities, excluded from calculations	0	2	1
Employee Stock Option [Member]
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Anti-dilutive securities, excluded from calculations	587	235	3,209
Restricted Stock Units [Member]
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Anti-dilutive securities, excluded from calculations	1,158	48	2

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020	Sep. 27, 2019
Tax Credit Carryforward [Line Items]
Foreign earnings repatriated	$ 175,000
Undistributed earnings of foreign subsidiaries	207,000
Net operating loss carryovers for federal tax purposes	2,600
Net operating loss carryovers for California tax purposes	5,600
NOL's not subject to expiration	7,700
R&D tax credit carryforwards	19,800
Valuation allowance, deferred tax assets, california	31,700
Valuation Allowance recorded against federal foreign tax credit deferred tax assets	2,900
Valuation allowance, deferred tax assets, foreign	$ 6,500
Effective tax rate	14.60%	10.30%	3.40%
Provision for income taxes	$ 31,381	$ 36,689	$ 8,096
Unrecognized tax benefits, gross	69,682	66,106	$ 60,691	$ 108,539
Unrecognized tax benefits if recognized, would affect our effective tax rate	44,000
Increase in interest expense for current tax provision	1,700	$ 1,000
Foreign Tax Credit Carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforward	16,400
California Research Tax Credit Carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforward	40,600
Research Tax Credit Carryforward
Tax Credit Carryforward [Line Items]
Tax credit carryforward	$ 4,000

Income Taxes (Components Of Inc

Income Taxes (Components Of Income Before Provision For Income Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Income Tax Disclosure [Abstract]
U.S.	$ 33,318	$ 104,741	$ 32,426
Foreign	181,961	249,771	207,289
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$ 215,279	$ 354,512	$ 239,715

Income Taxes (Schedule Of Provi

Income Taxes (Schedule Of Provision For Income Taxes ) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Current:
Federal	$ 2,008	$ 7,216	$ (48,517)
State	553	953	735
Foreign	58,285	65,568	61,153
Total current	60,846	73,737	13,371
Deferred:
Federal	(29,990)	(36,035)	(4,674)
State	8	(63)	(111)
Foreign	517	(950)	(490)
Total deferred	(29,465)	(37,048)	(5,275)
Provision for income taxes	$ 31,381	$ 36,689	$ 8,096

Income Taxes (Summary Of Tax Ef

Income Taxes (Summary Of Tax Effects Of The Temporary Differences Between Carrying Amounts And Amounts Used For Tax) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Income Tax Disclosure [Abstract]
Investments	$ 1,339	$ 1,439
Inventories	6,851	6,551
Net operating loss	2,507	3,305
Accrued expenses	11,536	17,686
Stock-based compensation	17,295	16,926
Revenue recognition	4,275	4,245
Depreciation and amortization	105,114	81,963
Lease liability	10,589	15,377
Research and development credits	40,149	31,635
Foreign tax credits	21,244	12,793
Deferred Tax Assets, Unrealized Currency Losses	10,724	9,788
Other	5,657	4,801
Total gross deferred income tax assets	237,280	206,509
Less: valuation allowance	(41,087)	(33,284)
Total deferred income tax assets	196,193	173,225
Right of use asset	(10,046)	(14,288)
Intangibles	(2,579)	(2,917)
Deferred income tax assets, net	183,568	$ 156,020
Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration	7,700
Deferred Tax Assets, Tax Credit Carryforwards, Research	$ 19,800

Income Taxes (Reconciliation Of

Income Taxes (Reconciliation Of Federal Statutory Tax Rate To Our Effective Tax Rate) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020	Sep. 27, 2019
Income Tax Disclosure [Abstract]
Federal statutory rate	21%	21%	21%
State income taxes, net of federal effect	0.20%	0.20%	0.20%
Stock-based compensation expense rate			(2.20%)
Stock-based compensation expense rate	(0.10%)	(5.10%)
Research and development tax credits	(5.00%)	(2.60%)	(3.00%)
Tax exempt interest	(2.30%)	(2.20%)	(2.20%)
U.S. tax on foreign entities	1.80%	0.80%	3.10%
Foreign rate differential	(1.80%)	(3.40%)	(1.80%)
Audit settlements	2.80%	2%	(12.90%)
Other	(2.00%)	(0.40%)	1.20%
Effective tax rate	14.60%	10.30%	3.40%
Unrecognized Tax Benefits	$ 69,682	$ 66,106	$ 60,691	$ 108,539
Unrecognized tax benefits if recognized, would affect our effective tax rate	$ 44,000

Income Taxes (Aggregate Changes

Income Taxes (Aggregate Changes In Balance Of Gross Unrecognized Tax Benefits, Excluding Interest And Penalties) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Income Tax Disclosure [Abstract]
Unrecognized tax benefits if recognized, would affect our effective tax rate	$ 44,000
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized Tax Benefits, Beginning Balance	66,106	$ 60,691	$ 108,539
Increases in balances related to tax positions taken during prior years	822	220	5,504
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions	(178)	(247)	0
Increases in balances related to tax positions taken during the current year	7,784	6,979	7,509
Settlements	0	(875)	(37)
Lapse of statute of limitations	(4,852)	(662)	(60,824)
Unrecognized Tax Benefits, Ending Balance	$ 69,682	$ 66,106	$ 60,691

Income Taxes (Interest and Pena

Income Taxes (Interest and Penalties on Unrecognized Tax Benefits) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Income Tax Disclosure [Abstract]
Accrued interest	$ 6,748	$ 5,030
Accrued penalties	119	47
Total	$ 6,867	$ 5,077

Restructuring (Summary of Chang

Restructuring (Summary of Changes in Restructuring Accruals) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance	$ 167	$ 0
Restructuring charges	10,623	10,240	$ 1,821
Cash payments	(5,009)	(10,073)
Restructuring reserve, ending balance	5,781	167	0
Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance	163	0
Restructuring charges	8,874	9,522
Cash payments	(3,256)	(9,359)
Restructuring reserve, ending balance	5,781	163	0
Facility Closing [Member]
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance	4	0
Restructuring charges	1,749	718
Cash payments	(1,753)	(714)
Restructuring reserve, ending balance	$ 0	$ 4	$ 0

Commitments And Contingencies_2

Commitments And Contingencies (Schedule Of Contractual Obligations And Commitments) (Details) $ in Thousands	12 Months Ended
	Sep. 30, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Naming rights, Fiscal 2021	$ 12,474
Naming rights, Fiscal 2022	12,794
Naming rights, Fiscal 2023	13,126
Naming rights, Fiscal 2024	13,472
Naming rights, Fiscal 2025	8,534
Naming rights, Thereafter	44,316
Naming rights, Total	104,716
Purchase obligations
Purchase Obligation, Fiscal 2021	28,228
Purchase Obligation, Fiscal 2022	8,425
Purchase Obligation, Fiscal 2023	1,270
Purchase Obligation, Fiscal 2024	252
Purchase Obligation, Fiscal 2025	0
Purchase Obligation, Thereafter	0
Unrecorded Unconditional Purchase Obligation	38,175
Donation commitments
Donation commitments, Fiscal 2021	1,797
Donation commitments, Fiscal 2022	116
Donation commitments, Fiscal 2023	116
Donation commitments, Fiscal 2024	116
Donation commitments, Fiscal 2025	86
Donation commitments, Thereafter	417
Donation commitments, Total	2,648
Total
Total, due in Fiscal 2021	42,499
Total, due in Fiscal 2022	21,335
Total, due in Fiscal 2023	14,512
Total, due in Fiscal 2024	13,840
Total, due in Fiscal 2025	8,620
Total, due Thereafter	44,733
Total due	$ 145,539
Naming Rights
Other Commitments [Line Items]
Term of agreement	20 years
Donation Commitments
Other Commitments [Line Items]
Term of agreement	15 years

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Thousands		12 Months Ended
	Jan. 31, 2022	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Business Acquisition [Line Items]
Total purchase consideration		$ 38,171	$ 4,500	$ 0
Goodwill		$ 365,147	$ 340,694	$ 336,945
Millicast, Inc.
Business Acquisition [Line Items]
Total purchase consideration	$ 38,800
Identifiable intangible assets	8,700
Goodwill	$ 31,700
Millicast, Inc. | Minimum [Member]
Business Acquisition [Line Items]
Weighted-average useful life	1 year 6 months
Millicast, Inc. | Maximum [Member]
Business Acquisition [Line Items]
Weighted-average useful life	8 years

Operating Segments and Geogra_3

Operating Segments and Geographic Data (Revenue By Geographic Region) (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenue from contract with customer	$ 1,253,793	$ 1,281,256	$ 1,161,792
United States
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenue from contract with customer	$ 468,246	$ 419,901	460,972
International
Segment Reporting, Revenue Reconciling Item [Line Items]
Revenue from contract with customer			$ 700,820

Operating Segments and Geogra_4

Operating Segments and Geographic Data (Schedule Of Concentration Of Revenue From Individual Geographic Regions) (Details)	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Revenue from External Customer [Line Items]
Document Period End Date	Sep. 30, 2022
Concentration of revenue from individual geographic regions	100%	100%	100%
United States
Revenue from External Customer [Line Items]
Concentration of revenue from individual geographic regions	37%	33%	40%
South Korea [Member]
Revenue from External Customer [Line Items]
Concentration of revenue from individual geographic regions	13%	14%	12%
China [Member]
Revenue from External Customer [Line Items]
Concentration of revenue from individual geographic regions	20%	23%	20%
Japan [Member]
Revenue from External Customer [Line Items]
Concentration of revenue from individual geographic regions	8%	11%	9%
Europe [Member]
Revenue from External Customer [Line Items]
Concentration of revenue from individual geographic regions	10%	10%	10%
Other [Member]
Revenue from External Customer [Line Items]
Concentration of revenue from individual geographic regions	12%	9%	9%

Operating Segments and Geogra_5

Operating Segments and Geographic Data (Schedule Of Long-Lived Assets, Net Of Accumulated Depreciation, By Geographic Region) (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Sep. 24, 2021
Revenues from External Customers and Long-Lived Assets [Line Items]
Total long-lived tangible assets, net of accumulated depreciation	$ 513,481	$ 534,381
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	415,493	432,968
International
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-lived assets	$ 97,988	$ 101,413

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($) $ in Thousands	12 Months Ended
	Sep. 30, 2022	Sep. 24, 2021	Sep. 25, 2020
Related Party Transaction [Line Items]
Restructuring charges	$ 10,623	$ 10,240	$ 1,821
Distribution to controlling interest	1,435	7,362	283
Operating Expense
Related Party Transaction [Line Items]
Related party rent expense	$ 0	$ (392)	$ 126
Dolby Properties Burbank, LLC
Related Party Transaction [Line Items]
Ownership interest (percent)	49%
Dolby Properties, LP
Related Party Transaction [Line Items]
Ownership interest (percent)	10%

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Jun. 25, 2021	Sep. 30, 2022	Sep. 24, 2021
Pension and Other Postretirement Benefits Cost (Reversal of Cost) [Abstract]
Document Period End Date		Sep. 30, 2022
Retirement plan expenses	$ 25,257	$ 27,378	$ 26,379